Disease on EC 3.1.1.8 - cholinesterase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Abortion, Spontaneous
Butyrylcholinesterase activity and lymphocyte subpopulations in peripheral blood of Kuwaiti women experiencing recurrent spontaneous abortion.
Abortion, Spontaneous
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
Abortion, Spontaneous
[BEHAVIOR OF THE CHOLINESTERASE ACTIVITY IN THE BLOOD AND IN PLACENTAL TISSUE DURING THE 1ST MONTHS OF PHYSIOLOGICAL PREGNANCY AND IN SPONTANEOUS ABORTIONS.]
Abortion, Threatened
[Changes in the concentration of copper and ceruloplasmin, and cholinesterase activity in the blood in threatened abortion]
acetylcholinesterase deficiency
[Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation]
Acidosis
Chronotropic and dromotropic actions of acetylcholine on the developing fetal heart.
Acidosis
Organophosphate poisoning: modifications in acid base equilibrium and use of sodium bicarbonate as an aid in the treatment of toxicity in dogs.
Acidosis
Suspected chlorpyrifos toxicosis in a llama, and plasma pseudocholinesterase activity in llamas given chlorpyrifos.
Acidosis, Lactic
Acute toxicity of methyl isocyanate in mammals. II. Induction of hyperglycemia, lactic acidosis, uraemia, and hypothermia in rats.
Acne Vulgaris
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2?years of age - a multicenter retrospective study.
Acquired Immunodeficiency Syndrome
Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients.
Acquired Immunodeficiency Syndrome
Concentrations of magnesium, zinc and copper in serum of patients with acquired immuno-deficiency syndrome.
Acquired Immunodeficiency Syndrome
[Research on risk factors of short-term outcome in AIDS patients with pneumocystis pneumonia].
Acromegaly
The evaluation of hypothalamic somatostatin tone using pyridostigmine and thyrotropin releasing hormone in patients with acromegaly.
Acute Coronary Syndrome
Butyrylcholinesterase Activity Predicts Long-Term Survival in Patients with Coronary Artery Disease.
Acute Coronary Syndrome
Butyrylcholinesterase predicts cardiac mortality in young patients with acute coronary syndrome.
Acute Coronary Syndrome
Low Serum-Butyrylcholinesterase Activity as a Prognostic Marker of Mortality Associates with Poor Cardiac Function in Acute Myocardial Infarction.
Acute Kidney Injury
Activation of ?7 Nicotinic Acetylcholine Receptor Ameliorates Zymosan-Induced Acute Kidney Injury in BALB/c Mice.
Acute Kidney Injury
Clinical characteristics and outcomes of critically ill COVID-19 patients in Sfax, Tunisia.
Acute Kidney Injury
Predictors of Morbidity and Mortality in Organophosphorus Poisoning: A Case Study in Rural Hospital in Karnataka, India.
Adenocarcinoma
HER-2 amplification but not butyrylcholinesterase multability reflects aggressiveness of European-originated ovarian tumors.
Adenocarcinoma
Production of butyrylcholinesterase by Caco-2 cells: lack of relationship with triglyceride production.
Adrenocortical Hyperfunction
Serum paraoxonase 1 and butyrylcholinesterase in dogs with hyperadrenocorticism.
Aggressive Periodontitis
Determination of pseudocholinesterase activity in the gingival crevicular fluid, saliva, and serum from patients with juvenile periodontitis and rapidly progressive periodontitis.
Airway Obstruction
Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing.
Airway Obstruction
[Emergency from anesthesia in small children. From laryngospasm to prolonged apnea]
Alcohol Withdrawal Delirium
[Proceedings: Relationship of serum cholinesterase level in chronic alcoholic liver disease and appearance of delirium tremens: therapeutic effect of oximes]
Alopecia
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Alzheimer Disease
"Clicking" fragment leads to novel dual-binding cholinesterase inhibitors.
Alzheimer Disease
"Value for money" in treating Alzheimer's disease with the new cholinesterase inhibitors.
Alzheimer Disease
(±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3? Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease.
Alzheimer Disease
1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
Alzheimer Disease
1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases.
Alzheimer Disease
2-Hydroxy-N-phenylbenzamides and Their Esters Inhibit Acetylcholinesterase and Butyrylcholinesterase.
Alzheimer Disease
6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.
Alzheimer Disease
9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Alzheimer Disease
9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model.
Alzheimer Disease
A 12-month study of the efficacy of rivastigmine in patients with advanced moderate Alzheimer's disease.
Alzheimer Disease
A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease.
Alzheimer Disease
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.
Alzheimer Disease
A case history illustrating how extended release cholinesterase inhibitors could improve management of Alzheimer's disease.
Alzheimer Disease
A Case Report on Dyskinesia Following Rivastigmine Patch 13.3 mg/24 hours for Alzheimer's Disease: Perspective in the Movement Disorders Spectrum Following Use of Cholinesterase Inhibitors.
Alzheimer Disease
A case with cholinesterase inhibitor responsive asymmetric posterior cortical atrophy.
Alzheimer Disease
A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease.
Alzheimer Disease
A double-blind crossover pilot study of l-deprenyl (selegiline) combined with cholinesterase inhibitor in Alzheimer's disease.
Alzheimer Disease
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
Alzheimer Disease
A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease.
Alzheimer Disease
A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques.
Alzheimer Disease
A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study.
Alzheimer Disease
A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy.
Alzheimer Disease
A modified binary particle swarm optimization with a machine learning algorithm and molecular docking for QSAR modelling of cholinesterase inhibitors.
Alzheimer Disease
A molecular modeling study of components of the ginger (Zingiber officinale) extract inside human butyrylcholinesterase: implications for Alzheimer disease.
Alzheimer Disease
A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
Alzheimer Disease
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group.
Alzheimer Disease
A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing.
Alzheimer Disease
A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesterase.
Alzheimer Disease
A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase.
Alzheimer Disease
A new way of data interpretation for cognition tests in rats used to characterise six choline esterase inhibitors with heterocyclic nitrogen bridgehead structure. Application in Alzheimer therapy.
Alzheimer Disease
A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor.
Alzheimer Disease
A novel series of tacrine-selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer's disease.
Alzheimer Disease
A palliative care perspective on deprescribing cholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
A patent review of butyrylcholinesterase inhibitors and reactivators 2010-2017.
Alzheimer Disease
A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer's disease.
Alzheimer Disease
A Platform for Screening Potential Anticholinesterase Fractions and Components Obtained from Anemarrhena asphodeloides Bge for Treating Alzheimer's Disease.
Alzheimer Disease
A population-based study of dosing and persistence with anti-dementia medications.
Alzheimer Disease
A potent and selective tacrine analog--biomembrane permeation and physicochemical characterization.
Alzheimer Disease
A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.
Alzheimer Disease
A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease.
Alzheimer Disease
A Randomized Phase I Study of Methanesulfonyl Fluoride, an Irreversible Cholinesterase Inhibitor, for the Treatment of Alzheimer's Disease.
Alzheimer Disease
A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease.
Alzheimer Disease
A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease Patients.
Alzheimer Disease
A retrospective study of cholinesterase inhibitors for Alzheimer's disease: cerebrovascular disease as a predictor of patient outcomes.
Alzheimer Disease
A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.
Alzheimer Disease
A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease.
Alzheimer Disease
A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease.
Alzheimer Disease
A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia.
Alzheimer Disease
A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease.
Alzheimer Disease
A systematic review of carbohydrate-based bioactive molecules for Alzheimer's disease.
Alzheimer Disease
A systematic review on donepezil-based derivatives as potential cholinesterase inhibitors for Alzheimer's disease.
Alzheimer Disease
A therapeutic approach to cerebrovascular diseases based on indole substituted hydrazides and hydrazines able to interact with human vascular adhesion protein-1, monoamine oxidases (A and B), AChE and BuChE.
Alzheimer Disease
A three-country randomized controlled trial of a psychosocial intervention for caregivers combined with pharmacological treatment for patients with Alzheimer disease: effects on caregiver depression.
Alzheimer Disease
Abhorring the vacuum: use of Alzheimers disease medications in frontotemporal dementia.
Alzheimer Disease
Acetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease.
Alzheimer Disease
Acetylcholinesterase activities and monoamine metabolite levels in the cerebrospinal fluid of patients with Alzheimer's disease.
Alzheimer Disease
Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
Alzheimer Disease
Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation.
Alzheimer Disease
Acetylcholinesterase and butyrylcholinesterase glycoforms are biomarkers of Alzheimer's disease.
Alzheimer Disease
Acetylcholinesterase and butyrylcholinesterase inhibition by nectriapyrone and tryptophol isolated from endophytic fungus Phomopsis sp.
Alzheimer Disease
Acetylcholinesterase and butyrylcholinesterase inhibitory activities of khellactone coumarin derivatives isolated from Peucedanum japonicum Thurnberg.
Alzheimer Disease
Acetylcholinesterase and butyrylcholinesterase inhibitory activity of Pinus species essential oils and their constituents.
Alzheimer Disease
Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease.
Alzheimer Disease
Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer's Disease Therapy.
Alzheimer Disease
Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.
Alzheimer Disease
Acetylcholinesterase inhibitors: SAR and kinetic studies on omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl derivatives.
Alzheimer Disease
Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts.
Alzheimer Disease
Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine.
Alzheimer Disease
Acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibition studies and antioxidant activities of 33 Scutellaria L. taxa from Turkey.
Alzheimer Disease
aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease.
Alzheimer Disease
Acridine-induced subcellular and functional changes in isolated human hepatocytes in vitro.
Alzheimer Disease
Acteylcholinesterase inhibitor rivastigmine enhances cellular defenses in neuronal and macrophage-like cell lines.
Alzheimer Disease
Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.
Alzheimer Disease
Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.
Alzheimer Disease
Activities and kinetic properties of lumbar cerebrospinal fluid cholinesterases in relation to clinical diagnosis, severity, and progression of Alzheimer's disease.
Alzheimer Disease
Acute Effects of Muscarinic M1 Receptor Modulation on A?PP Metabolism and Amyloid-? Levels in vivo: A Microdialysis Study.
Alzheimer Disease
Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: an event-related potential study.
Alzheimer Disease
Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
Alzheimer Disease
Adherence, persistence and continuation with cholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition.
Alzheimer Disease
Advances in the treatment of cognitive impairment in Parkinson's disease.
Alzheimer Disease
Adverse drug events affecting medication persistence with rivastigmine patch application.
Alzheimer Disease
Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.
Alzheimer Disease
Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada.
Alzheimer Disease
Age-dependent association between butyrylcholinesterase K-variant and Alzheimer disease-related neuropathology in human brains.
Alzheimer Disease
Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome.
Alzheimer Disease
Ajmalicine and its Analogues against AChE and BuChE for the Management of Alzheimer's Disease: An In-silico study.
Alzheimer Disease
Alanine-to-threonine substitutions and amyloid diseases: Butyrylcholinesterase as a case study.
Alzheimer Disease
Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease.
Alzheimer Disease
Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.
Alzheimer Disease
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
Alzheimer Disease
Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease.
Alzheimer Disease
Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice.
Alzheimer Disease
Alzheimer Disease: Pharmacologic and Nonpharmacologic Therapies for Cognitive and Functional Symptoms.
Alzheimer Disease
Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?
Alzheimer Disease
Alzheimer's disease in France: too many patients exposed to drug interactions involving cholinesterase inhibitors.
Alzheimer Disease
Alzheimer's Disease Pharmacotherapy in Relation to Cholinergic System Involvement.
Alzheimer Disease
Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Alzheimer Disease
Alzheimer's disease: recent advances in etiology, diagnosis, and management.
Alzheimer Disease
Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies.
Alzheimer Disease
Amelioration of scopolamine-induced amnesia by phosphatidylserine and curcumin in the day-old chick.
Alzheimer Disease
Aminoalcoholate-driven tetracopper(II) cores as dual acetyl and butyrylcholinesterase inhibitors: Experimental and theoretical elucidation of mechanism of action.
Alzheimer Disease
Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
Alzheimer Disease
Amyloid precursor protein 96-110 and beta-amyloid 1-42 elicit developmental anomalies in sea urchin embryos and larvae that are alleviated by neurotransmitter analogs for acetylcholine, serotonin and cannabinoids.
Alzheimer Disease
Amyloid processing and signal transduction properties of antiparkinson-antialzheimer neuroprotective drugs rasagiline and TV3326.
Alzheimer Disease
Amyloid-? peptides act as allosteric modulators of cholinergic signalling through formation of soluble BA?ACs.
Alzheimer Disease
An audit of a specialist old age psychiatry liaison service to a medium and a high secure forensic psychiatry unit.
Alzheimer Disease
An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors.
Alzheimer Disease
An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease.
Alzheimer Disease
An evaluation of neonicotinoids' potential to inhibit human cholinesterases: Protein-ligand docking and interaction profiling studies.
Alzheimer Disease
An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.
Alzheimer Disease
An Overview on Natural Cholinesterase Inhibitors - A Multi-Targeted Drug Class - and Their Mass Production.
Alzheimer Disease
An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease.
Alzheimer Disease
Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K).
Alzheimer Disease
Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
Alzheimer Disease
Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
Alzheimer Disease
Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease.
Alzheimer Disease
Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
Alzheimer Disease
Antagonism of anticholinesterase (DFP) toxicity by donepezil plus scopolamine: a preliminary study.
Alzheimer Disease
Anti-Alzheimer potential, metabolomic profiling and molecular docking of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea aqueous extracts.
Alzheimer Disease
Anti-Alzheimer's disease activity of compounds from the root bark of Morus alba L.
Alzheimer Disease
Anti-Alzheimer's multitarget-directed ligands with serotonin 5-HT6 antagonist, butyrylcholinesterase inhibitory, and antioxidant activity.
Alzheimer Disease
Antibacterial, antioxidant, anti-cholinesterase potential and flavonol glycosides of Biscutella raphanifolia (Brassicaceae).
Alzheimer Disease
Anticholinesterase activity of plastoquinones from Sargassum sagamianum: lead compounds for Alzheimer's disease therapy.
Alzheimer Disease
Anticholinesterase-induced symptoms improved by pacemaker implantation in patients with Alzheimer's disease: analysis of 6 cases.
Alzheimer Disease
Antioxidant activity and acetylcholinesterase inhibition of grape skin anthocyanin (GSA).
Alzheimer Disease
Antioxidant and Cholinesterase Inhibitory Activity of a New Peptide From Ziziphus jujuba Fruits.
Alzheimer Disease
Antioxidant properties of eugenol, butylated hydroxylanisole, and butylated hydroxyl toluene with key biomolecules relevant to Alzheimer's diseases-In vitro.
Alzheimer Disease
Antioxidant, Antidiabetic, and Anticholinesterase Activities and Phytochemical Profile of Azorella glabra Wedd.
Alzheimer Disease
Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
Alzheimer Disease
ApoE genotyping and response to galanthamine in Alzheimer's disease--a real life retrospective study.
Alzheimer Disease
Apolipoprotein ?4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease.
Alzheimer Disease
Aporphines and Alzheimer's disease: Towards a Medical Approach Facing the Future.
Alzheimer Disease
Aporphinoid Alkaloids Derivatives as Selective Cholinesterases Inhibitors: Biological Evaluation and Docking Study.
Alzheimer Disease
Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
Alzheimer Disease
Arylbenzofurans from the Root Bark of Morus alba as Triple Inhibitors of Cholinesterase, ?-Site Amyloid Precursor Protein Cleaving Enzyme 1, and Glycogen Synthase Kinase-3?: Relevance to Alzheimer's Disease.
Alzheimer Disease
Assessment of cholinesterase and tyrosinase inhibitory and antioxidant effects of Hypericum perforatum L. (St. John's wort)
Alzheimer Disease
Assessment of enzyme inhibitory and antioxidant activities of lignans from Taxus baccata L.
Alzheimer Disease
Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK.
Alzheimer Disease
Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.
Alzheimer Disease
Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population.
Alzheimer Disease
Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
Alzheimer Disease
Association between low-density lipoprotein receptor-related protein gene, butyrylcholinesterase gene and Alzheimer' s disease in Chinese.
Alzheimer Disease
Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors.
Alzheimer Disease
Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease.
Alzheimer Disease
Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis.
Alzheimer Disease
Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
Alzheimer Disease
Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial.
Alzheimer Disease
Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
Alzheimer Disease
Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010.
Alzheimer Disease
Axo-axonal interaction in autonomic regulation of the cerebral circulation.
Alzheimer Disease
Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors.
Alzheimer Disease
BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.
Alzheimer Disease
Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
Alzheimer Disease
Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia.
Alzheimer Disease
Benefit-risk considerations in the treatment of dementia with Lewy bodies.
Alzheimer Disease
Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease.
Alzheimer Disease
Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease.
Alzheimer Disease
Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents.
Alzheimer Disease
Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation.
Alzheimer Disease
Beyond Cholinesterase Inhibition: Anti-Inflammatory Role and Pharmacological Profile of Current Drug Therapy for Alzheimer's Disease.
Alzheimer Disease
Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
Alzheimer Disease
Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease.
Alzheimer Disease
Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs.
Alzheimer Disease
Biochemical and Histochemical Comparison of Cholinesterases in Normal and Alzheimer Brain Tissues.
Alzheimer Disease
Biochemical Differentiation of Cholinesterases from Normal and Alzheimer's Disease Cortex.
Alzheimer Disease
Biological Evaluation of Endophytic Fungus, Chaetomium globosum JN711454, as Potential Candidate for Improving Drug Discovery.
Alzheimer Disease
Biophenols: Enzymes (?-secretase, Cholinesterases, histone deacetylase and tyrosinase) inhibitors from olive (Olea europaea L.).
Alzheimer Disease
Blood cells cholinesterase activity in early stage Alzheimer's disease and vascular dementia.
Alzheimer Disease
Blood markers in Alzheimer disease: subnormal acetylcholinesterase and butyrylcholinesterase in lymphocytes and erythrocytes.
Alzheimer Disease
Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
Alzheimer Disease
BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia.
Alzheimer Disease
Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem.
Alzheimer Disease
Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
Alzheimer Disease
Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype.
Alzheimer Disease
Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-? peptide in mice.
Alzheimer Disease
Butyrylcholinesterase is associated with ?-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease.
Alzheimer Disease
Butyrylcholinesterase K and Apolipoprotein ?4 Affect Cortical Thickness and Neuropsychiatric Symptoms in Alzheimer's Disease.
Alzheimer Disease
Butyrylcholinesterase K and Apolipoprotein E-?4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
Alzheimer Disease
Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis.
Alzheimer Disease
Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients.
Alzheimer Disease
Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.
Alzheimer Disease
Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
Alzheimer Disease
Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease.
Alzheimer Disease
Butyrylcholinesterase-knockout reduces brain deposition of fibrillar ?-amyloid in an Alzheimer mouse model.
Alzheimer Disease
Butyrylcholinesterase: an important new target in Alzheimer's disease therapy.
Alzheimer Disease
Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment.
Alzheimer Disease
Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer's disease in a Southern Brazilian population.
Alzheimer Disease
Can Persistence With Cholinesterase Inhibitor Treatment Lower Mortality and Health-Care Costs Among Patients With Alzheimer's Disease? A Population-Based Study in Taiwan.
Alzheimer Disease
Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study.
Alzheimer Disease
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease.
Alzheimer Disease
Capillary zone electrophoresis determination of galanthamine in biological fluids and pharmaceutical preparatives: experimental design and artificial neural network optimization.
Alzheimer Disease
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.
Alzheimer Disease
Carbazole-based semicarbazones and hydrazones as multifunctional anti-Alzheimer agents.
Alzheimer Disease
Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias.
Alzheimer Disease
Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease.
Alzheimer Disease
Caregiver acceptance of adverse effects and use of cholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
Caregiver-specific outcomes in antidementia clinical drug trials: a systematic review and meta-analysis.
Alzheimer Disease
Carotid intima-media thickness as a predictor of response to cholinesterase inhibitors in Alzheimer's disease: an open-label trial.
Alzheimer Disease
Causes of syncope in patients with Alzheimer's disease treated with donepezil.
Alzheimer Disease
CDR State Transition Probabilities in Alzheimer's Disease with and without Cholinesterase Inhibitor Intervention in an Observational Cohort.
Alzheimer Disease
Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease.
Alzheimer Disease
Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study.
Alzheimer Disease
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease.
Alzheimer Disease
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
Alzheimer Disease
Cerebrovascular Pathology and Responsiveness to Treatment in Alzheimer's Disease: A Systematic Review.
Alzheimer Disease
Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment.
Alzheimer Disease
Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
Alzheimer Disease
Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: A microdialysis study.
Alzheimer Disease
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.
Alzheimer Disease
Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease : a nonrandomised controlled trial with magnetic resonance spectroscopy.
Alzheimer Disease
Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors.
Alzheimer Disease
Characteristics of patients with Alzheimer's disease who switch to rivastigmine transdermal patches in routine clinical practice.
Alzheimer Disease
Chemical Characterization of Narcissus poeticus from Sirente -Velino (Apennines - Italy): Galantamine Accumulation and Distribution of Allergenic Compounds in the Flower.
Alzheimer Disease
Chemical composition of the essential oil and hexane extract of Salvia chionantha and their antioxidant and anticholinesterase activities.
Alzheimer Disease
Chemical composition, antioxidant and anticholinesterase activity of the essential oil of algerian cachrys sicula L.
Alzheimer Disease
Chemical composition, biological properties and bioinformatics analysis of two Caesalpina species: A new light in the road from nature to pharmacy shelf.
Alzheimer Disease
Chemistry and functional properties in prevention of neurodegenerative disorders of five Cistus species essential oils.
Alzheimer Disease
Chinese Medicine for Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Trials.
Alzheimer Disease
Chlorinated tacrine analogs: Design, synthesis and biological evaluation of their anti-cholinesterase activity as potential treatment for Alzheimer's disease.
Alzheimer Disease
Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease: epidemiology and management.
Alzheimer Disease
Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
Alzheimer Disease
Cholinergic enhancement of frontal lobe activity in mild cognitive impairment.
Alzheimer Disease
Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Alzheimer Disease
Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: the cholinergic-vascular hypothesis.
Alzheimer Disease
Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Alzheimer Disease
Cholinesterase Activity and mRNA Level of Nicotinic Acetylcholine Receptors (alpha4 and beta2 Subunits) in Blood of Elderly Chinese Diagnosed as Alzheimer's Disease.
Alzheimer Disease
Cholinesterase activity and mRNA level of nicotinic acetylcholine receptors (alpha4 and beta2 Subunits) in blood of elderly Chinese diagnosed as Alzheimer's disease.
Alzheimer Disease
Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid.
Alzheimer Disease
Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae).
Alzheimer Disease
Cholinesterase based amperometric biosensors for assay of anticholinergic compounds.
Alzheimer Disease
Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
Alzheimer Disease
Cholinesterase Inhibition in Alzheimer's Disease: Is Specificity the Answer?
Alzheimer Disease
Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health.
Alzheimer Disease
Cholinesterase inhibition: is there evidence for disease-modifying effects?
Alzheimer Disease
Cholinesterase inhibitor affects the amyloid precursor protein isoforms in patients with Alzheimer's disease.
Alzheimer Disease
Cholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use in older adults with end-stage dementia: a survey of hospice medical directors.
Alzheimer Disease
Cholinesterase inhibitor blockade and its prevention by statins of sympathetic alpha7-nAChR-mediated cerebral nitrergic neurogenic vasodilation.
Alzheimer Disease
Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials.
Alzheimer Disease
Cholinesterase Inhibitor Donepezil Increases Mitochondrial Biogenesis through AMP-Activated Protein Kinase in the Hippocampus.
Alzheimer Disease
Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer's disease.
Alzheimer Disease
Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors.
Alzheimer Disease
Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease.
Alzheimer Disease
Cholinesterase inhibitor therapy for Alzheimer dementia: what do animal models tell us?
Alzheimer Disease
Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates.
Alzheimer Disease
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease.
Alzheimer Disease
Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease.
Alzheimer Disease
Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.
Alzheimer Disease
Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
Alzheimer Disease
Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project.
Alzheimer Disease
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1-42 antibodies in Alzheimer's disease patients.
Alzheimer Disease
Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation.
Alzheimer Disease
Cholinesterase inhibitors and add-on nutritional supplements in Alzheimer's disease: a systematic review of randomized controlled trials.
Alzheimer Disease
Cholinesterase Inhibitors and Behavioral & Psychological Symptoms of Alzheimer's Disease.
Alzheimer Disease
Cholinesterase inhibitors and Gingko extracts--are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration.
Alzheimer Disease
Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.
Alzheimer Disease
Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs as Alzheimer's disease therapies: an updated umbrella review of systematic reviews and meta-analyses.
Alzheimer Disease
Cholinesterase inhibitors and opiate antagonists in patients with Alzheimer's disease.
Alzheimer Disease
Cholinesterase inhibitors are compatible with psychosocial intervention for Alzheimer disease patients suggested by neuroimaging findings.
Alzheimer Disease
Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature.
Alzheimer Disease
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death.
Alzheimer Disease
Cholinesterase inhibitors exert a protective effect on endothelial damage in Alzheimer disease patients.
Alzheimer Disease
Cholinesterase inhibitors for Alzheimer disease.
Alzheimer Disease
Cholinesterase Inhibitors for Alzheimer Disease: Do They Provide More Than Symptomatic Benefits?
Alzheimer Disease
Cholinesterase inhibitors for Alzheimer's disease.
Alzheimer Disease
Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning.
Alzheimer Disease
Cholinesterase inhibitors for Alzheimer's disease: variations in clinical practice in the north-west of England.
Alzheimer Disease
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.
Alzheimer Disease
Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
Alzheimer Disease
Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly.
Alzheimer Disease
Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on.
Alzheimer Disease
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
Alzheimer Disease
Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.
Alzheimer Disease
Cholinesterase Inhibitors in Alzheimer's Disease. Proceedings of a symposium. Sweden, June 1, 1993.
Alzheimer Disease
Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?
Alzheimer Disease
Cholinesterase inhibitors in Alzheimer's disease: efficacy in a non-selected population.
Alzheimer Disease
Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.
Alzheimer Disease
Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry.
Alzheimer Disease
Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment.
Alzheimer Disease
Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
Alzheimer Disease
Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.
Alzheimer Disease
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients.
Alzheimer Disease
Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.
Alzheimer Disease
Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
Alzheimer Disease
Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons.
Alzheimer Disease
Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Alzheimer Disease
Cholinesterase inhibitors reduce aggression, wandering, and paranoia in Alzheimer disease.
Alzheimer Disease
Cholinesterase inhibitors slow decline in executive functions, rather than memory, in Alzheimer's disease: a 1-year observational study in the sunnybrook dementia cohort.
Alzheimer Disease
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Alzheimer Disease
Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease.
Alzheimer Disease
Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Alzheimer Disease
Cholinesterase Inhibitory Activities of Selected Halogenated Thiophene Chalcones.
Alzheimer Disease
Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM analyses and Crystalline Structure of Pharmacophore Site.
Alzheimer Disease
Cholinesterase inhibitory activity of tinosporide and 8-hydroxytinosporide isolated from Tinospora cordifolia: In vitro and in silico studies targeting management of Alzheimer's disease.
Alzheimer Disease
Cholinesterase inhibitory effects of Rhizophora lamarckii, Avicennia officinalis, Sesuvium portulacastrum and Suaeda monica: Mangroves inhabiting an Indian coastal area (Vellar Estuary).
Alzheimer Disease
Cholinesterase Inhibitory Potential of Quercetin towards Alzheimer's Disease - A Promising Natural Molecule or Fashion of the Day? - A Narrowed Review.
Alzheimer Disease
Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's disease.
Alzheimer Disease
Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease.
Alzheimer Disease
Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.
Alzheimer Disease
Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease.
Alzheimer Disease
CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients.
Alzheimer Disease
CHRNA7 polymorphisms and response to cholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Alzheimer Disease
Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease.
Alzheimer Disease
Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.
Alzheimer Disease
Clinanthus microstephus, an Amaryllidaceae species with cholinesterase inhibitor alkaloids: structure-activity analysis of haemanthamine skeleton derivatives.
Alzheimer Disease
Clinical and analytical considerations in the utilization of cholinesterase measurements.
Alzheimer Disease
Clinical Compliance of Donepezil in Treating Alzheimer's Disease in Taiwan.
Alzheimer Disease
Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.
Alzheimer Disease
Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
Alzheimer Disease
Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease.
Alzheimer Disease
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
Alzheimer Disease
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.
Alzheimer Disease
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
Alzheimer Disease
Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.
Alzheimer Disease
Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro.
Alzheimer Disease
Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
Alzheimer Disease
Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study.
Alzheimer Disease
Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease.
Alzheimer Disease
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study.
Alzheimer Disease
Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years.
Alzheimer Disease
Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years.
Alzheimer Disease
Cognitive rehabilitation of mildly impaired Alzheimer disease patients on cholinesterase inhibitors.
Alzheimer Disease
Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics.
Alzheimer Disease
Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis.
Alzheimer Disease
Combination therapy for early Alzheimer's disease: what are we waiting for?
Alzheimer Disease
Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: a systematic review and meta-analysis.
Alzheimer Disease
Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil.
Alzheimer Disease
Combined in Vitro and in Silico Studies for the Anticholinesterase Activity and Pharmacokinetics of Coumarinyl Thiazoles and Oxadiazoles.
Alzheimer Disease
Combined Memantine and Donepezil Treatment Improves Behavioral and Psychological Symptoms of Dementia-Like Behaviors in Olfactory Bulbectomized Mice.
Alzheimer Disease
Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease.
Alzheimer Disease
Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection.
Alzheimer Disease
Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti- Alzheimer's study.
Alzheimer Disease
Comparative effects of the alpha7 nicotinic partial agonist, S 24795, and the cholinesterase inhibitor, donepezil, against aging-related deficits in declarative and working memory in mice.
Alzheimer Disease
Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials.
Alzheimer Disease
Comparative Study of Chemical Composition, Cholinesterase Inhibition and Antioxidant Potential of Mentha pulegium L. Essential Oil.
Alzheimer Disease
Comparative study of selective in vitro and in silico BACE1 inhibitory potential of glycyrrhizin together with its metabolites, 18?- and 18?-glycyrrhetinic acid, isolated from Hizikia fusiformis.
Alzheimer Disease
Comparing treatment effects in a clinical sample of patients with probable Alzheimer's disease treated with two different cholinesterase inhibitors.
Alzheimer Disease
Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.
Alzheimer Disease
Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro.
Alzheimer Disease
Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer's disease.
Alzheimer Disease
Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects.
Alzheimer Disease
Competitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease.
Alzheimer Disease
Computational and experimental studies on the interaction between butyrylcholinesterase and fluoxetine: Implications in health and disease.
Alzheimer Disease
Computational and In-Vitro Validation of Natural Molecules as Potential Acetylcholinesterase Inhibitors and Neuroprotective Agents.
Alzheimer Disease
Computational and Kinetic Studies of Acetylcholine Esterase Inhibition by Phenserine.
Alzheimer Disease
Computational exploration and experimental validation to identify a dual inhibitor of cholinesterase and amyloid-beta for the treatment of Alzheimer's disease.
Alzheimer Disease
Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients.
Alzheimer Disease
Conjugates of ?-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease.
Alzheimer Disease
Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors.
Alzheimer Disease
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile.
Alzheimer Disease
Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM).
Alzheimer Disease
Converting maslinic acid into an effective inhibitor of acylcholinesterases.
Alzheimer Disease
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.
Alzheimer Disease
Cortical activation during cholinesterase-inhibitor treatment in Alzheimer disease: preliminary findings from a pharmaco-fMRI study.
Alzheimer Disease
Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease: a review with methodological considerations.
Alzheimer Disease
Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulation.
Alzheimer Disease
Could the potential benefits of cholinesterase inhibitors in Alzheimer's disease be reduced after adjusting for coexisting diseases and multiple medications?
Alzheimer Disease
Coumarin, anthroquinone and stilbene derivatives with anticholinesterase activity.
Alzheimer Disease
CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival.
Alzheimer Disease
CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients.
Alzheimer Disease
Current smoking and response to cholinesterase inhibitor therapy in Alzheimer's disease.
Alzheimer Disease
Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's disease.
Alzheimer Disease
Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease.
Alzheimer Disease
Deep cerebral microbleeds are associated with poor cholinesterase inhibitor treatment response in people with Alzheimer disease.
Alzheimer Disease
Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.
Alzheimer Disease
Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Alzheimer Disease
Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease.
Alzheimer Disease
Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Alzheimer Disease
Design, synthesis and biological evaluation of bambuterol analogues as novel inhibitors of butyrylcholinesterase.
Alzheimer Disease
Design, synthesis and biological evaluation of new 2-benzoxazolinone derivatives as potential cholinesterase inhibitors for therapy of alzheimer's disease.
Alzheimer Disease
Design, synthesis and biological evaluation of novel 6H-benzo[c]chromen-6-one, and 7,8,9,10-tetrahydro-benzo[c]chromen-6-one derivatives as potential cholinesterase inhibitors.
Alzheimer Disease
Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer's disease.
Alzheimer Disease
Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease.
Alzheimer Disease
Design, synthesis and biological evaluation of tacrine-1,2,3-triazole derivatives as potent cholinesterase inhibitors.
Alzheimer Disease
Design, synthesis and evaluation of dihydropyranoindole derivatives as potential cholinesterase inhibitors against Alzheimer's disease.
Alzheimer Disease
Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.
Alzheimer Disease
Design, synthesis and evaluation of novel indandione derivatives as multifunctional agents with cholinesterase inhibition, anti-?-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer's disease.
Alzheimer Disease
Design, synthesis and evaluation of novel tacrine-(?-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Alzheimer Disease
Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Alzheimer Disease
Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents.
Alzheimer Disease
Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
Alzheimer Disease
Design, Synthesis, and In Vitro Biological Activities of a Bio-Oxidizable Prodrug to Deliver Both ChEs and DYRK1A Inhibitors for AD Therapy.
Alzheimer Disease
Design, synthesis, in vivo and in vitro studies of 1,2,3,4-tetrahydro-9H-carbazole derivatives, highly selective and potent butyrylcholinesterase inhibitors.
Alzheimer Disease
Design, synthesis, in vitro and in vivo evaluation of benzylpiperidine-linked 1,3-dimethylbenzimidazolinones as cholinesterase inhibitors against Alzheimer's disease.
Alzheimer Disease
Design, synthesis, molecular docking, and cholinesterase inhibitory potential of phthalimide-dithiocarbamate hybrids as new agents for treatment of Alzheimer's disease.
Alzheimer Disease
Design, synthesis, molecular modeling and neuroprotective effects of a new framework of cholinesterase inhibitors for Alzheimer's disease.
Alzheimer Disease
Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Alzheimer Disease
Development and validation of a capillary zone electrophoretic method for rapid and sensitive determination of galanthamine: Application in plant and pharmaceuticals.
Alzheimer Disease
Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles.
Alzheimer Disease
Development of acetophenone ligands as potential neuroimaging agents for cholinesterases.
Alzheimer Disease
Development of donepezil-induced hypokalemia following treatment of cognitive impairment.
Alzheimer Disease
Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer's Disease.
Alzheimer Disease
Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes.
Alzheimer Disease
Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry.
Alzheimer Disease
Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.
Alzheimer Disease
Differential blockade by huperzine A and donepezil of sympathetic nicotinic acetylcholine receptor-mediated nitrergic neurogenic dilations in porcine basilar arteries.
Alzheimer Disease
Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.
Alzheimer Disease
Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus.
Alzheimer Disease
Differential effects of donepezil on methamphetamine and cocaine dependencies.
Alzheimer Disease
Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
Alzheimer Disease
Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.
Alzheimer Disease
Differentiated cerebrovascular effects of physostigmine and tacrine in cortical areas deafferented from the nucleus basalis magnocellularis suggest involvement of basalocortical projections to microvessels.
Alzheimer Disease
Differentiation Between Dementia With Lewy Bodies And Alzheimer's Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter Study.
Alzheimer Disease
Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
Alzheimer Disease
Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.
Alzheimer Disease
Discontinuation of donepezil for the treatment of Alzheimer's disease in geriatric practice.
Alzheimer Disease
Discontinuation, efficacy and safety of cholinesterase inhibitors for Alzheimer's disease: a meta-analysis and meta-regression of 44 randomized clinical trials enrolling 16,245 patients.
Alzheimer Disease
Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts.
Alzheimer Disease
Discorhabdin alkaloids from Antarctic Latrunculia spp. sponges as a new class of cholinesterase inhibitors.
Alzheimer Disease
Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening.
Alzheimer Disease
Discovery of 9-phenylacridinediones as highly selective butyrylcholinesterase inhibitors through structure-based virtual screening.
Alzheimer Disease
Discovery of Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for Live-Cell and In Vivo Imaging.
Alzheimer Disease
Discovery of drug-like acetylcholinesterase inhibitors by rapid virtual screening of a 6.9 million compound database.
Alzheimer Disease
Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode.
Alzheimer Disease
Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis.
Alzheimer Disease
Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.
Alzheimer Disease
Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
Alzheimer Disease
Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening.
Alzheimer Disease
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties.
Alzheimer Disease
Discovery, biological evaluation and molecular dynamic simulations of butyrylcholinesterase inhibitors through structure-based pharmacophore virtual screening.
Alzheimer Disease
Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.
Alzheimer Disease
Disease stage in Alzheimer disease and treatment effects of rivastigmine.
Alzheimer Disease
Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation.
Alzheimer Disease
Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immunohistochemical study.
Alzheimer Disease
DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice.
Alzheimer Disease
Do blood pressure and age predict response to tacrine (THA) in Alzheimer's disease? A preliminary report.
Alzheimer Disease
Do Cholinesterase Inhibitors Act Primarily on Attention Deficit? A Naturalistic Study in Alzheimer's Disease Patients.
Alzheimer Disease
Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?
Alzheimer Disease
Donepezil and life expectancy in Alzheimer's disease: A retrospective analysis in the Tajiri Project.
Alzheimer Disease
Donepezil and Rivastigmine: Pharmacokinetic Profile and Brain-targeting After Intramuscular Administration in Rats.
Alzheimer Disease
Donepezil blocks voltage-gated ion channels in rat dissociated hippocampal neurons.
Alzheimer Disease
Donepezil Effects on Hippocampal and Prefrontal Functional Connectivity in Alzheimer's Disease: Preliminary Report.
Alzheimer Disease
Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation.
Alzheimer Disease
Donepezil in low micromolar concentrations modulates voltage-gated potassium currents in pyramidal neurons of rat hippocampus.
Alzheimer Disease
Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.
Alzheimer Disease
Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
Alzheimer Disease
Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain.
Alzheimer Disease
Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones.
Alzheimer Disease
Donepezil Treatment for Alzheimer's Disease in Chronic Dialysis Patients.
Alzheimer Disease
Donepezil use for advanced Alzheimer's disease--a case study from a long-term care facility.
Alzheimer Disease
Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease.
Alzheimer Disease
Donepezil, a cholinesterase inhibitor used in Alzheimer's disease therapy, is actively exported out of the brain by abcb1ab p-glycoproteins in mice.
Alzheimer Disease
Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months.
Alzheimer Disease
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
Alzheimer Disease
Donepezil-induced cervical dystonia in Alzheimer's disease: a case report and literature review of dystonia due to cholinesterase inhibitors.
Alzheimer Disease
Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys.
Alzheimer Disease
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application.
Alzheimer Disease
Double-blind placebo-controlled study of velnacrine in Alzheimer's disease.
Alzheimer Disease
Drug Design of Inhibitors of Alzheimer's Disease (AD): POM and DFT Analyses of Cholinesterase Inhibitory Activity of ?-amino di-Carbonyl Derivatives.
Alzheimer Disease
Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's disease.
Alzheimer Disease
Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings.
Alzheimer Disease
Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease.
Alzheimer Disease
Drugs and falls in community-dwelling older people: a national veterans study.
Alzheimer Disease
Drugs for Alzheimer's disease. Guidelines for prescribing cholinesterase inhibitors in Australia are similar to those in UK.
Alzheimer Disease
Dual functional cholinesterase and MAO inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of homoisoflavonoid derivatives.
Alzheimer Disease
Dual functional cholinesterase and PDE4D inhibitors for the treatment of Alzheimer's disease: Design, synthesis and evaluation of tacrine-pyrazolo[3,4-b]pyridine hybrids.
Alzheimer Disease
Dual inhibitors of monoamine oxidase and cholinesterase for the treatment of Alzheimer disease.
Alzheimer Disease
Dual monoamine oxidase and cholinesterase Inhibitors with different heterocyclic scaffolds.
Alzheimer Disease
Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.
Alzheimer Disease
Duration of therapy with acetylcholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease as reported in the literature.
Alzheimer Disease
Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
Alzheimer Disease
Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands.
Alzheimer Disease
Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
Alzheimer Disease
Economic evaluation of the impact of memantine on time to nursing home admission in the treatment of Alzheimer disease.
Alzheimer Disease
Economic evaluations during early (phase II) drug development: a role for clinical trial simulations?
Alzheimer Disease
Effect of APOE and CHRNA7 Genotypes on the Cognitive Response to Cholinesterase Inhibitor Treatment at Different Stages of Alzheimer's Disease.
Alzheimer Disease
Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease.
Alzheimer Disease
Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.
Alzheimer Disease
Effect of CYP2D6 and CYP3A4 Genotypes on the Efficacy of Cholinesterase Inhibitors in Southern Chinese Patients With Alzheimer's Disease.
Alzheimer Disease
Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
Alzheimer Disease
Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice.
Alzheimer Disease
Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.
Alzheimer Disease
Effect of genetic polymorphisms on Alzheimer's disease treatment outcomes: an update.
Alzheimer Disease
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.
Alzheimer Disease
Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats.
Alzheimer Disease
Effect of long-term treatment with galantamine on weight of patients with Alzheimer's dementia.
Alzheimer Disease
Effect of MDL 73,745 on acetylcholine and biogenic amine levels in rat cortex.
Alzheimer Disease
Effect of neostigmine on the hippocampal noradrenaline release: role of cholinergic receptors.
Alzheimer Disease
Effect of QT Prolongation in Patients Taking Cholinesterase Inhibitors (Donepezil) for Alzheimer's Disease.
Alzheimer Disease
Effect of rivastigmine on plasma butyrylcholine esterase activity and plasma ghrelin levels in patients with dementia in Alzheimer's disease.
Alzheimer Disease
Effect of rivastigmine on regional cerebral blood flow in Alzheimer's disease.
Alzheimer Disease
Effect of Rivastigmine or Memantine Add-on Therapy Is Affected by Butyrylcholinesterase Genotype in Patients with Probable Alzheimer's Disease.
Alzheimer Disease
Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
Alzheimer Disease
Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
Alzheimer Disease
Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer's disease in daily practice.
Alzheimer Disease
Effectiveness of donepezil, rivastigmine and ({+/-})huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: Comparison with galantamine.
Alzheimer Disease
Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: a review.
Alzheimer Disease
Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease.
Alzheimer Disease
Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease.
Alzheimer Disease
Effects of cholinesterase inhibitor on brain activation in Alzheimer's patients measured with functional near-infrared spectroscopy.
Alzheimer Disease
Effects of cholinesterase inhibitors and clonidine coadministration on rat cortex neurotransmitters in vivo.
Alzheimer Disease
Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy.
Alzheimer Disease
Effects of cholinesterase inhibitors on behavioural disturbances in Alzheimer's disease: a systematic review.
Alzheimer Disease
Effects of Cholinesterase Inhibitors on the Activities and Protein Levels of Cholinesterases in the Cerebrospinal Fluid of Patients with Alzheimer's Disease: A Review of Recent Clinical Studies.
Alzheimer Disease
Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies.
Alzheimer Disease
Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures.
Alzheimer Disease
Effects of cholinesterase inhibitors on visual attention in drivers with Alzheimer disease.
Alzheimer Disease
Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients.
Alzheimer Disease
Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders.
Alzheimer Disease
Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression.
Alzheimer Disease
Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study.
Alzheimer Disease
Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: Data from the ICTUS study.
Alzheimer Disease
Effects of metrifonate on impairment of learning and dysfunction of cholinergic neuronal system in basal forebrain-lesioned rats.
Alzheimer Disease
Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats-Is there a potential for Alzheimer's disease treatment?
Alzheimer Disease
Effects of rivastigmine and memantine alone and in combination on learning and memory in rats with scopolamine-induced amnesia.
Alzheimer Disease
Effects of simultaneous administration of desferrioxamine and tacrine in rats.
Alzheimer Disease
Effects of simvastatin on malondialdehyde level and esterase activity in plasma and tissue of normolipidemic rats.
Alzheimer Disease
Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells.
Alzheimer Disease
Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease.
Alzheimer Disease
Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats.
Alzheimer Disease
Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's disease.
Alzheimer Disease
Effects of two-year treatment with the cholinesterase inhibitor rivastigmine on behavioural symptoms in Alzheimer's disease.
Alzheimer Disease
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.
Alzheimer Disease
Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
Alzheimer Disease
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
Alzheimer Disease
Efficacy and safety of galantamine treatment for patients with Alzheimer's disease: a meta-analysis of randomized controlled trials.
Alzheimer Disease
Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil.
Alzheimer Disease
Efficacy and safety of switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch in patients with probable Alzheimer's disease.
Alzheimer Disease
Efficacy and Tolerability of a Combination Treatment of Memantine and Donepezil for Alzheimer's Disease: A Literature Review Evidence.
Alzheimer Disease
Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.
Alzheimer Disease
Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients.
Alzheimer Disease
Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease.
Alzheimer Disease
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors.
Alzheimer Disease
Efficacy, Safety, and Tolerability of Switching from Oral Cholinesterase Inhibitors to Rivastigmine Transdermal Patch with 1-Step Titration in Patients with Mild to Moderate Alzheimer's Disease: A 24-Week, Open-Label, Multicenter Study in Japan.
Alzheimer Disease
EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.
Alzheimer Disease
Electrocardiogram Changes of Donepezil Administration in Elderly Patients with Ischemic Heart Disease.
Alzheimer Disease
Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease.
Alzheimer Disease
Empirical evidence of neuroprotection by dual cholinesterase inhibition in Alzheimer's disease.
Alzheimer Disease
Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys.
Alzheimer Disease
Enhancement of Fear Extinction Memory and Resistance to Age-Related Cognitive Decline in Butyrylcholinesterase Knockout Mice and (R)-Bambuterol Treated Mice.
Alzheimer Disease
Ensemble Molecular Dynamics of a Protein-Ligand Complex: Residual Inhibitor Entropy Enhances Drug Potency in Butyrylcholinesterase.
Alzheimer Disease
Established donepezil treatment modulates task relevant regional brain activation in early Alzheimer's disease.
Alzheimer Disease
Estimation of neuroprotective effects of Laurocerasus officinalis Roem. (cherry laurel) by in vitro methods
Alzheimer Disease
Estimation of plasma tacrine concentrations using an in vitro cholinesterase inhibition assay.
Alzheimer Disease
Evaluating Fmoc-amino acids as selective inhibitors of butyrylcholinesterase.
Alzheimer Disease
Evaluating the Memory Enhancing Effects of Angelica gigas in Mouse Models of Mild Cognitive Impairments.
Alzheimer Disease
Evaluation of Anticholinesterase and Inflammation Inhibitory Activity of Medicinal Mushroom Phellinus pini (Basidiomycetes) Fruiting Bodies.
Alzheimer Disease
Evaluation of blood-brain barrier and blood-cerebrospinal fluid barrier permeability of 2-phenoxy-indan-1-one derivatives using in vitro cell models.
Alzheimer Disease
Evaluation of butyrylcholinesterase inhibitory activity by chlorogenic acids and coffee extracts assed in ITC and docking simulation models.
Alzheimer Disease
Evaluation of cholinergic treatment in demented patients by P300 evoked related potentials.
Alzheimer Disease
Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Alzheimer Disease
Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease.
Alzheimer Disease
Evaluation of salivary acetylcholinesterase and pseudocholinesterase in patients with Alzheimer's disease: A case-control study.
Alzheimer Disease
Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.
Alzheimer Disease
Evaluation of the neuroprotective and antidiabetic potential of phenol-rich extracts from virgin olive oils by in vitro assays.
Alzheimer Disease
Evidence that the clinical effects of cholinesterase inhibitors are related to potency and targeting of action.
Alzheimer Disease
Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation.
Alzheimer Disease
Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors.
Alzheimer Disease
Exploring the halophyte Cistanche phelypaea (L.) Cout as a source of health promoting products: In vitro antioxidant and enzyme inhibitory properties, metabolomic profile and computational studies.
Alzheimer Disease
Facile synthesis of new carbon-11 labeled conformationally restricted rivastigmine analogues as potential PET agents for imaging AChE and BChE enzymes.
Alzheimer Disease
Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting.
Alzheimer Disease
Factors associated with use of medications with potential to impair cognition or cholinesterase inhibitors among Alzheimer's disease patients.
Alzheimer Disease
Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease.
Alzheimer Disease
Fatal aspiration pneumonia during transition from donepezil to rivastigmine.
Alzheimer Disease
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents.
Alzheimer Disease
First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease.
Alzheimer Disease
Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy.
Alzheimer Disease
Focus on the Correlations between Alzheimer's Disease and Type 2 Diabetes.
Alzheimer Disease
Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
Alzheimer Disease
For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?
Alzheimer Disease
Forebrain deletion of the vesicular acetylcholine transporter results in deficits in executive function, metabolic, and RNA splicing abnormalities in the prefrontal cortex.
Alzheimer Disease
Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample.
Alzheimer Disease
From high doses of oral rivastigmine to transdermal rivastigmine patches: user experience and satisfaction among caregivers of patients with mild to moderate Alzheimer disease.
Alzheimer Disease
From toxic precursors to safe drugs. Mechanisms and relevance of idiosyncratic drug reactions.
Alzheimer Disease
Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.
Alzheimer Disease
Functional and subcellular organelle changes in isolated rat and human hepatocytes induced by tetrahydroaminoacridine.
Alzheimer Disease
Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort.
Alzheimer Disease
Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
Alzheimer Disease
Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.
Alzheimer Disease
Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.
Alzheimer Disease
Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease.
Alzheimer Disease
Galantamine-based hybrid molecules with acetylcholinesterase, butyrylcholinesterase and ?-secretase inhibition activities.
Alzheimer Disease
Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease.
Alzheimer Disease
Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[ (18)F]Fluoro-A-85380 PET.
Alzheimer Disease
Galantamine: a pharmacoeconomic review of its use in Alzheimer's disease.
Alzheimer Disease
Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease.
Alzheimer Disease
Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats.
Alzheimer Disease
GC/MS Analysis of Alkaloids in Galanthus fosteri Baker and Determination of Its Anticholinesterase Activity.
Alzheimer Disease
Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study.
Alzheimer Disease
Gender-related differences in circadian rhythm of rat plasma acetyl- and butyrylcholinesterase: Effects of sex hormone withdrawal.
Alzheimer Disease
Gene-gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer's disease risk.
Alzheimer Disease
Genoprotective and neuroprotective effects of Daphne gnidium leaf methanol extract, tested on male mice.
Alzheimer Disease
Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
Alzheimer Disease
Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
Alzheimer Disease
Good rate of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease after three months of treatment: An open-label study.
Alzheimer Disease
Growth Hormone Responses to Low-Dose Physostigmine in Elderly vs. Young Women and Men.
Alzheimer Disease
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review.
Alzheimer Disease
Hemodynamic effects of cholinesterase inhibition in mild Alzheimer's disease.
Alzheimer Disease
High Expression Level of Antioxidants and Pharmaceutical Bioactivities of Endophytic Fungus Chaetomium Globosum JN711454.
Alzheimer Disease
High-performance liquid chromatography with fast-scanning fluorescence detection and multivariate curve resolution for the efficient determination of galantamine and its main metabolites in serum.
Alzheimer Disease
Higher levels of thyroxine may predict a favorable response to donepezil treatment in patients with Alzheimer disease: a prospective, case-control study.
Alzheimer Disease
Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease.
Alzheimer Disease
Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection.
Alzheimer Disease
Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease.
Alzheimer Disease
Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model.
Alzheimer Disease
Hippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
Homozygosity for the K variant of BCHE gene increases the risk for development of neurofibrillary pathology but not amyloid deposits at young ages.
Alzheimer Disease
Honey as the Potential Natural Source of Cholinesterase Inhibitors in Alzheimer's Disease.
Alzheimer Disease
How Prolific is Psychotropic Medicines Use in People with Dementia in Australia Within the Community Setting? A Retrospective Analysis.
Alzheimer Disease
How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis.
Alzheimer Disease
HPLC-MS/MS chemical characterization and biological properties of Origanum onites extracts: a recent insight.
Alzheimer Disease
Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro.
Alzheimer Disease
Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
Identification and molecular docking study of fish roe-derived peptides as potent BACE 1, AChE, and BChE inhibitors.
Alzheimer Disease
Identification of cytochrome P450 1A2 as enzyme involved in the microsomal metabolism of Huperzine A.
Alzheimer Disease
Immobilized butyrylcholinesterase in the characterization of new inhibitors that could ease Alzheimer's disease.
Alzheimer Disease
Immobilized cholinesterases capillary reactors on-flow screening of selective inhibitors.
Alzheimer Disease
Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Alzheimer Disease
Immunomodulation by 9-amino-1,2,3,4-tetrahydroacridine (THA): 1. Down-regulation of natural cell-mediated cytotoxicity in vitro.
Alzheimer Disease
Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease.
Alzheimer Disease
Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer's disease: a meta-analysis.
Alzheimer Disease
Impact of cholinesterase inhibitors or memantine on survival in adults with Down syndrome and dementia: clinical cohort study.
Alzheimer Disease
Impact of CYP2D6 and CYP3A4 genetic polymorphism on combined cholinesterase inhibitors and memantine treatment in mild to moderate Alzheimer's disease.
Alzheimer Disease
Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
Alzheimer Disease
Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.
Alzheimer Disease
Impaired spatial learning and suppression of sharp wave ripples by cholinergic activation at the goal location.
Alzheimer Disease
Implementation of the Pharmacists' Patient Care Process in a Medicinal Chemistry Course.
Alzheimer Disease
Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering.
Alzheimer Disease
Important error in 'systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias' by muayqil and camicioli.
Alzheimer Disease
In silico ligand-receptor docking of potentially selective butyrylcholinesterase inhibitors structurally related to the marine natural product debromoflustramine B.
Alzheimer Disease
In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease.
Alzheimer Disease
In silico modeling of the specific inhibitory potential of thiophene-2,3-dihydro-1,5-benzothiazepine against BChE in the formation of beta-amyloid plaques associated with Alzheimer's disease.
Alzheimer Disease
In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
Alzheimer Disease
In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
Alzheimer Disease
IN VITRO ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORY POTENTIALS OF JATROPHA GOSSYPIFOLIA PLANT EXTRACTS.
Alzheimer Disease
In vitro and in silico analysis of novel astaxanthin-s-allyl cysteine as an inhibitor of butyrylcholinesterase and various globular forms of acetylcholinesterases.
Alzheimer Disease
In vitro and in vivo metabolism and inhibitory activities of vasicine, a potent acetylcholinesterase and butyrylcholinesterase inhibitor.
Alzheimer Disease
In vitro anticholinesterase, antimonoamine oxidase and antioxidant properties of alkaloid extracts from kola nuts (Cola acuminata and Cola nitida).
Alzheimer Disease
In vitro antioxidant and cholinesterase inhibitory activities of Elatostema papillosum leaves and correlation with their phytochemical profiles: a study relevant to the treatment of Alzheimer's disease.
Alzheimer Disease
In Vitro Antioxidant, Anti-Diabetes, Anti-Dementia, and Inflammation Inhibitory Effect of Trametes pubescens Fruiting Body Extracts.
Alzheimer Disease
In vitro metabolism of BYZX in human liver microsomes and the structural elucidation of metabolite by liquid chromatography-mass spectrometry method.
Alzheimer Disease
In vitro neuroprotective effects of the leaf and fruit extracts of Juglans regia L. (walnut) through enzymes linked to Alzheimer's disease and antioxidant activity.
Alzheimer Disease
In vitro reactivation of trichlorfon-inhibited butyrylcholinesterase using HI-6, obidoxime, pralidoxime and K048.
Alzheimer Disease
In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
Alzheimer Disease
Inactivation of cholinesterase induced by non-steroidal anti-inflammatory drugs with horseradish peroxidase: implication for Alzheimer's disease.
Alzheimer Disease
Increase in Platelet Immunoglobulin in Alzheimer's Disease is Lowered Following Cholinesterase Inhibitor Treatment: Preliminary Results.
Alzheimer Disease
Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.
Alzheimer Disease
Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists.
Alzheimer Disease
Increasing rational use of cholinesterase inhibitors for Alzheimer's disease in Brazil: public health strategy combining guideline with peer-review of prescriptions.
Alzheimer Disease
Individualized evaluation of cholinesterase inhibitors effects in dementia with adaptive cognitive testing.
Alzheimer Disease
Indole alkaloids from Ervatamia hainanensis with potent acetylcholinesterase inhibition activities.
Alzheimer Disease
Influence of APOE gene polymorphisms on interferon-beta treatment response in multiple sclerosis.
Alzheimer Disease
Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.
Alzheimer Disease
Influence of different extraction techniques on the chemical profile and biological properties of Anthemis cotula L.: Multifunctional aspects for potential pharmaceutical applications.
Alzheimer Disease
Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer's disease.
Alzheimer Disease
Influence of tacrine on dopamine-induced reactions of the gastric smooth muscle of rats.
Alzheimer Disease
Inhibition of ?-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.
Alzheimer Disease
Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
Alzheimer Disease
Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies.
Alzheimer Disease
Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
Alzheimer Disease
Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
Alzheimer Disease
Inhibitory evaluation of oligonol on ?-glucosidase, protein tyrosine phosphatase 1B, cholinesterase, and ?-secretase 1 related to diabetes and Alzheimer's disease.
Alzheimer Disease
Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer's disease.
Alzheimer Disease
Initiating and monitoring cholinesterase inhibitor treatment for Alzheimer's disease.
Alzheimer Disease
Innovations: geriatric psychiatry: diagnosis and treatment of neuropsychiatric symptoms in Alzheimer's disease.
Alzheimer Disease
Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Alzheimer Disease
Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk.
Alzheimer Disease
Interaction between estrogen receptor-alpha and butyrylcholinesterase genes modulates Alzheimer's disease risk.
Alzheimer Disease
Interaction of Exogenous Butyrylcholinesterase with ?-Amyloid Plaques in 5XFAD/Butyrylcholinesterase-Knockout Mouse Brain.
Alzheimer Disease
Intra-operative bradycardia in a patient with Alzheimer's disease treated with two cholinesterase inhibitors.
Alzheimer Disease
Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Alzheimer Disease
Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer's disease.
Alzheimer Disease
Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications.
Alzheimer Disease
Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline.
Alzheimer Disease
Is Combining an Anticholinergic with a Cholinesterase Inhibitor a Good Strategy for High-Level CNS Cholinesterase Inhibition?
Alzheimer Disease
Is donepezil therapy associated with reduced mortality in nursing home residents with dementia?
Alzheimer Disease
Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?
Alzheimer Disease
Is rivastigmine safe as pretreatment against nerve agents poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers.
Alzheimer Disease
Is the risk of developing Alzheimer's disease really higher in rural areas? A multilevel longitudinal study of 261,669 Australians aged 45 years and older tracked over 11 years.
Alzheimer Disease
Isolation, crystal structure determination and cholinesterase inhibitory potential of isotalatizidine hydrate from Delphinium denudatum.
Alzheimer Disease
Isolation, identification, and quantification of Pentylcurcumene from Geophila repens: A new class of cholinesterase inhibitor for Alzheimer's disease.
Alzheimer Disease
Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability.
Alzheimer Disease
Isothiocyanates: cholinesterase inhibiting, antioxidant, and anti-inflammatory activity.
Alzheimer Disease
Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Alzheimer Disease
Juliflorine: a potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer's disease therapy.
Alzheimer Disease
Kinetics and computational analysis of cholinesterase inhibition by REVERC3, a bisdemethoxycurcumin-rich Curcuma longa extract: Relevance to the treatment of Alzheimer's disease.
Alzheimer Disease
Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-D-sedoheptulose derived from Corni fructus as cholinesterase and ?-secretase 1 inhibitors.
Alzheimer Disease
Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental Alzheimer therapeutic, dihydrobenzodioxepine cymserine.
Alzheimer Disease
Kinetics of Torpedo californica Acetylcholinesterase Inhibition by Bisnorcymserine and Crystal Structure of the Complex with its Leaving Group.
Alzheimer Disease
Ladostigil: A novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment.
Alzheimer Disease
Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion.
Alzheimer Disease
Left frontal lobe hypoperfusion and depressive symptoms in Alzheimer's disease patients taking cholinesterase inhibitors.
Alzheimer Disease
Lepidine B from Lepidium Sativum Seeds as Multi-Functional Anti-Alzheimer's Disease Agent: In Vitro and In Silico Studies.
Alzheimer Disease
Lifestyle improvement or anti-dementia drugs in Alzheimer's disease: A comment on Kapaki et al. The cognitive effects of cholinesterase inhibitor treatment in every-day practice. Curr Med Res Opin 2005; 21(6): 871-5.
Alzheimer Disease
Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease.
Alzheimer Disease
Long-term cholinesterase inhibitor therapy for Alzheimer's disease: implications for long-term care.
Alzheimer Disease
Long-Term Cholinesterase Inhibitor Therapy for Alzheimer's Disease: Practical Considerations for the Primary Care Physician.
Alzheimer Disease
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.
Alzheimer Disease
Long-term effect of galantamine on cognitive function in patients with Alzheimer's disease versus a simulated disease trajectory: an observational study in the clinical setting.
Alzheimer Disease
Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality.
Alzheimer Disease
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer's disease.
Alzheimer Disease
Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease.
Alzheimer Disease
Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment.
Alzheimer Disease
Long-Term Response to Cholinesterase Inhibitor Treatment Is Related to Functional MRI Response in Alzheimer's Disease.
Alzheimer Disease
Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services.
Alzheimer Disease
Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease.
Alzheimer Disease
Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.
Alzheimer Disease
Low dose, high dose, or no dose: better prescribing of cholinesterase inhibitors for Alzheimer's disease.
Alzheimer Disease
Low Plasma Cholinesterase Activities are Associated with Deficits in Spatial Orientation, Reduced Ability to Perform Basic Activities of Daily Living, and Low Body Mass Index in Patients with Progressed Alzheimer's Disease.
Alzheimer Disease
M1 agonists as a potential disease-modifying therapy for Alzheimer's disease.
Alzheimer Disease
Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy.
Alzheimer Disease
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
Alzheimer Disease
Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease.
Alzheimer Disease
Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model.
Alzheimer Disease
Melatonin as a structural template in the development of novel drugs for neurodegenerative disorders.
Alzheimer Disease
Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review.
Alzheimer Disease
Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease.
Alzheimer Disease
Memantine combined with an acetyl cholinesterase inhibitor - hope for the future?
Alzheimer Disease
Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors.
Alzheimer Disease
Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy.
Alzheimer Disease
Memantine treatment for Japanese patients with moderate to severe Alzheimer's disease: a meta-analysis of double-blind, randomized, placebo-controlled trials.
Alzheimer Disease
Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.
Alzheimer Disease
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
Alzheimer Disease
Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.
Alzheimer Disease
Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease.
Alzheimer Disease
Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias.
Alzheimer Disease
Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.
Alzheimer Disease
Metabolite Profiling by Hyphenated Liquid Chromatographic Mass Spectrometric Technique (HPLC-DAD-ESI-Q-TOF-MS/MS) and Neurobiological Potential of Haplophyllum sahinii and H. vulcanicum Extracts.
Alzheimer Disease
Methanesulfonyl fluoride (MSF) blocks scopolamine-induced amnesia in rats.
Alzheimer Disease
Metrifonate (Trichlorfon): a review of the pharmacology, pharmacokinetics and clinical experience with a new acetylcholinesterase inhibitor for Alzheimer's disease.
Alzheimer Disease
Metrifonate and tacrine: a comparative study on their effect on acetylcholine dynamics in mouse brain.
Alzheimer Disease
Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
Alzheimer Disease
Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits.
Alzheimer Disease
Microwave-assisted synthesis of novel purine nucleosides as selective cholinesterase inhibitors.
Alzheimer Disease
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
Alzheimer Disease
Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.
Alzheimer Disease
Modulation of brain acetylcholine levels with cholinesterase inhibitors as a treatment of Alzheimer disease.
Alzheimer Disease
Modulation of cholinergic transmission enhances excitability of hippocampal pyramidal neurons and ameliorates learning impairments in aging animals.
Alzheimer Disease
Modulation of fusiform cortex activity by cholinesterase inhibition predicts effects on subsequent memory.
Alzheimer Disease
Modulation of N-methyl-D-aspartate receptors by donepezil in rat cortical neurons.
Alzheimer Disease
Modulatory effect of caffeic acid on cholinesterases inhibitory properties of donepezil.
Alzheimer Disease
Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate].
Alzheimer Disease
Molecular design and synthesis of novel peptides from amphibians skin acting as inhibitors of cholinesterase enzymes.
Alzheimer Disease
Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and ?-amyloid inhibitors for Alzheimer's disease.
Alzheimer Disease
Molecular Dynamics Revealing a Detour-Forward Release Mechanism of Tacrine: Implication for the Specific Binding Characteristics in Butyrylcholinesterase.
Alzheimer Disease
Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controls.
Alzheimer Disease
Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
Alzheimer Disease
Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
Alzheimer Disease
Multi-target approach for Alzheimer's disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-N-phenylaminoquinoline derivative reveal promising potentials.
Alzheimer Disease
Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease.
Alzheimer Disease
Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.
Alzheimer Disease
Multifunctional Activity of Polyphenolic Compounds Associated with a Potential for Alzheimer's Disease Therapy from Ecklonia cava.
Alzheimer Disease
Multifunctional cholinesterase inhibitors for Alzheimer's disease: Synthesis, biological evaluations, and docking studies of o/p-propoxyphenylsubstituted-1H-benzimidazole derivatives.
Alzheimer Disease
Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors.
Alzheimer Disease
Multifunctional tacrine-flavonoid hybrids with cholinergic, ?-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
Alzheimer Disease
Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains.
Alzheimer Disease
Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
Alzheimer Disease
Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
Alzheimer Disease
Muscarinic, Ca(++) antagonist and specific butyrylcholinesterase inhibitory activity of dried ginger extract might explain its use in dementia.
Alzheimer Disease
N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.
Alzheimer Disease
N-[18F]fluoroethylpiperidin-4-ylmethyl butyrate: a novel radiotracer for quantifying brain butyrylcholinesterase activity by positron emission tomography.
Alzheimer Disease
Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans.
Alzheimer Disease
Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer disease.
Alzheimer Disease
Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Alzheimer Disease
Neuropharmacological effect of Mangiferin on brain cholinesterase and brain biogenic amines in the management of Alzheimer's disease.
Alzheimer Disease
Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease.
Alzheimer Disease
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and ?-amyloid in aging and Alzheimer's disease.
Alzheimer Disease
Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs.
Alzheimer Disease
Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/?-Catenin Signalling Pathway.
Alzheimer Disease
Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/? Catenin Signaling Pathway in Rodent Models of Alzheimer's Disease.
Alzheimer Disease
Neuropsychological rehabilitation program and behavioral disturbances in early-stage Alzheimer patients.
Alzheimer Disease
Neurotransmitter Imbalance in the Brain and Alzheimer's Disease Pathology.
Alzheimer Disease
New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease.
Alzheimer Disease
New 4-N-phenylaminoquinoline derivatives as antioxidant, metal chelating and cholinesterase inhibitors for Alzheimer's disease.
Alzheimer Disease
New anthrarobin acyl derivatives as butyrylcholinesterase inhibitors: synthesis, in vitro and in silico studies.
Alzheimer Disease
New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
Alzheimer Disease
New cholinesterase inhibitors for Alzheimer's disease: Structure Activity Studies (SARs) and molecular docking of isoquinolone and azepanone derivatives.
Alzheimer Disease
New Drug Research and Development for Alzheimer's Pathology: Present and Prospect.
Alzheimer Disease
New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition.
Alzheimer Disease
New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer's Disease Treatment.
Alzheimer Disease
New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.
Alzheimer Disease
New pharmacological strategies for cognitive enhancement using a rat model of age-related memory impairment.
Alzheimer Disease
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.
Alzheimer Disease
New trends in cholinergic therapy for Alzheimer disease: nicotinic agonists or cholinesterase inhibitors?
Alzheimer Disease
Newly developed drugs for Alzheimer's disease in relation to energy metabolism, cholinergic and monoaminergic neurotransmission.
Alzheimer Disease
NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?
Alzheimer Disease
Nicotine and sensory memory in Alzheimer's disease: an event-related potential study.
Alzheimer Disease
Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function.
Alzheimer Disease
No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese.
Alzheimer Disease
No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
Alzheimer Disease
No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.
Alzheimer Disease
No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.
Alzheimer Disease
No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model.
Alzheimer Disease
Non-anticholinesterase, non-cholinergic effect of tacrine on gastrointestinal smooth muscle tissues of rat.
Alzheimer Disease
Non-cholinergic strategies for treating and preventing Alzheimer's disease.
Alzheimer Disease
Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease.
Alzheimer Disease
Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Alzheimer Disease
Novel AChE and BChE Inhibitors Using Combined Virtual Screening, Text mining and In Vitro Binding Assays.
Alzheimer Disease
Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
Alzheimer Disease
Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
Alzheimer Disease
Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
Alzheimer Disease
Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease.
Alzheimer Disease
Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and ?-glucosidase inhibitors.
Alzheimer Disease
Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation.
Alzheimer Disease
Novel N-benzylpiperidine carboxamide derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease.
Alzheimer Disease
Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease.
Alzheimer Disease
Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's Disease.
Alzheimer Disease
Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
Alzheimer Disease
Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and ?-secretase inhibition activities.
Alzheimer Disease
Nutraceutical Potential of Phenolics from 'Brava' and 'Mansa' Extra-Virgin Olive Oils on the Inhibition of Enzymes Associated to Neurodegenerative Disorders in Comparison with Those of 'Picual' and 'Cornicabra'.
Alzheimer Disease
Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
Alzheimer Disease
Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease.
Alzheimer Disease
Older patients are still under-represented in clinical trials of Alzheimer's disease.
Alzheimer Disease
Omega-3 Fatty Acids Increase Amyloid-? Immunity, Energy, and Circadian Rhythm for Cognitive Protection of Alzheimer's Disease Patients Beyond Cholinesterase Inhibitors.
Alzheimer Disease
On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases.
Alzheimer Disease
Oral donepezil reduces hypersensitivity after nerve injury by a spinal muscarinic receptor mechanism.
Alzheimer Disease
Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.
Alzheimer Disease
Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease.
Alzheimer Disease
Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors.
Alzheimer Disease
Outlining In Vitro and In Silico Cholinesterase Inhibitory Activity of Twenty-Four Natural Products of Various Chemical Classes: Smilagenin, Kokusaginine, and Methyl Rosmarinate as Emboldening Inhibitors.
Alzheimer Disease
Parallel improvement of cognitive functions and P300 latency following donepezil treatment in patients with Alzheimer's disease: a case-control study.
Alzheimer Disease
Parkinson's disease dementia: clinical correlates of brain spect perfusion and treatment.
Alzheimer Disease
Patient and caregiver outcomes after 6 +/- 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: the Belgian FExT study.
Alzheimer Disease
Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months.
Alzheimer Disease
Pelargonidin improves memory deficit in amyloid ?25-35 rat model of Alzheimer's disease by inhibition of glial activation, cholinesterase, and oxidative stress.
Alzheimer Disease
Peripheral cholinoceptor antagonist anisodamine counteracts cholinergic adverse effects and facilitates cognitive amelioration of rivastigmine.
Alzheimer Disease
Peripheral vascular responses to acetylcholine as a predictive tool for response to cholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's disease.
Alzheimer Disease
Persistence with cholinesterase inhibitor treatment in Alzheimer's disease.
Alzheimer Disease
Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer's disease (AD).
Alzheimer Disease
Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.
Alzheimer Disease
Pharmaco-EEG test dose response predicts cholinesterase inhibitor treatment outcome in Alzheimer's disease.
Alzheimer Disease
Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.
Alzheimer Disease
Pharmacodynamics and pharmacokinetics of eptastigmine in elderly subjects.
Alzheimer Disease
Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
Alzheimer Disease
Pharmacoeconomics of Alzheimer's disease (AD) treatment with cholinesterase inhibitors.
Alzheimer Disease
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.
Alzheimer Disease
Pharmacogenetic Aspects of Therapy with Cholinesterase Inhibitors: The Role of CYP2D6 in Alzheimer's Disease Pharmacogenetics.
Alzheimer Disease
Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.
Alzheimer Disease
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease.
Alzheimer Disease
Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.
Alzheimer Disease
Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats.
Alzheimer Disease
Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease.
Alzheimer Disease
Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
Alzheimer Disease
Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review.
Alzheimer Disease
Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers.
Alzheimer Disease
Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species.
Alzheimer Disease
Pharmacokinetics, excretion and metabolites analysis of DL0410, a dual?acting cholinesterase inhibitor and histamine?3 receptor antagonist.
Alzheimer Disease
Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people.
Alzheimer Disease
Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl- and Thioxo-1,2,4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors.
Alzheimer Disease
Pharmacological therapy for people with Alzheimer's disease: the balance of clinical effectiveness, ethical issues and social and healthcare costs.
Alzheimer Disease
Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics.
Alzheimer Disease
Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease.
Alzheimer Disease
Pharmacophore based 3DQSAR of phenothiazines as specific human butyrylcholinesterase inhibitors for treatment of Alzheimer's disease.
Alzheimer Disease
Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease.
Alzheimer Disease
Pharmacophore-based virtual screening and molecular docking to identify promising dual inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Alzheimer Disease
Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors.
Alzheimer Disease
Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
Alzheimer Disease
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?
Alzheimer Disease
Phenolic Profiles, Antioxidant, and Inhibitory Activities of Kadsura heteroclita (Roxb.) Craib and Kadsura coccinea (Lem.) A.C. Sm.
Alzheimer Disease
Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents.
Alzheimer Disease
Physicians' efficacy requirements for prescribing medications to persons with Alzheimer's disease*.
Alzheimer Disease
Physiological and neurobehavioral effects of cholinesterase inhibition in healthy adults.
Alzheimer Disease
Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain.
Alzheimer Disease
Phytochemical Analysis and Cholinesterase Inhibitory and Antioxidant Activities of Enhydra fluctuans Relevant in the Management of Alzheimer's Disease.
Alzheimer Disease
Phytochemical Analysis and Evaluation of Biological Activity of Lawsonia inermis Seeds Related to Alzheimer's Disease.
Alzheimer Disease
Phytochemical profile and anticholinesterase and antimicrobial activities of supercritical versus conventional extracts of Satureja montana.
Alzheimer Disease
Phytochemical profile of a blend of black chokeberry and lemon juice with cholinesterase inhibitory effect and antioxidant potential
Alzheimer Disease
Phytochemical profile of a blend of black chokeberry and lemon juice with cholinesterase inhibitory effect and antioxidant potential.
Alzheimer Disease
Phytomedicines as potential inhibitors of ? amyloid aggregation: significance to Alzheimer's disease.
Alzheimer Disease
Plant-Based Synthesis of Zinc Oxide Nanoparticles (ZnO-NPs) Using Aqueous Leaf Extract of Aquilegia pubiflora: Their Antiproliferative Activity against HepG2 Cells Inducing Reactive Oxygen Species and Other In Vitro Properties.
Alzheimer Disease
Plasma Abeta levels as predictors of response to rivastigmine treatment in Alzheimer's disease.
Alzheimer Disease
Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies?
Alzheimer Disease
Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer's disease and aging.
Alzheimer Disease
Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer's disease.
Alzheimer Disease
Policy-induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia.
Alzheimer Disease
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
Alzheimer Disease
Potential alternatives to current cholinesterase inhibitors: an in silico drug repurposing approach.
Alzheimer Disease
Potential anti-cholinesterase and ?-site amyloid precursor protein cleaving enzyme 1 inhibitory activities of cornuside and gallotannins from Cornus officinalis fruits.
Alzheimer Disease
Potential for intermittent stimulation of nucleus basalis of Meynert to impact treatment of alzheimer's disease.
Alzheimer Disease
Potential long-term effects of rivastigmine on disease progression may be linked to drug effects on vascular changes in Alzheimer brains.
Alzheimer Disease
Potential Nutraceutical Properties of Leaves from Several Commonly Cultivated Plants.
Alzheimer Disease
Potential role for estrogen replacement in the treatment of Alzheimer's dementia.
Alzheimer Disease
Potentially inappropriate prescriptions of anticholinergics drugs in Alzheimer's disease patients.
Alzheimer Disease
Potentially procholinergic effects of medications commonly used in older adults.
Alzheimer Disease
Pratensein attenuates A?-induced cognitive deficits in rats: Enhancement of synaptic plasticity and cholinergic function.
Alzheimer Disease
Precision medicine in Alzheimer's disease: An origami paper-based electrochemical device for cholinesterase inhibitors.
Alzheimer Disease
Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
Alzheimer Disease
Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease.
Alzheimer Disease
Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease.
Alzheimer Disease
Prediction models for assessing long-term outcome in Alzheimer's disease: a review.
Alzheimer Disease
Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery.
Alzheimer Disease
Predictive Factors of Clinical Response to Cholinesterase Inhibitors in Mild and Moderate Alzheimer's Disease and Mixed Dementia: A One-Year Naturalistic Study.
Alzheimer Disease
Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study.
Alzheimer Disease
Predictors of long-term treatment effect of rivastigmine in Alzheimer's disease: a role for beta-amyloid plasma levels?
Alzheimer Disease
Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.
Alzheimer Disease
Predictors of sustained response to rivastigmine in patients with Alzheimer's disease: a retrospective analysis.
Alzheimer Disease
Preliminary evidence that rivastigmine-induced inhibition of serum butyrylcholinesterase activity improves behavioral symptoms in Japanese patients with Alzheimer's disease.
Alzheimer Disease
Preparation and characterization of rivastigmine loaded human serum albumin (HSA) nanoparticles.
Alzheimer Disease
Prescribing Cholinesterase Inhibitors for Alzheimer Disease: Timing Matters.
Alzheimer Disease
Prescription patterns and efficacy of drugs for patients with dementia: physicians' perspective in Italy.
Alzheimer Disease
Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients.
Alzheimer Disease
Pretreatment postural blood pressure drop as a possible predictor of response to the cholinesterase inhibitor velnacrine (HP 029) in Alzheimer's disease.
Alzheimer Disease
Prevalence of positive carotid sinus massage and related risk of syncope in patients with Alzheimer's disease.
Alzheimer Disease
Preventive role of Indian black pepper in animal models of Alzheimer's disease.
Alzheimer Disease
Profiling Auspicious Butyrylcholinesterase Inhibitory Activity of Two Herbal Molecules: Hyperforin and Hyuganin C.
Alzheimer Disease
Progress in clinical neurosciences: Treatment of Alzheimer's disease and other dementias--review and comparison of the cholinesterase inhibitors.
Alzheimer Disease
Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism.
Alzheimer Disease
Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.
Alzheimer Disease
Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer's disease.
Alzheimer Disease
Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activation.
Alzheimer Disease
Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
Alzheimer Disease
Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease.
Alzheimer Disease
Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease.
Alzheimer Disease
Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Alzheimer Disease
Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-?-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Alzheimer Disease
Pteryxin - A promising butyrylcholinesterase-inhibiting coumarin derivative from Mutellina purpurea.
Alzheimer Disease
Purification of Acetylcholinesterase by 9-Amino-1,2,3,4-tetrahydroacridine from Human Erythrocytes.
Alzheimer Disease
Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists.
Alzheimer Disease
Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast ?-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Alzheimer Disease
Quality of life and cholinesterase inhibitors: a qualitative study of patients with Alzheimer's Disease and their carers.
Alzheimer Disease
Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
Alzheimer Disease
Quantitative whole-body autoradiographic determination of tacrine tissue distribution in rats following intravenous or oral dose.
Alzheimer Disease
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
Alzheimer Disease
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy.
Alzheimer Disease
Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity.
Alzheimer Disease
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
Alzheimer Disease
Rapid and sensitive detection of the inhibitive activities of acetyl- and butyryl-cholinesterases inhibitors by UPLC-ESI-MS/MS.
Alzheimer Disease
Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening.
Alzheimer Disease
Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
Alzheimer Disease
Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis.
Alzheimer Disease
Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer's disease.
Alzheimer Disease
Rational design of a drug for Alzheimer's disease with cholinesterase inhibitory and neuroprotective activity.
Alzheimer Disease
Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.
Alzheimer Disease
RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?
Alzheimer Disease
rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine.
Alzheimer Disease
Re: Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease.
Alzheimer Disease
Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial.
Alzheimer Disease
Reassessment of the dementia diagnosis of Alzheimer's disease in patients enrolled on the cholinesterase inhibitors dispensation program.
Alzheimer Disease
Recent developments in tau-based therapeutics for neurodegenerative diseases.
Alzheimer Disease
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Alzheimer Disease
Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer's Disease.
Alzheimer Disease
Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease.
Alzheimer Disease
Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease.
Alzheimer Disease
Regulators of cholinergic signaling in disorders of the central nervous system.
Alzheimer Disease
Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.
Alzheimer Disease
Relationship between cholinesterase inhibitors and Pisa syndrome in a cohort of five French patients with Alzheimer's disease.
Alzheimer Disease
Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group.
Alzheimer Disease
Relationship between Pisa syndrome and cholinesterase inhibitor use for elderly adults with Alzheimer's disease.
Alzheimer Disease
Removal of Drugs for Alzheimer's Disease from the List of Reimbursable Drugs in France: Analysis of Change in Drug Use, Disease Management and Cognition Using the National Alzheimer Data Bank (BNA).
Alzheimer Disease
Reports in pharmacological treatments in geriatric psychiatry: is there anything new or just adding to old evidence?
Alzheimer Disease
Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor.
Alzheimer Disease
Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
Alzheimer Disease
Responders to ChEI treatment of Alzheimer's disease show restitution of normal regional cortical activation.
Alzheimer Disease
Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression.
Alzheimer Disease
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.
Alzheimer Disease
Response to letter from Garcia and colleagues on cholinesterase inhibitors and Alzheimer's disease outcomes.
Alzheimer Disease
Responses of hypothalamo-pituitary-adrenal axis to a cholinesterase inhibitor.
Alzheimer Disease
Responsiveness to cholinesterase inhibitors in Alzheimer's disease: a possible role for the 192 Q/R polymorphism of the PON-1 gene.
Alzheimer Disease
Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study.
Alzheimer Disease
Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study.
Alzheimer Disease
Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates.
Alzheimer Disease
Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
Alzheimer Disease
Review: cholinesterase inhibitors have a modest effect on neuropsychiatric and functional outcomes in Alzheimer's disease.
Alzheimer Disease
Review: Cholinesterase inhibitors may be effective in Alzheimer's disease.
Alzheimer Disease
Review: cholinesterase inhibitors reduce burden and care time for informal carers of people with Alzheimer's disease.
Alzheimer Disease
Risk Factors for Nursing Home Placement in Alzheimer's Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment.
Alzheimer Disease
Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.
Alzheimer Disease
Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study.
Alzheimer Disease
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
Alzheimer Disease
Rivastigmine for Alzheimer's disease.
Alzheimer Disease
Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia.
Alzheimer Disease
Rivastigmine improves dual-task gait velocity in patients with Alzheimer's disease.
Alzheimer Disease
Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Alzheimer Disease
Rivastigmine modifies the ?-secretase pathway and potentially early Alzheimer's disease.
Alzheimer Disease
Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment.
Alzheimer Disease
Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand.
Alzheimer Disease
Rivastigmine transdermal patch 13.3 mg/24 h: a review of its use in the management of mild to moderate Alzheimer's dementia.
Alzheimer Disease
Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.
Alzheimer Disease
Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type.
Alzheimer Disease
Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease.
Alzheimer Disease
Rivastigmine. A pharmacoeconomic review of its use in Alzheimer's disease.
Alzheimer Disease
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.
Alzheimer Disease
Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis.
Alzheimer Disease
Role of Cholinesterase Inhibitors in Managing Behavioral Problems in Alzheimer's Disease.
Alzheimer Disease
Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease.
Alzheimer Disease
Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study.
Alzheimer Disease
Safety and efficacy of rivastigmine in patients with Alzheimer's disease not responding adequately to donepezil: an open-label study.
Alzheimer Disease
Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.
Alzheimer Disease
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
Alzheimer Disease
Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.
Alzheimer Disease
Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia.
Alzheimer Disease
Savings from sub-groups?: policy guidance and Alzheimer's disease treatments.
Alzheimer Disease
Scocycamides, a Pair of Macrocyclic Dicaffeoylspermidines with Butyrylcholinesterase Inhibition and Antioxidation Activity from the Roots of Scopolia tangutica.
Alzheimer Disease
Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets.
Alzheimer Disease
Screening and identification of secondary metabolites in the bark of Bauhinia variegata to treat Alzheimer's disease by using molecular docking and molecular dynamics simulations.
Alzheimer Disease
Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force.
Alzheimer Disease
Seizures in an Alzheimer's disease patient as a complication of colonoscopy premedication with meperidine.
Alzheimer Disease
Selective Acetyl- and Butyrylcholinesterase Inhibitors Reduce amyloid-? Ex Vivo Activation of Peripheral Chemo-Cytokines from Alzheimer's Disease Subjects: Exploring the Cholinergic Anti-Inflammatory Pathway.
Alzheimer Disease
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.
Alzheimer Disease
Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease?
Alzheimer Disease
Selective in vitro and in silico butyrylcholinesterase inhibitory activity of diterpenes and rosmarinic acid isolated from Perovskia atriplicifolia Benth. and Salvia glutinosa L.
Alzheimer Disease
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse Model.
Alzheimer Disease
Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.
Alzheimer Disease
Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems.
Alzheimer Disease
Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Alzheimer Disease
Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease.
Alzheimer Disease
Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease.
Alzheimer Disease
Sex and Gender Differences in the Brain Cholinergic System and in the Response to Therapy of Alzheimer Disease with Cholinesterase Inhibitors.
Alzheimer Disease
Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.
Alzheimer Disease
Short- and long-term efficacy of cholinesterase inhibitors in older adults with alzheimer's disease and mixed dementia: results of a 21-month observational study.
Alzheimer Disease
Short-Term Response is not Predictive of Long-Term Response to Acetylcholinesterase Inhibitors in Old Age Subjects with Alzheimer's Disease: A "Real World" Study.
Alzheimer Disease
Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.
Alzheimer Disease
Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.
Alzheimer Disease
Significant effects of cholinesterase inhibitors on tau pathology in the Alzheimer's disease continuum: An in vivo positron emission tomography study.
Alzheimer Disease
Simultaneous release of glutamate and acetylcholine from single magnocellular "cholinergic" basal forebrain neurons.
Alzheimer Disease
Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.
Alzheimer Disease
Spatial discrimination deficits by excitotoxic lesions in the Morris water escape task.
Alzheimer Disease
Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.
Alzheimer Disease
Species- and concentration-dependent differences of Acetyl- and Butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Alzheimer Disease
Spiro Heterocyclic Compounds as Potential Anti-Alzheimer agents (Part 2): their Metal Chelation Capacity, POM Analyses and DFT Studies.
Alzheimer Disease
Spotlight on rivastigmine transdermal patch: in dementia of the Alzheimer's type.
Alzheimer Disease
Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.
Alzheimer Disease
Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease not affected by co-administration of memantine: an open-label, crossover, single-centre study.
Alzheimer Disease
Stereoselective glucuronidation metabolism, pharmacokinetics, anti-amnesic pharmacodynamics, and toxic properties of vasicine enantiomers in vitro and in vivo.
Alzheimer Disease
Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.
Alzheimer Disease
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors.
Alzheimer Disease
Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism.
Alzheimer Disease
Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.
Alzheimer Disease
Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
Alzheimer Disease
Structure-activity relationship, in vitro and in vivo evaluation of novel dienyl sulphonyl fluorides as selective BuChE inhibitors for the treatment of Alzheimer's disease.
Alzheimer Disease
Structure-based virtual screening leading to discovery of highly selective butyrylcholinesterase inhibitors with solanaceous alkaloid scaffolds.
Alzheimer Disease
Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer's disease: a cumulative meta-analysis and trial sequential analysis.
Alzheimer Disease
Subchronic use of rivastigmine increases procognitive flexibility across multimodal behavioral tasks in healthy male rats.
Alzheimer Disease
Suboptimal Baseline Serum Vitamin B12 Is Associated With Cognitive Decline in People With Alzheimer's Disease Undergoing Cholinesterase Inhibitor Treatment.
Alzheimer Disease
Switching cholinesterase inhibitors in patients with Alzheimer's disease.
Alzheimer Disease
Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France.
Alzheimer Disease
Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease.
Alzheimer Disease
Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Alzheimer Disease
Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
Alzheimer Disease
Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.
Alzheimer Disease
Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Alzheimer Disease
Synthesis and bio-evaluation of a novel selective butyrylcholinesterase inhibitor discovered through structure-based virtual screening.
Alzheimer Disease
Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Alzheimer Disease
Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and A?1-42 Aggregation Inhibitors for Alzheimer's Disease Therapy.
Alzheimer Disease
Synthesis and biological evaluation of 3-arylbenzofuranone derivatives as potential anti-Alzheimer's disease agents.
Alzheimer Disease
Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease.
Alzheimer Disease
Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer's Disease.
Alzheimer Disease
Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Alzheimer Disease
Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and ?-glycosidase inhibitors.
Alzheimer Disease
Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease.
Alzheimer Disease
Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
Alzheimer Disease
Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.
Alzheimer Disease
Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine-new tacrine derivate with cholinergic properties.
Alzheimer Disease
Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer's disease treatment.
Alzheimer Disease
Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
Alzheimer Disease
Synthesis and In Vitro Screening of Novel Heterocyclic ?-d-Gluco- and ?-d-Galactoconjugates as Butyrylcholinesterase Inhibitors.
Alzheimer Disease
Synthesis and Initial Characterization of a Selective, Pseudo-irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer.
Alzheimer Disease
Synthesis and pharmacological evaluation of multi-functional homoisoflavonoid derivatives as potent inhibitors of monoamine oxidase B and cholinesterase for the treatment of Alzheimer's disease.
Alzheimer Disease
Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
Alzheimer Disease
Synthesis and Preliminary Evaluation of Piperidinyl and Pyrrolidinyl Iodobenzoates as Imaging Agents for Butyrylcholinesterase.
Alzheimer Disease
Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
Alzheimer Disease
Synthesis of 5-methyl-2,4-dihydro-3H-1,2,4-triazole-3-one's aryl Schiff base derivatives and investigation of carbonic anhydrase and cholinesterase (AChE, BuChE) inhibitory properties.
Alzheimer Disease
Synthesis of carbon-11-labeled bivalent ?-carbolines as new PET agents for imaging of cholinesterase in Alzheimer's disease.
Alzheimer Disease
Synthesis of donepezil-based multifunctional agents for the treatment of Alzheimer's disease.
Alzheimer Disease
Synthesis of N-phenylsulfonamide derivatives and investigation of some esterase enzymes inhibiting properties.
Alzheimer Disease
Synthesis of novel bis-sulfone derivatives and their inhibition properties on some metabolic enzymes including carbonic anhydrase, acetylcholinesterase, and butyrylcholinesterase.
Alzheimer Disease
Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
Alzheimer Disease
Synthesis of novel purine nucleosides towards a selective inhibition of human butyrylcholinesterase.
Alzheimer Disease
Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics.
Alzheimer Disease
Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer's disease.
Alzheimer Disease
Synthesis, Characterization, and Inhibition Study of Novel Substituted Phenylureido Sulfaguanidine Derivatives as ?-Glycosidase and Cholinesterase Inhibitors.
Alzheimer Disease
Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
Alzheimer Disease
Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease.
Alzheimer Disease
Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
Alzheimer Disease
Synthesis, molecular modeling and evaluation of novel N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone derivatives as dual inhibitors for cholinesterases and A? aggregation.
Alzheimer Disease
Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Alzheimer Disease
Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias.
Alzheimer Disease
Systematic Review of Cholinesterase Inhibitors on Cognition and Behavioral Symptoms in Patients of Chinese Descent with Alzheimer's Disease, Vascular Dementia, or Mixed Dementia.
Alzheimer Disease
Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia.
Alzheimer Disease
Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells.
Alzheimer Disease
Tacrine hydrochloride treatment IND: methods for rapid physician and patient enrollment and data retrieval.
Alzheimer Disease
Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography.
Alzheimer Disease
Tacrine sinusoidal uptake and biliary excretion in sandwich-cultured primary rat hepatocytes.
Alzheimer Disease
Tacrine, an Oral Acetylcholinesterase Inhibitor, Induced Hepatic Oxidative Damage, Which Was Blocked by Liquiritigenin through GSK3-beta Inhibition.
Alzheimer Disease
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors.
Alzheimer Disease
Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease.
Alzheimer Disease
Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
Alzheimer Disease
Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil.
Alzheimer Disease
Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease.
Alzheimer Disease
Terpenes and Phenylpropanoids as Acetyl- and Butyrylcholinesterase Inhibitors: A Comparative Study.
Alzheimer Disease
Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons.
Alzheimer Disease
Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease.
Alzheimer Disease
THA improves word priming and clonidine enhances fluency and working memory in Alzheimer's disease.
Alzheimer Disease
The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine-A randomized, double-blind, placebo-controlled trial.
Alzheimer Disease
The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression.
Alzheimer Disease
The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: Interim Results after Two Years of Treatment.
Alzheimer Disease
The ASCOMALVA trial: Association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: Interim results.
Alzheimer Disease
The Association Between the Use of Cholinesterase Inhibitors and Cardiovascular Events Among Older Patients With Alzheimer Disease.
Alzheimer Disease
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
Alzheimer Disease
The benefits of cholinesterase inhibitors: managing the behavioral and neuropsychiatric symptoms of Alzheimer's disease.
Alzheimer Disease
The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations.
Alzheimer Disease
The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.
Alzheimer Disease
The butyrylcholinesterase K variant confers structurally-derived risks for Alzheimer's pathology.
Alzheimer Disease
The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.
Alzheimer Disease
The butyrylcholinesterase K-variant shows similar cellular protein turnover and quaternary interaction to the wild-type enzyme.
Alzheimer Disease
The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.
Alzheimer Disease
The cerebrovascular effects of physostigmine are not mediated through the substantia innominata.
Alzheimer Disease
The cerebrovascular role of the cholinergic neural system in Alzheimer's disease.
Alzheimer Disease
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
Alzheimer Disease
The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
Alzheimer Disease
The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis.
Alzheimer Disease
The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patients.
Alzheimer Disease
The cognitive effects of cholinesterase inhibitor treatment in every-day practice.
Alzheimer Disease
The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis.
Alzheimer Disease
The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice?
Alzheimer Disease
The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach.
Alzheimer Disease
The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model.
Alzheimer Disease
The effect of APOE ?4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity magnetic resonance imaging.
Alzheimer Disease
The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort.
Alzheimer Disease
The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia.
Alzheimer Disease
The effect of drugs for Alzheimer disease assessed by means of neuroradiological techniques.
Alzheimer Disease
The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate.
Alzheimer Disease
The effect of tacrine and lecithin in Alzheimer's disease. A population pharmacodynamic analysis of five clinical trials.
Alzheimer Disease
The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex.
Alzheimer Disease
The effects of donepezil on quantitative EEG in patients with Alzheimer's disease.
Alzheimer Disease
The effects of donepezil on the P300 auditory and visual cognitive evoked potentials of patients with Alzheimer's disease.
Alzheimer Disease
The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.
Alzheimer Disease
The efficacy and safety of memantine for the treatment of Alzheimer's disease.
Alzheimer Disease
The evidence for the efficacy of cholinesterase inhibitors in the treatment of Alzheimer's disease is convincing.
Alzheimer Disease
The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics.
Alzheimer Disease
The exploration of thienothiazines as selective butyrylcholinesterase inhibitors.
Alzheimer Disease
The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer's Disease.
Alzheimer Disease
The impact of memantine and cholinesterase inhibitor initiation for Alzheimer disease on the use of antipsychotic agents: analysis using the Régie de l'Assurance Maladie du Québec database.
Alzheimer Disease
The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.
Alzheimer Disease
The impact of some phenolic compounds on serum acetylcholinesterase: kinetic analysis of an enzyme/inhibitor interaction and molecular docking study.
Alzheimer Disease
The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase.
Alzheimer Disease
The International Psychogeriatric Association--ninth congress. 15-20 August 1999, Vancouver, Canada.
Alzheimer Disease
The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity.
Alzheimer Disease
The modulatory role of prime identified compounds in Geophila repens in mitigating scopolamine-induced neurotoxicity in experimental rats of Alzheimer's disease via attenuation of cholinesterase, ?-secretase, MAPt levels and inhibition of oxidative stress imparts inflammation.
Alzheimer Disease
The National Institute for Health and Clinical Excellence (NICE) and drug treatment for Alzheimer's disease.
Alzheimer Disease
The neuroprotective mechanism of action of the multimodal drug ladostigil.
Alzheimer Disease
The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesis.
Alzheimer Disease
The new cholinesterase inhibitors for Alzheimer's disease, Part 1: their similarities are different.
Alzheimer Disease
The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action.
Alzheimer Disease
The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system.
Alzheimer Disease
The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats.
Alzheimer Disease
The oxidation products of melatonin derivatives exhibit acetylcholinesterase and butyrylcholinesterase inhibitory activity.
Alzheimer Disease
The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease.
Alzheimer Disease
The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's disease.
Alzheimer Disease
The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient.
Alzheimer Disease
The ratio of acetylcholinesterase to butyrylcholinesterase influences the specificity of assays for each enzyme in human brain.
Alzheimer Disease
The recovery of cerebrospinal fluid acetylcholinesterase activity in Alzheimer's disease patients after treatment with metrifonate.
Alzheimer Disease
The response of the autonomic nervous system to the cholinesterase inhibitor, donepezil.
Alzheimer Disease
The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer's Disease Pathogenesis.
Alzheimer Disease
The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease.
Alzheimer Disease
The safety and tolerability of donepezil in patients with Alzheimer's disease.
Alzheimer Disease
The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.
Alzheimer Disease
The Serum Protein and Lipid Oxidation Marker Levels in Alzheimer's Disease and Effects of Cholinesterase Inhibitors and Antipsychotic Drugs Therapy.
Alzheimer Disease
The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease.
Alzheimer Disease
The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.
Alzheimer Disease
The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease.
Alzheimer Disease
The utility of muscarinic agonists in the treatment of Alzheimer's disease.
Alzheimer Disease
Thioesters for the in vitro evaluation of agents to image brain cholinesterases.
Alzheimer Disease
Thyroid function in patients with Alzheimer's disease treated with cholinesterase inhibitors.
Alzheimer Disease
To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease.
Alzheimer Disease
Toxicological Differences Between NMDA Receptor Antagonists and Cholinesterase Inhibitors.
Alzheimer Disease
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
Alzheimer Disease
Treating Alzheimer's disease with cholinesterase inhibitors: what have we learned so far?
Alzheimer Disease
Treating Alzheimer's disease: do clinical trial methods produce unnecessary practitioner dilemmas?
Alzheimer Disease
Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate.
Alzheimer Disease
Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study.
Alzheimer Disease
Treatment effects of EGb 761 and cholinesterase inhibitors--why available studies do not demonstrate superiority of the latter.
Alzheimer Disease
Treatment effects of therapeutic cholinesterase inhibitors on visuospatial processing in Alzheimer's disease: a longitudinal functional MRI study.
Alzheimer Disease
Treatment of advanced Alzheimer's disease with cholinesterase inhibitors.
Alzheimer Disease
Treatment of Alzheimer disease by continuous intravenous infusion of physostigmine.
Alzheimer Disease
Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants.
Alzheimer Disease
Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.
Alzheimer Disease
Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Alzheimer Disease
Treatment strategies in Alzheimer's disease with a focus on early pharmacological interventions.
Alzheimer Disease
Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative.
Alzheimer Disease
Treatment with rivastigmine or galantamine and risk of urinary incontinence: results from a Dutch database study.
Alzheimer Disease
Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer's disease dispensed by the Brazilian public health system - 2008 to 2014: a nation-wide analysis.
Alzheimer Disease
Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
Alzheimer Disease
Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease.
Alzheimer Disease
TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease.
Alzheimer Disease
Two-year treatment of Alzheimer's disease with eptastigmine. The Eptastigmine Study Group.
Alzheimer Disease
Ultrastructural localization of butyrylcholinesterase in senile plaques in the brains of aged and Alzheimer disease patients.
Alzheimer Disease
Ultrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patients.
Alzheimer Disease
Use of antidementia agents in vascular dementia: beyond Alzheimer disease.
Alzheimer Disease
Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study.
Alzheimer Disease
Use of artificial networks in clinical trials: a pilot study to predict responsiveness to donepezil in Alzheimer's disease.
Alzheimer Disease
Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.
Alzheimer Disease
Use of Cholinesterase Inhibitors Increases Initiation of Urinary Anticholinergics in Persons with Alzheimer's Disease.
Alzheimer Disease
Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands.
Alzheimer Disease
Using a distribution-based approach and systematic review methods to derive minimum clinically important differences.
Alzheimer Disease
Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups.
Alzheimer Disease
Utility of an effect size analysis for communicating treatment effectiveness: a case study of cholinesterase inhibitors for Alzheimer's disease.
Alzheimer Disease
Utilization of Antihypertensives, Antidepressants, Antipsychotics, and Hormones in Alzheimer Disease.
Alzheimer Disease
Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group.
Alzheimer Disease
What are the benefits of cognitive enhancers for Alzheimer's Disease: use of Population Impact Measures.
Alzheimer Disease
What are the treatment options for patients with severe Alzheimer's disease?
Alzheimer Disease
What constitutes clinical evidence for neuroprotection in Alzheimer disease: support for the cholinesterase inhibitors?
Alzheimer Disease
Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease?
Alzheimer Disease
Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain.
Alzheimer Disease
Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties.
Alzheimer Disease
Withanolides: Biologically Active Constituents in the Treatment of Alzheimer Disease.
Alzheimer Disease
[A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia]
Alzheimer Disease
[Access to medicines for Alzheimer's disease provided by the Brazilian Unified National Health System in Minas Gerais State, Brazil].
Alzheimer Disease
[Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko]
Alzheimer Disease
[Biological therapies of behavioral and psychological symptoms of dementia: update and prospects]
Alzheimer Disease
[Cardiovascular effects of cholinesterase inhibitors in Alzheimer's disease]
Alzheimer Disease
[Changes in butyrylcholinesterase activity in patients with Alzheimer disease treated with acetylcholinesterase inhibitors.]
Alzheimer Disease
[Cholinergic deficiency syndrome as an indicator for the cholinesterase inhibitors]
Alzheimer Disease
[Cholinesterase activity assays and their use in the diagnosis of various pathological states including poisoning by neurotoxic agents].
Alzheimer Disease
[Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies]
Alzheimer Disease
[Cholinesterase inhibitors for Alzheimer disease: preliminary recommendations for treatment. Dutch Society for Psychiatry, Section of Geriatric Psychiatry]
Alzheimer Disease
[Cholinesterase inhibitors in Alzheimer disease: preliminary recommendations for the practice]
Alzheimer Disease
[Cholinesterase inhibitors in Alzheimer disease: preliminary recommendations for treatment]
Alzheimer Disease
[Cholinesterase inhibitors in Alzheimer disease; preliminary recommendations for the practice]
Alzheimer Disease
[Cholinesterase inhibitors in dementia: the precarious balance between efficacy and safety]
Alzheimer Disease
[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]
Alzheimer Disease
[Detection of Alzheimer's disease in general medicine: preliminary results of a Sentinelles general practitioner's network survey]
Alzheimer Disease
[Donepezil in patients with Alzheimer's disease--a critical appraisal of the AD2000 study]
Alzheimer Disease
[Inhibitory effects of sinapine on activity of acetylcholinesterase in cerebral homogenate and blood serum of rats]
Alzheimer Disease
[Mortality rates in patients with Alzheimer's disease treated with atypical neuroleptic drugs]
Alzheimer Disease
[Mortality-associated factors in patients with Alzheimer's disease treated with galantamine]
Alzheimer Disease
[Neuropsychological assessment in the diagnosis and differential diagnosis of fronto-temporal dementia.]
Alzheimer Disease
[Newly approved drugs for Alzheimer disease: effectiveness and limitation].
Alzheimer Disease
[Oral galantamine versus rivastigmine transdermal patch: a descriptive study at a memory clinic in The Netherlands]
Alzheimer Disease
[Posterior cortical atrophy. Pathology, diagnosis and treatment of a rare form of dementia].
Alzheimer Disease
[Prescription of cholinesterase inhibitors in Alzheimer's disease in France in 2000-2001: an assessment of compliance with national guidelines for diagnosis and follow-up]
Alzheimer Disease
[Present trends in the development of drugs within the cholinesterase inhibitor group as therapeutic agents for Alzheimer's disease]
Alzheimer Disease
[Problems and questions of pharmacological therapy of Alzheimer's disease with cholinesterase inhibitors]
Alzheimer Disease
[Quality of life and dementia. I. Model of assessment of wellbeing in dementia patients]
Alzheimer Disease
[Relation between Pisa syndrome and choline esterase inhibitors in a cohort of Alzheimer's disease patients]
Alzheimer Disease
[Rivastigmine in a case of autopsy proved frontotemporal dementia (Pick's disease)]
Alzheimer Disease
[Severe bradycardia in general anaesthesia in a patient treated with cholinesterase inhibitors for dementia.]
Alzheimer Disease
[Study on the activity of cholinesterase and its distribution in molecular form in the cerebrospinal fluid of patients with Alzheimer's disease, a possible diagnostic marker?]
Alzheimer Disease
[Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine]
Alzheimer Disease
[The effect of a cholinesterase inhibitor on the vitality in Alzheimer disease]
Alzheimer Disease
[Treatment of Alzheimer's disease according to the S3 guidelines on dementia. Choline esterase inhibitors for all and for ever?].
Alzheimer Disease
[Treatment of Alzheimer's disease utilising the best available evidence-based medicine -- utopia?]
Alzheimer Disease
[Treatment pattern of Alzheimer's disease with cholinesterase inhibitors (TRAIN study)]
Amblyopia
Donepezil Does Not Enhance Perceptual Learning in Adults with Amblyopia: A Pilot Study.
Amnesia
Ameliorative effect of deoxyvasicine on scopolamine-induced cognitive dysfunction by restoration of cholinergic function in mice.
Amnesia
Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.
Amnesia
An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.
Amnesia
Characterization of the effects of scopolamine on the habituation of exploratory activity: differential effects of oxotremorine and physostigmine.
Amnesia
Comparison of three different extracts of Centella asiatica for anti-amnesic, antioxidant and anticholinergic activities: in vitro and in vivo study.
Amnesia
Effects of a new synthetic butyrylcholinesterase inhibitor, HBU-39, on cell proliferation and neuroblast differentiation in the hippocampal dentate gyrus in a scopolamine-induced amnesia animal model.
Amnesia
Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats.
Amnesia
FK960, a potential anti-dementia drug, increases synaptic density in the hippocampal CA3 region of aged rats.
Amnesia
Role of cholinergic and GABAergic neuronal systems in cycloheximide-induced amnesia in mice.
Amnesia
Synthesis and evaluation of novel 4-[(3H,3aH,6aH)-3-phenyl)-4,6-dioxo-2-phenyldihydro-2H-pyrrolo[3,4-d]isoxazol-5(3H,6H,6aH)-yl]benzoic acid derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents.
Amyloidosis
Serum esterase activity in reactive systemic amyloidosis and its relation to amyloid A degrading activity.
Amyotrophic Lateral Sclerosis
Acetylcholinesterase and ATPases in motor neuron degenerative diseases.
Amyotrophic Lateral Sclerosis
Cholinesterase activity of whole blood and plasma in amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Cholinesterase inhibitors lack therapeutic effect in amyotrophic lateral sclerosis. A controlled study of physostigmine versus neostigmine.
Anaphylaxis
[Iodine 131 with autography, hyperglycemia, cholinesterase, metabolism, thiomidil, anaphylactic shock, immunisation in hibernation.]
Anaphylaxis
[On changes of cholinesterase activity in the blood of the rabbit by sensitization and anaphylactic shock.]
Anaphylaxis
[Radioactive iodine with autography, hyperglycemia, cholinesterase, metabolism, thiomidil, anaphylactic shock, and immunization in hibernation.]
Anaphylaxis
[Role of cholinesterase in the mechanism of certain phenomena of anaphylactic shock.]
Anaphylaxis
[Variations of the cholinesterase power of the serum during anaphylactic shock and asthmatic attack artificially induced by acetylcholine and histamine aerosols.]
Anemia
A patient with Churg-Strauss syndrome who underwent endoscopic sinus surgery under general anesthesia -A case report-.
Anemia
Analysis of functional abnormalities uncovered during preoperative evaluation of donor candidates for living-related liver transplantation.
Anemia
Erythrocyte cholinesterase activity in normal pregnancy and in megaloblastic and other anemias of pregnancy and the puerperium.
Anemia
Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion.
Anemia
Plasma fibrinogen, cholinesterase activity, and anemia: utility of fibrinogen in multiphasic screening and in assessing the activity of diseases.
Anemia
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2?years of age - a multicenter retrospective study.
Anemia
[Factors for the onset of and the exacerbation of tuberculosis. 4. Clinical factors related to the onset and exacerbation of tuberculosis. b. Middle-aged and elderly patients]
Anemia
[Research in the relation between the defense action of certain antianemic substances (vitamin B12, pteroylglutamic acid) and the cholinesterase effect of the serum in experimental anemia of the rat].
Anemia, Aplastic
GM-CSF-mediated impairment of liver to synthesize albumin, cholinesterase, and cholesterol.
Anemia, Pernicious
A study of cholinesterase activity of the blood of patients with pernicious anemia.
Anemia, Pernicious
CHOLINE ESTERASE OF BLOOD CELLS AND PLASMA IN BLOOD DYSCRASIAS, WITH SPECIAL REFERENCE TO PERNICIOUS ANEMIA.
Anemia, Pernicious
[Cholinesterase in the plasma, erythrocytes and whole blood in pernicious anemia and leukemia.]
Anencephaly
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
Aneurysm
Activity of enzymes with different subcellular localization in the blood plasma of patients with aortic aneurysm.
Aneurysm
Cholinergic treatment of amnesia following basal forebrain lesion due to aneurysm rupture--an open-label pilot study.
Angina Pectoris
[The effect of new cholinesterase retarding substance on sympathicotonic circulation disorder, with special reference to angina pectoris.]
Anhedonia
Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats.
Anterior Wall Myocardial Infarction
[Electrocardiographic changes in acute organophosphate poisoning]
Aphasia, Primary Progressive
Primary Progressive Aphasia as a Prodromal State of Dementia With Lewy Bodies: A Case Report.
Apnea
A color reaction based rapid screening for null activity of butyrylcholinesterase: a step towards point of care screening for succinylcholine apnea.
Apnea
A mutation linked with autism reveals a common mechanism of endoplasmic reticulum retention for the alpha,beta-hydrolase fold protein family.
Apnea
A single mutation near the C-terminus in alpha/beta hydrolase fold protein family causes a defect in protein processing.
Apnea
Analysis of mutations in the plasma cholinesterase gene of patients with a history of prolonged neuromuscular block during anesthesia.
Apnea
Apnea in an atypical-fluoride resistant (E1aE1f) heterozygote for serum cholinesterase.
Apnea
Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.
Apnea
Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy.
Apnea
Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
Apnea
Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
Apnea
Characterization of four BCHE mutations associated with prolonged effect of suxamethonium.
Apnea
Cholinesterase unit establishment and issuing of >>Warning Cards<< for carriers of suxamethonium sensitive serum butyrylcholinesterase variants.
Apnea
Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran.
Apnea
Ethnic differences in the frequency of distribution of serum cholinesterase activity in the Iranian population.
Apnea
Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine.
Apnea
Increased sensitivity to succinylcholine in a patient heterozygous for the silent and the fluoride-resistant gene.
Apnea
Is succinyldicholine the substrate of choice for the measurement of cholinesterase activity?
Apnea
Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India.
Apnea
Prolonged apnea after ECT in organophosphorus poisoning - the need to redefine norms.
Apnea
Prolonged apnea caused by inherited cholinesterase deficiency after strabismus surgery.
Apnea
Prolonged apnea following succinylcholine administration in undiagnosed acute organophosphate poisoning.
Apnea
Prolonged neuromuscular blockade as a result of malnutrition-induced pseudocholinesterase deficiency.
Apnea
Prolonged Neuromuscular Paralysis Following Rapid-Sequence Intubation with Succinylcholine (April).
Apnea
Prolonged postoperative apnea complicating gynecologic surgery; atypical cholinesterase and myasthenia gravis.
Apnea
Prolonged postoperative succinylcholine-induced apnea with pseudocholinesterase deficiency.
Apnea
Prolonged succinylcholine-induced apnea caused by atypical cholinesterase: report of case.
Apnea
Rapid detection of BCHE atypical variant (p.Asp70Gly) by high resolution melting curve analysis.
Apnea
Reversal of succinylcholine induced apnea with an organophosphate scavenging recombinant butyrylcholinesterase.
Apnea
Succinylcholine-induced prolonged apnea in a 3-week-old newborn: treatment with human plasma cholinesterase.
Apnea
Suxamethonium induced prolonged apnea in a patient receiving electroconvulsive therapy.
Apnea
The allele frequency of T920C mutation in butyrylcholinesterase gene is high in an Indian population.
Apnea
The relation between plasma cholinesterase and prolonged apnea caused by succinylcholine.
Apnea
Therapy of prolonged apnea after suxamthonium with purified pseudocholinesterase. New data on kinetics of the hydrolysis of succinyldicholine and succinylmonocholine and further data on N-acetyltransferase-polymorphism.
Apnea
Transient respiratory depression of the newborn. Its occurrence after succinylcholine administration to the mother.
Apnea
[Data on serum cholinesterase activity in cases of prolonged apnea due to succinylcholine]
Apnea
[EFFECT OF THE STORAGE ON THE PSEUDOCHOLINESTERASE ACTIVITY IN DONOR'S BLOOD AND ITS SIGNIFICANCE IN THE TREATMENT OF APNEA.]
Apnea
[Phenotype of plasma cholinesterase in prolonged apnea and sensitivity to succinylcholine]
Apnea
[Plasma cholinesterase (CHE, pseudocholinesterase), its importance in liver diseases and prolonged succinyldicholine-induced apnea]
Apnea
[Plasma cholinesterase variations as a result of prolonged neuromuscular blockade. Review and problems encountered in two cases of prolonged neuromuscular blockade after muscle relaxation with succinylcholine as compared to mivacurium]
Apnea
[Polymorphism of plasma cholinesterase in Pyrennees populations. Problems in geographic hematology and pharmacogenetics]
Apnea
[Procedure for identifying atypical variants of pseudocholinesterase for the prevention of prolonged apnea induced by succinylcholine]
Apnea
[Prolonged apnea after suxamethonium related to congenital abnormality of plasma pseudocholinesterase]
Apnea
[Prolonged apnea caused by succinylcholine iodide, related to a lowered blood cholinesterase content.]
Apnea
[Pseudocholinesterase deficiency; a complication in bronchoscopy in anesthesia and apnea.]
Apnea
[Relation between serum cholinesterase polymorphism, long-term apnea and hypoventilation during surgery and in the postoperative period]
Apnea
[Research on serum cholinesterase activity in subjects with prolonged apnea caused by succinylcholine]
Apnea
[Succinyldicholin sensitivity resulting from genetically determined serumcholinesterase variants]
Apnea
[The effect of etomidate on the activity of human pseudocholinesterase. In vivo-in vitro-enzymekinetics (author's transl)]
Arrhythmia, Sinus
Monitoring the chronic effects of anticholinesterase pesticides in aerial applicators.
Arrhythmias, Cardiac
Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
Arrhythmias, Cardiac
Inhibitory effect of quinidine on plasma pseudocholinesterase activity in pregnant women.
Arrhythmias, Cardiac
Manifestations of and risk factors for acute myocardial injury after acute organophosphorus pesticide poisoning.
Arrhythmias, Cardiac
Pseudocholinesterase in patients with coronary artery disease with cardiac arrhythmias.
Arrhythmias, Cardiac
Role of plasma pseudocholinesterase activity in the diagnosis of acute myocardial infarction with special reference to cardiac arrhythmias.
Arteritis
[Studies on blood cholesterase in chronic arteritis; activities of certain cholinesterase inhibitors in normal subjects and in chronic arteritis.]
Arthritis, Rheumatoid
Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: correlation with systemic inflammatory markers and oxidative stress, preliminary report.
Arthrogryposis
Determination of cholinesterase and acetylcholinesterase in amniotic fluid. Uses in prenatal diagnosis and quality control.
Ascariasis
[Cholinesterase activity and acetylcholine of the blood serum in experimental ascariasis.]
Ascariasis
[The effect of thiamine on cholinesterase activity and the quantity of acetylcholine in the blood serum in experimental ascariasis.]
Asphyxia Neonatorum
[CHOLINESTERASE ACTIVITY OF THE BLOOD SERUM IN FETAL DEATH, ASPHYXIA NEONATORUM AND FETAL DEFORMITIES.]
Asthma
Acetylcholine and cholinesterase in the blood of patients suffering with bronchial asthma.
Asthma
Microbial biotransformation of bioactive and clinically useful steroids and some salient features of steroids and biotransformation.
Asthma
Risk factors for allergy due to the two-spotted spider mite (Tetranychus urticae) among table grape farm workers.
Asthma
[Blood levels of acetylcholine and serum cholinesterase activity in children with neurodermatitis constitutionalis with and without bronchial asthma]
Asthma
[Erythrocyte acetylcholinesterase activity and non-specific cholinesterase and ceruloplasmin activity in serum of patients with bronchial asthma]
Astrocytoma
Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma.
Asymptomatic Infections
Cholinesterase as an inflammatory marker of subclinical infection of dairy cows infected by Neospora caninum and risk factors for disease.
Ataxia
Relationship between the pharmacological effects and the biodisposition of [3H]diisopropylfluorophosphate in mice after inhalation.
Atherosclerosis
Rhizoma Coptidis for Alzheimer's Disease and Vascular Dementia: A Literature Review.
Atherosclerosis
[Changes of choline, cholesterol and cholinesterase in the blood in atherosclerosis.]
Atherosclerosis
[Dynamic activity of cholinesterase and choline content in various forms of atherosclerosis.]
Atherosclerosis
[Effect of vitamin E on activity of blood cholinesterase in atherosclerosis.]
Atherosclerosis
[On cholinesterase activity in rabbit brain during experimental atherosclerosis and functional loading]
Atrial Fibrillation
Antithrombin III is associated with acute liver failure in patients with end-stage heart failure undergoing mechanical circulatory support.
Atrial Fibrillation
Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
Atrial Fibrillation
The production of block and auricular fibrillation in the heart-lung preparation by inhibitors of cholinesterase.
Atrial Fibrillation
[Changes in blood cholinesterase activity in patients with heart defects accompanied by auricular fibrillation treated by electric defibrillation]
Avitaminosis
[Role of hormonal and seasonal factors in the effect of vitamin E on cholinesterase activity in the nervous system]
Babesiosis
Evaluation of some acute phase proteins in cattle naturally infected with Babesia bigemina.
Babesiosis
The effect of diminazene aceturate on cholinesterase activity in dogs with canine babesiosis.
Bacterial Infections
Value of Serum Cholinesterase Activity in the Diagnosis of Septic Shock Due to Bacterial Infections.
Bacterial Infections
[Decrease in plasmatic cholinesterase activity in severe bacterial infections: comparison with the decrease observed in severe liver cirrhosis]
Bacterial Infections
[Research on risk factors of short-term outcome in AIDS patients with pneumocystis pneumonia].
Basal Ganglia Diseases
A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor.
Beriberi
[True and pseudo cholinesterase in the central nervous system and blood of pigeons with beriberi]
beta-Thalassemia
Biochemical genetics and mental retardation: a study of hemoglobins, Australia antigen and the enzymes pseudocholinesterase and glucose-6-phosphate dehydrogenase.
beta-Thalassemia
[SERUM CHOLINESTERASE IN PATIENTS WITH COOLEY'S ANEMIA AND IN THEIR FAMILIES.]
Biliary Tract Diseases
Colorimetric determination of serum cholinesterase: its value in hepatic and biliary tract diseases.
Biliary Tract Diseases
[Ceruloplasmin, cholinesterase and aldolase activity in children with biliary tract disease]
Bradycardia
Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
Bradycardia
Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease.
Bradycardia
Cholinergic Crisis Owing to Distigmine Bromide Complicated by Hyperosmolar Hyperglycemic State.
Bradycardia
Cholinesterase inhibitor treatment may double the risk of hospitalisation for bradycardia.
Bradycardia
Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.
Bradycardia
Cholinesterase Inhibitors and Incidence of Bradycardia in Patients with Dementia in the Veterans Affairs New England Healthcare System.
Bradycardia
Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.
Bradycardia
Different properties of the bradycardia produced by neostigmine and edrophonium in the cat.
Bradycardia
Electrocardiogram Changes of Donepezil Administration in Elderly Patients with Ischemic Heart Disease.
Bradycardia
Fresh frozen plasma as a successful antidotal supplement in acute organophosphate poisoning.
Bradycardia
Intra-operative bradycardia in a patient with Alzheimer's disease treated with two cholinesterase inhibitors.
Bradycardia
Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats.
Bradycardia
Much caution does no harm! Organophosphate poisoning often causes pancreatitis.
Bradycardia
Prevalence of positive carotid sinus massage and related risk of syncope in patients with Alzheimer's disease.
Bradycardia
Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.
Bradycardia
The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada.
Bradycardia
[Acute respiratory failure associated with cholinergic crisis: report of five cases and review of the literature].
Bradycardia
[Analysis of the bradycardia action of cholinesterase inhibitor paraoxon (diethyl-p-nitrophenylphosphate) on isolated hearts of warm-blooded animals.]
Bradycardia
[Hemodynamic effects in antagonism of neuromuscular blockage: atropine-pyridostigmine versus ipratropium bromide-pyridostigmine]
Bradycardia
[Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients].
Bradycardia
[Severe bradycardia in general anaesthesia in a patient treated with cholinesterase inhibitors for dementia.]
Brain Concussion
Evaluating the Memory Enhancing Effects of Angelica gigas in Mouse Models of Mild Cognitive Impairments.
Brain Diseases
Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy.
Brain Diseases
Delayed-onset encephalopathy and coma in acute organophosphate poisoning in humans.
Brain Diseases
Poor prediction of blood transfusion requirements in adult liver transplantations from preoperative variables.
Brain Diseases
Predictive value of serum procollagen-III-peptide for the survival of patients with cirrhosis.
Brain Diseases
Role of Nicotinic and Muscarinic Receptors on Synaptic Plasticity and Neurological Diseases.
Brain Diseases
Survival and prognostic indicators in compensated and decompensated cirrhosis.
Brain Diseases
Tissue Distribution and Pharmacodynamics of Rivastigmine after Intranasal and Intravenous Administration in Rats.
Brain Edema
Cerebral edema induced in mice by a convulsive dose of soman. Evaluation through diffusion-weighted magnetic resonance imaging and histology.
Brain Edema
Changes in mouse brain metabolism following a convulsive dose of soman: a proton HRMAS NMR study.
Brain Infarction
Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment.
Brain Infarction
Increased monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of patients with acute stroke.
Brain Injuries
Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury.
Brain Injuries
Effect of tetrahydroaminoacridine, a cholinesterase inhibitor, on cognitive performance following experimental brain injury.
Brain Injuries
Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced seizure activity in the guinea pig.
Brain Injuries
Unexpected extrapyramidal symptoms and pulmonary aspergillosis in exertional heatstroke with fulminant liver failure: a case report.
Brain Injuries, Traumatic
Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review.
Brain Injuries, Traumatic
Neuropharmacological modulation of cognitive deficits after brain damage.
Brain Injuries, Traumatic
Serum Total Cholinesterase Activity on Admission Is Associated with Disease Severity and Outcome in Patients with Traumatic Brain Injury.
Brain Ischemia
Ameliorative effects of the centrally active cholinesterase inhibitor, NIK-247, on impairment of working memory in rats.
Brain Ischemia
Correlations Between Cholinesterase Activity and Cognitive Scores in Post-Ischemic Rats and Patients with Vascular Dementia.
Brain Ischemia
Network pharmacology study on the active components of Pterocypsela elata and the mechanism of their effect against cerebral ischemia.
Brain Ischemia
Sub-regional hippocampal vulnerability in various animal models leading to cognitive dysfunction.
Brain Neoplasms
Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors.
Breast Neoplasms
Amplification and deletion of the ACHE and BCHE cholinesterase genes in sporadic breast cancer.
Breast Neoplasms
Breast cancer metastasis alters acetylcholinesterase activity and the composition of enzyme forms in axillary lymph nodes.
Breast Neoplasms
Chemical profile, antiproliferative, antioxidant, and enzyme inhibition activities and docking studies of Cymbopogon schoenanthus (L.) Spreng. and Cymbopogon nervatus (Hochst.) Chiov. from Sudan.
Breast Neoplasms
Cholinesterase activity and acetylcholinesterase glycosylation are altered in human breast cancer.
Breast Neoplasms
Diagnostic and prognostic significance of serum cholinesterase and lactate dehydrogenase in breast cancer.
Breast Neoplasms
Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients.
Breast Neoplasms
[Influence of total parenteral nutrition (TPN) on nutritional incidences in patients with recurrent cancer]
Bronchitis, Chronic
Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy.
Brucellosis
[Acetylcholine, cholinesterase, catecholamine and vitamin indices in chronic brucellosis]
Budd-Chiari Syndrome
Single-Center Retrospective Study of Clinical and Laboratory Features That Predict Survival of Patients With Budd-Chiari Syndrome After Liver Transplant.
Bulbo-Spinal Atrophy, X-Linked
Acetylcholinesterase inhibitor responsive myasthenia in a Filipino male with X-linked recessive spinal and bulbar muscular atrophy.
Bundle-Branch Block
Changes in cholinesterase activity distribution in ventricular muscle in chronic, experimental bundle branch block in the dog.
CADASIL
Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
Carcinogenesis
Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors.
Carcinogenesis
Amplification and deletion of the ACHE and BCHE cholinesterase genes in sporadic breast cancer.
Carcinogenesis
Breast cancer metastasis alters acetylcholinesterase activity and the composition of enzyme forms in axillary lymph nodes.
Carcinogenesis
Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study.
Carcinogenesis
Role of serum cholinesterase in patients treated with salvage radical prostatectomy.
Carcinoma
Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas.
Carcinoma
Activated cholinergic signaling provides a target in squamous cell lung carcinoma.
Carcinoma
Acute phase proteins and biomarkers of oxidative status in feline spontaneous malignant mammary tumours.
Carcinoma
Biological Evaluation of Azomethine-dihydroquinazolinone Conjugates as Cancer and Cholinesterase Inhibitors.
Carcinoma
Butyrylcholinesterase: An economical marker of disease activity in oral squamous cell carcinoma before and after therapy.
Carcinoma
Cholinesterase activity and acetylcholinesterase glycosylation are altered in human breast cancer.
Carcinoma
Diagnostic and prognostic significance of serum cholinesterase and lactate dehydrogenase in breast cancer.
Carcinoma
Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study.
Carcinoma
Expression of cholinesterases in human kidney and its variation in renal cell carcinoma types.
Carcinoma
Hypercholinesterasemia in patients with hepatocellular carcinoma: a new paraneoplastic syndrome.
Carcinoma
Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinomas treated with three-dimensional conformal radiotherapy.
Carcinoma
Oxidative stress and inflammatory response biomarkers in dogs with mammary carcinoma.
Carcinoma
Plasma cholinesterase activity in patients with uterine cervical cancer during radiotherapy.
Carcinoma
Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients.
Carcinoma
Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy.
Carcinoma
Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma.
Carcinoma
Serum cholinesterase and lactate dehydrogenase levels in cases of squamous cell carcinoma of oral cavity.
Carcinoma
Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.
Carcinoma
Studies of cholinesterase activity. V. Serum cholinesterase in patients with carcinoma.
Carcinoma
Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells.
Carcinoma
[A study of the effect of endoxan on the serum cholinesterase activity in gynecologic carcinomas]
Carcinoma
[Diagnostic value of biochemical tumor markers in serum of patients with cancer of the ovary]
Carcinoma, Bronchogenic
[Assessment of serum cholinesterase activity in the differential diagnosis of bronchial carcinoma]
Carcinoma, Bronchogenic
[Determination of cholinesterase activity and iron-copper ratio in the differential diagnosis of bronchial carcinoma]
Carcinoma, Hepatocellular
Abnormalities of serum cholinesterase isozyme in liver cirrhosis and hepatoma (Part II).
Carcinoma, Hepatocellular
Arylesterase isoenzymes and activity in normal healthy adults and in patients with cancer and with other diseases.
Carcinoma, Hepatocellular
Cholinesterase activity of liver and blood serum from rats during the development of hepatoma by carcinogen feeding.
Carcinoma, Hepatocellular
Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein.
Carcinoma, Hepatocellular
Goodyschle A, a new butenolide with significant BchE inhibitory activity from Goodyera schlechtendaliana.
Carcinoma, Hepatocellular
High cholinesterase predicts tolerance to sorafenib treatment and improved prognosis in patients with transarterial chemoembolization refractory intermediate stage hepatocellular carcinoma.
Carcinoma, Hepatocellular
Histochemical and cytochemical study of butyrylcholinesterase activity in rat hepatocellular carcinomas induced by 3'-methyl-4-dimethylaminoazobenzene.
Carcinoma, Hepatocellular
Impact of pretreatment serum cholinesterase level in unresectable advanced hepatocellular carcinoma patients treated with sorafenib.
Carcinoma, Hepatocellular
Increase of fucosylated serum cholinesterase in relation to high risk groups for hepatocellular carcinomas.
Carcinoma, Hepatocellular
Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases.
Carcinoma, Hepatocellular
Quality of life after hepatectomy in patients with hepatocellular carcinoma: implication of change in hepatic protein synthesis.
Carcinoma, Hepatocellular
Some properties and electrophoretic patterns of rat liver esterases in relation to hepatocarcinogenesis by 3'-methyl-4-(dimethylamino) azobenzene.
Carcinoma, Hepatocellular
Survival and prognostic indicators in compensated and decompensated cirrhosis.
Carcinoma, Hepatocellular
The human hepatoma cell line, HepG2, secretes functional cholinesterase.
Carcinoma, Hepatocellular
[Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases]
Carcinoma, Hepatocellular
[Clinical evaluation of the measurement of hepatosplenic volume ratio by computed tomography]
Carcinoma, Medullary
Acetylcholinesterase and butyrylcholinesterase activities in human thyroid cancer cells.
Carcinoma, Papillary
Acetylcholinesterase and butyrylcholinesterase activities in human thyroid cancer cells.
Carcinoma, Renal Cell
Expression of cholinesterases in human kidney and its variation in renal cell carcinoma types.
Carcinoma, Renal Cell
Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy.
Carcinoma, Squamous Cell
Serum cholinesterase and lactate dehydrogenase levels in cases of squamous cell carcinoma of oral cavity.
Cardiomegaly
Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload.
Cardiomyopathies
Changes in cholinesterase activities after daunorubicin administration to rabbits.
Cardiomyopathies
Cholinesterases in dexrazoxane-treated daunorubicin cardiomyopathy in rabbits.
Cardiomyopathies
Congenital "histiocytoid" cardiomyopathy: evidence suggesting a developmental disorder of the Purkinje cell system of the heart.
Cardiomyopathies
Role of acetylcholine in pyridostigmine-induced myocardial injury: possible involvement of parasympathetic nervous system in the genesis of cardiomyopathy.
Cardiotoxicity
Validation of Corrected and Dispersed QT as Predictors of Adverse Outcomes in Acute Cardiotoxicities.
Cardiovascular Diseases
C5 variant is associated with decreased risk of coronary artery disease in outpatients with severe hypercholinesterasemia.
Cardiovascular Diseases
Cholinesterase inhibitors and cardiovascular disease: a survey of old age psychiatrists' practice.
Cardiovascular Diseases
Cholinesterase: Conflicting Aspects of Two Cardiovascular Diseases.
Cardiovascular Diseases
Facile synthesis of new carbon-11 labeled conformationally restricted rivastigmine analogues as potential PET agents for imaging AChE and BChE enzymes.
Cardiovascular Diseases
Serum pseudocholinesterase: high density lipoprotein cholesterol ratio as an index of risk for cardiovascular disease.
Cardiovascular Diseases
[Serum cholinesterase activity in patients with cardiovascular diseases]
Cardiovascular Diseases
[Study of cholinesterase activity in mixed saliva of patients with somatic pathology.]
Catalepsy
Morphine-induced catalepsy in the rat: effect on striatal acetylcholine & cholinesterase.
Catalepsy
Striatal cholinergic activity during morphine-induced catalepsy in the rat: development of tolerance.
Catalepsy
[Neurochemical aspects of corrective effect of fluoracizine in triphthazine-induced catalepsy in rats]
Catalepsy
[The role of catecholamines, acetylcholine and cholinesterase activity in the development of the cataleptic action of triftazin following repeated administration]
Cataplexy
Potentiation of a functional autoantibody in narcolepsy by a cholinesterase inhibitor.
Cataract
Effect of a cholinesterase inhibitor on salmonid lens: a possible cause for the increased incidence of cataract in salmon Salmo salar (L.).
Cataract
[Cholinesterase activity in the humor of the anterior chamber and in the blood in patients with glaucoma and cataract]
Central Nervous System Neoplasms
Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.
Central Nervous System Neoplasms
Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.
Cerebral Amyloid Angiopathy
Butyrylcholinesterase K variant and cerebral amyloid angiopathy.
Cerebral Amyloid Angiopathy
Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy.
Cerebral Infarction
CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients.
Cerebral Infarction
[Histochemical demonstration of glial enzyme activity. II. Reagent and neoplastic glia]
Cerebrovascular Disorders
A retrospective study of cholinesterase inhibitors for Alzheimer's disease: cerebrovascular disease as a predictor of patient outcomes.
Cerebrovascular Disorders
A therapeutic approach to cerebrovascular diseases based on indole substituted hydrazides and hydrazines able to interact with human vascular adhesion protein-1, monoamine oxidases (A and B), AChE and BuChE.
Cerebrovascular Disorders
Cholinesterase inhibitors and vascular dementia: another string to their bow?
Cerebrovascular Disorders
Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease.
Cerebrovascular Disorders
Predictive Factors of Clinical Response to Cholinesterase Inhibitors in Mild and Moderate Alzheimer's Disease and Mixed Dementia: A One-Year Naturalistic Study.
Cerebrovascular Disorders
Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.
Cerebrovascular Disorders
[Changes in blood cholinesterase activity in cerebrovascular disorders]
Chagas Disease
Cholinesterase inhibition reduces arrhythmias in asymptomatic Chagas disease.
Chagas Disease
Correlation of plasma butyrylcholinesterase concentration with Acethylcholinesterase H353N polymorphism in the inflammatory response of Chagas disease patients.
Chagas Disease
[Cholinesterase activity in plasma and erythrocytes of patients with cardiac and undetermined forms of Chagas disease]
Chemical and Drug Induced Liver Injury
[Effect of splenic humoral factors on the cholinesterase activity of liver tissue and blood serum in experimental toxic hepatitis in rats]
Chemical and Drug Induced Liver Injury
[The effect of sodium- and calcium chloride mineral water from the Spalis spring (Druskininkai health resort) on serum pseudocholinesterase activity and the protein-synthesizing function of the liver in experimental acute toxic hepatitis]
Cholangiocarcinoma
Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients.
Cholestasis
Evaluation of the diagnostic value of serum bile acid in the detection and functional assessment of liver diseases.
Cholesteatoma
Correlation between peri-operative complication in middle ear cholesteatoma surgery using STAMCO, ChOLE, and SAMEO-ATO classifications.
Cholesteatoma
Evaluating hearing outcome, recidivism and complications in cholesteatoma surgery using the ChOLE classification system.
Cholesteatoma
Mapping the ChOLE classification to hearing outcomes and disease-specific health-related quality of life.
Cholesteatoma
Practical applicability of the STAMCO and ChOLE classification in cholesteatoma care.
Cholesteatoma
[Characteristics of diagnosis and surgical treatment of various forms of congenital temporal bone cholesteatoma].
Cholesteatoma, Middle Ear
Correlation between peri-operative complication in middle ear cholesteatoma surgery using STAMCO, ChOLE, and SAMEO-ATO classifications.
cholinesterase deficiency
A Case of Pseudocholinesterase Deficiency Resulting From Malnutrition.
cholinesterase deficiency
A conundrum: general or neuraxial anesthesia and the use of ROTEM.
cholinesterase deficiency
A patient with Churg-Strauss syndrome who underwent endoscopic sinus surgery under general anesthesia -A case report-.
cholinesterase deficiency
A patient with Sanfilippo syndrome and pseudocholinesterase deficiency, further complicated by post-tonsillectomy haemorrhage.
cholinesterase deficiency
Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia.
cholinesterase deficiency
Acquired pseudocholinesterase deficiency after high-dose cyclophosphamide.
cholinesterase deficiency
Allergic reaction to suxamethonium during emergency caesarean section and pseudocholinesterase deficiency in the same patient.
cholinesterase deficiency
Apnoea due to suxamethonium associated with familial pseudocholinesterase deficiency.
cholinesterase deficiency
Awareness during emergence from anaesthesia: significance of neuromuscular monitoring in patients with butyrylcholinesterase deficiency.
cholinesterase deficiency
Break the Spasm with Succinylcholine, but Risk Intraoperative Awareness with Undiagnosed Pseudocholinesterase Deficiency.
cholinesterase deficiency
Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review.
cholinesterase deficiency
Butyrylcholinesterase deficiency identified by preoperative patient interview.
cholinesterase deficiency
Butyrylcholinesterase Deficiency Promotes Adipose Tissue Growth and Hepatic Lipid Accumulation in Male Mice on High-Fat Diet.
cholinesterase deficiency
Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
cholinesterase deficiency
Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
cholinesterase deficiency
Cholinesterase variants: rapid characterisation by PCR/SSCP and evidence for molecular homogeneity.
cholinesterase deficiency
Comparison between succinylcholine and rocuronium as neuromuscular blocking agents for electroconvulsive therapy in a patient with pseudocholinesterase deficiency.
cholinesterase deficiency
COMPLETE PSEUDOCHOLINESTERASE DEFICIENCY: GENETIC AND IMMUNOLOGIC CHARACTERIZATION.
cholinesterase deficiency
Corrected scoliosis, cholinesterase deficiency, and cesarean section: a case report.
cholinesterase deficiency
Customized anesthetic preservation of ictal threshold in electroconvulsive therapy: role of adjunctive remifentanil with etomidate.
cholinesterase deficiency
Delayed Emergence From Anesthesia: A Simulation Case for Anesthesia Learners.
cholinesterase deficiency
Delayed recovery from paralysis associated with plasma cholinesterase deficiency.
cholinesterase deficiency
Delayed recovery from paralysis by succinylcholine in patient with preoperatively unrecognized and inherited pseudocholinesterase deficiency.
cholinesterase deficiency
Dental local anesthesia for patients with pseudocholinesterase deficiency.
cholinesterase deficiency
Discrimination of phenotypes in human serum cholinesterase deficiency.
cholinesterase deficiency
Emergency anaesthesia in a patient with plasma cholinesterase deficiency.
cholinesterase deficiency
Fresh frozen plasma and edrophonium in a patient with a plasma cholinesterase deficiency.
cholinesterase deficiency
Genetic analysis of a Japanese patient with butyrylcholinesterase deficiency.
cholinesterase deficiency
Genetic mutations associated with susceptibility to perioperative complications in a longitudinal biorepository with integrated genomic and electronic health records.
cholinesterase deficiency
Genetic screening in the Persian Jewish community: A pilot study.
cholinesterase deficiency
Grand mal seizures after 2-chloroprocaine epidural anesthesia in a patient with plasma cholinesterase deficiency.
cholinesterase deficiency
Hereditary cholinesterase deficiency: a report of a family with two rare genotypes.
cholinesterase deficiency
Hereditary pseudocholinesterase deficiency discovery after electroconvulsive therapy.
cholinesterase deficiency
Hereditary serum cholinesterase deficiency associated with severe lipid deposition in the kidney.
cholinesterase deficiency
Heterozygous pseudocholinesterase deficiency: a case report and review of the literature.
cholinesterase deficiency
In vitro remifentanil metabolism: the effects of whole blood constituents and plasma butyrylcholinesterase.
cholinesterase deficiency
LEFT-SIDED AMOEBIC LIVER ABSCESS WITH PULMONARY INVOLVEMENT, PERICARDITIS, AND PSEUDOCHOLINESTERASE DEFICIENCY.
cholinesterase deficiency
Novel mutations in the BCHE gene in patients with no butyrylcholinesterase activity.
cholinesterase deficiency
Optimizing electroconvulsive therapy in non-suspected pseudocholinesterase deficiency: laryngeal mask use and neuromuscular selection.
cholinesterase deficiency
Patient information sheet for plasma cholinesterase deficiency.
cholinesterase deficiency
Pharmacodynamic and hemodynamic effects of mivacurium in infants anesthetized with halothane and nitrous oxide.
cholinesterase deficiency
Pharmacogenetics and anaesthetic drugs: Implications for perioperative practice.
cholinesterase deficiency
Plasma cholinesterase deficiency. A possible complication during anesthesia.
cholinesterase deficiency
Plasma pseudo cholinesterase deficiency leading to seven hour apnoea in a child undergoing adeno-tonsillectomy.
cholinesterase deficiency
Plasma pseudocholinesterase deficiency associated with diethylstilbestrol therapy.
cholinesterase deficiency
Postoperative ileus, pregnancy-related cholinesterase deficiency and suxamethonium after-pains. A case report.
cholinesterase deficiency
Prehospital airway management complicated by reported pseudocholinesterase deficiency.
cholinesterase deficiency
Premature awakening and underuse of neuromuscular monitoring in a registry of patients with butyrylcholinesterase deficiency.
cholinesterase deficiency
Problem with detection of an insertion-type mutation in the BCHE gene in a patient with butyrylcholinesterase deficiency.
cholinesterase deficiency
Prolonged apnea caused by inherited cholinesterase deficiency after strabismus surgery.
cholinesterase deficiency
Prolonged neuromuscular block associated with cholinesterase deficiency.
cholinesterase deficiency
Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency.
cholinesterase deficiency
Prolonged neuromuscular block in a patient undergoing renal transplantation.
cholinesterase deficiency
Prolonged neuromuscular block with mivacurium in a patient with cholinesterase deficiency.
cholinesterase deficiency
Prolonged neuromuscular blockade as a result of malnutrition-induced pseudocholinesterase deficiency.
cholinesterase deficiency
Prolonged Neuromuscular Paralysis Following Rapid-Sequence Intubation with Succinylcholine (April).
cholinesterase deficiency
Prolonged postoperative apnea with pseudocholinesterase deficiency.
cholinesterase deficiency
Prolonged postoperative succinylcholine-induced apnea with pseudocholinesterase deficiency.
cholinesterase deficiency
Properties of the trace enzyme in human serum cholinesterase deficiency.
cholinesterase deficiency
Pseudocholinesterase activity of human whole blood, bank blood, and blood protein solutions.
cholinesterase deficiency
Pseudocholinesterase Deficiency - Is Succinylcholine Still Needed to Facilitate Endotracheal Intubation?
cholinesterase deficiency
PSEUDOCHOLINESTERASE DEFICIENCY IN A OCTOGENARIAN UNDERGOING TOTAL INTRAVENOUS ANESTHESIA; IMPLICATIONS FOR NEUROMONITORING.
cholinesterase deficiency
Pseudocholinesterase Deficiency in an ECT Patient: A Case Report.
cholinesterase deficiency
Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired, and drug influences.
cholinesterase deficiency
Pseudocholinesterase deficiency: a dangerous, unrecognized complication of the ovarian hyperstimulation syndrome.
cholinesterase deficiency
Pseudocholinesterase deficiency: an additional preoperative consideration in outpatient diagnostic procedures.
cholinesterase deficiency
Pseudocholinesterase Deficiency: What the Proceduralist Needs to Know.
cholinesterase deficiency
Pseudocholinesterases. II. Two cases of pseudocholinesterase deficiency.
cholinesterase deficiency
Recognizing Pseudocholinesterase Deficiency in the Post-operative Patient: Diagnosis and Management in the ICU.
cholinesterase deficiency
Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus.
cholinesterase deficiency
Remifentanil's effect is not prolonged in a patient with pseudocholinesterase deficiency.
cholinesterase deficiency
Rocuronium antagonized by sugammadex for series of electroconvulsive therapy (ECT) in a patient with pseudocholinesterase deficiency.
cholinesterase deficiency
Safe use of landiolol hydrochloride in a patient with marked pseudocholinesterase deficiency.
cholinesterase deficiency
Screening for plasma cholinesterase deficiency: an automated succinylcholine based assay.
cholinesterase deficiency
Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
cholinesterase deficiency
Serum cholinesterase: effect on the action of suxamethonium following administration to a patient with cholinesterase deficiency.
cholinesterase deficiency
Sick Sinus Syndrome Observed in a Patient with Cholinesterase Deficiency.
cholinesterase deficiency
Suxamethonium and mivacurium sensitivity from pregnancy-induced plasma cholinesterase deficiency.
cholinesterase deficiency
Suxamethonium apnoea in an infant; expression of familial pseudocholinesterase deficiency in three generations.
cholinesterase deficiency
The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency.
cholinesterase deficiency
Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.
cholinesterase deficiency
Unexpected prolonged neuromuscular block after mivacurium: a case report.
cholinesterase deficiency
Unknown Pseudocholinesterase Deficiency in a Patient Undergoing TIVA with Planned Motor Evoked Potential Monitoring: A Case Report.
cholinesterase deficiency
Urgent cesarean delivery and prolonged ventilatory support in a parturient with Fontan circulation and undiagnosed pseudocholinesterase deficiency.
cholinesterase deficiency
Use of atracurium in a patient with plasma cholinesterase deficiency.
cholinesterase deficiency
Variations in serum cholinesterase activity in different age and sex groups.
cholinesterase deficiency
Violent fasciculations may not signal pseudocholinesterase deficiency.
cholinesterase deficiency
[A case of silent gene of heterozygote inherited serum cholinesterase deficiency]
cholinesterase deficiency
[A family of adult polycystic kidney disease associated with pseudocholinesterase deficiency]
cholinesterase deficiency
[Butyrylcholinesterase deficiency: how to analyse the cholinesterase activity in small children?]
cholinesterase deficiency
[Coexistence of ankylosing pelvispondylitis and cholinesterase deficiency in univitelline twins]
cholinesterase deficiency
[Delay of decurarization related to pseudocholinesterase deficiency]
cholinesterase deficiency
[On the problem of pseudocholinesterase deficiency syndrome. Anesthesia accident in a 4-months-old infant during an ophthalmological operation in congenital buphthalmos.]
cholinesterase deficiency
[Prolonged apnea after suxamethonium administration during staphylococcal toxic shock]
cholinesterase deficiency
[Prolonged curarisation following succinylcholine injection on butyrylcholinesterase deficiency and potentiated by a lithium treatment: a case report].
cholinesterase deficiency
[Prolonged neuromuscular block after administration of mivacurium caused by plasma psueudocholinesterase deficiency]
cholinesterase deficiency
[Pseudocholinesterase deficiency; a complication in bronchoscopy in anesthesia and apnea.]
cholinesterase deficiency
[Relation of the functional disorder of external respiration to cholinesterase deficiency in burn patients in the septicotoxemia stage]
cholinesterase deficiency
[Residual relaxant block due to pseudocholinesterase deficiency - First manifestation in an elderly patient].
cholinesterase deficiency
[Succinylcholine-induced apnea and familial cholinesterase deficiency]
cholinesterase deficiency
[Succinyldicholin sensitivity resulting from genetically determined serumcholinesterase variants]
Coccidiosis
[Alteration of enzyme activities in serum of Eimeria stiedai infected rabbits (author's transl)]
Coinfection
Relationship of nematode cholinesterase activity and nematode burdens to the development of resistance to trichostrongyle infections in sheep.
Colic
Health effects from exposure to organophosphate pesticides in workers and residents in Israel.
Colitis, Ulcerative
Rivastigmine alleviates experimentally induced colitis in mice and rats by acting at central and peripheral sites to modulate immune responses.
Collagen Diseases
A patient with Churg-Strauss syndrome who underwent endoscopic sinus surgery under general anesthesia -A case report-.
Colonic Neoplasms
Acetyl- and butyrylcholinesterase activities decrease in human colon adenocarcinoma.
Colonic Neoplasms
Chemical profile, antiproliferative, antioxidant, and enzyme inhibition activities and docking studies of Cymbopogon schoenanthus (L.) Spreng. and Cymbopogon nervatus (Hochst.) Chiov. from Sudan.
Colonic Neoplasms
[Changes in the activity of serum lactate dehydrogenase and serum cholinesterase in surgical treatment of cancer of the colon]
Colonic Pseudo-Obstruction
Cholinergic interactions between donepezil and prucalopride in human colon: potential to treat severe intestinal dysmotility.
Colonic Pseudo-Obstruction
Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans.
Colonic Pseudo-Obstruction
Prokinetics in the treatment of acute intestinal pseudo-obstruction.
Colonic Pseudo-Obstruction
Review article: the pharmacological treatment of acute colonic pseudo-obstruction.
Colorectal Neoplasms
A single unit of transfused allogeneic blood increases postoperative infections.
Colorectal Neoplasms
Combination of Serum Albumin and Cholinesterase Levels as Prognostic Indicator in Patients ith Colorectal Cancer.
Colorectal Neoplasms
Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma.
Colorectal Neoplasms
Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients.
Colorectal Neoplasms
Tissue concentration of platelet-derived endothelial cell growth factor in colorectal cancer.
Coma
Clinical emergency treatment of 68 critical patients with severe organophosphorus poisoning and prognosis analysis after rescue.
Coma
Early Serum Biomarkers for Intensive Care Unit Treatment within the First 24 Hours in Patients with Intracerebral Hemorrhage.
Coma
Prognostic factors of organophosphate poisoning between the death and survival groups.
Coma
[Evaluation of gastric lavage treatment for severe acute organophosphorus pesticides poisoning complicated by respiratory failure requiring mechanical ventilation]
Common Cold
Nonsense mutation in exon 2 of the butyrylcholinesterase gene: a case of familial cholinesterasemia.
Communicable Diseases
[Association of mutant alleles of serum cholinesterase with various multi-factorial and infectious diseases]
Communicable Diseases
[Pseudocholinesterase in patients with and without liver diseases (author's transl)]
Congenital Abnormalities
Acetylcholinesterase and butyrylcholinesterase measurement in the pre-natal detection of neural tube defects and other fetal malformations.
Congenital Abnormalities
Amniotic fluid cholinesterase measurement as a rapid method for the exclusion of fetal neural tube defects.
Congenital Abnormalities
Biochemical effects of chlorpyrifos on two developmental stages of Xenopus laevis.
Congenital Abnormalities
Distribution profiles of paraoxonase and cholinesterase phenotypes in a Spanish population.
Congenital Abnormalities
Scanning gel densitometry of amniotic fluid acetylcholinesterase and butyrylcholinesterase: quantification of 'faint-positive' bands in fetal malformations.
Congenital Abnormalities
[CHOLINESTERASE ACTIVITY OF THE BLOOD SERUM IN FETAL DEATH, ASPHYXIA NEONATORUM AND FETAL DEFORMITIES.]
Congenital Abnormalities
[Prolonged apnea after suxamethonium related to congenital abnormality of plasma pseudocholinesterase]
Congenital Disorders of Glycosylation
Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.
Congenital Hypothyroidism
Suxamethonium apnoea associated with pregnancy and liver dysfunction in a treated cretin.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Folding anomalies of neuroligin3 caused by a mutation in the alpha/beta-hydrolase fold domain.
Conjunctivitis
The Correlative Study of Serum Pseudo-cholinesterase, Biological Parameters and Symptoms Among Occupational Workers.
Conjunctivitis
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Contracture
Pyridostigmine-induced decrement in skeletal muscle contracture is not augmented by soman.
Contracture
[Cholinesterase activity in muscles and muscular sensitivity to acetylcholine in contractures induced by immobilization of extremities.]
Contracture
[Intracellular calcium ion mobilization and nicotinic acetylcholine receptor-mediated signal transduction in neuro-skeletal muscle synapse]
Coronary Aneurysm
Predictive factors of coronary aneurysm in Kawasaki disease--correlation between coronary arterial lesions and serum albumin, cholinesterase activity, prealbumin, retinol-binding protein and immature neutrophils.
Coronary Artery Disease
Butyrylcholinesterase activity and risk factors for coronary artery disease.
Coronary Artery Disease
Butyrylcholinesterase Activity Predicts Long-Term Survival in Patients with Coronary Artery Disease.
Coronary Artery Disease
Butyrylcholinesterase K variant and the APOE-epsilon4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.
Coronary Artery Disease
Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran.
Coronary Artery Disease
Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia.
Coronary Artery Disease
Effect of intensive lipid-lowering therapies on cholinesterase activity in patients with coronary artery disease.
Coronary Artery Disease
Influence of Serum Cholinesterase Levels on Patients Suspected of Having Stable Coronary Artery Disease.
Coronary Artery Disease
Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
Coronary Artery Disease
Pseudocholinesterase in patients with coronary artery disease with cardiac arrhythmias.
Coronary Artery Disease
Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.
Coronary Artery Disease
Serum pseudocholinesterase levels in the patients of coronary artery disease & their 'normal' first degree relatives.
Coronary Artery Disease
Studies on pseudocholinesterase in patients with coronary artery disease.
Coronary Artery Disease
Variation of the Butyrylcholinesterase (BChE) and Acetylcholinesterase (AChE) genes in coronary artery disease.
Coronary Disease
Cholinergic stimulation with pyridostigmine prevents the impairment in ventricular function during mental stress in coronary artery disease patients.
Coronary Disease
Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
Coronary Disease
Pyridostigmine reduces QTc interval during recovery from maximal exercise in ischemic heart disease.
Coronary Disease
[Butyrylcholinesterase activity and trace element levels in different variants of coronary disease]
Corticobasal Degeneration
Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.
COVID-19
Microfabricated potentiometric sensor for personalized methacholine challenge tests during the COVID-19 pandemic.
COVID-19
Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.
COVID-19
[Serum C-reactive protein, cholinesterase and prealbumin are correlated with prognosis of severe coronavirus disease 2019 patients].
Craniocerebral Trauma
Acetylcholine and neuronal activity; cholinesterase patterns and acetylcholine in the cerebrospinal fluids of patients with craniocerebral trauma.
Craniocerebral Trauma
[Activities of lactate dehydrogenase, acetylcholinesterase and cholinesterase in the cerebrospinal fluid and blood of patients with craniocerebral injuries]
Craniocerebral Trauma
[Cholinesterase activity in death due to traumatic shock, craniocerebral injury and stress]
Craniopharyngioma
Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors.
Crohn Disease
Are single measurements of pseudocholinesterase and albumin markers for inflammatory activity or nutritional status in Crohn's disease?
Crohn Disease
Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn's disease.
Crohn Disease
Course of pseudocholinesterase isozymes during an acute phase in Crohn's disease.
Cushing Syndrome
Abnormal blood chemistry data in Cushing's syndrome: comparison with those for fatty liver.
Cushing Syndrome
Changes of platelets, serum lactic dehydrogenase, gamma-glutamyltranspeptidase, choline esterase and creatine phosphokinase levels in patients with Cushing's syndrome.
Cushing Syndrome
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
cystathionine beta-synthase deficiency
Lipid, Oxidative and Inflammatory Profile and Alterations in the Enzymes Paraoxonase and Butyrylcholinesterase in Plasma of Patients with Homocystinuria Due CBS Deficiency: The Vitamin B12 and Folic Acid Importance.
Cystic Fibrosis
Detection of human DNA mutations with nonradioactive, allele-specific oligonucleotide probes.
Cystic Fibrosis
Mapping the human acetylcholinesterase gene to chromosome 7q22 by fluorescent in situ hybridization coupled with selective PCR amplification from a somatic hybrid cell panel and chromosome-sorted DNA libraries.
Cystic Fibrosis
Plasma esterases in cystic fibrosis: the impact of a respiratory exacerbation and its treatment.
Cysts
Determination of cholinesterase and acetylcholinesterase in amniotic fluid. Uses in prenatal diagnosis and quality control.
Cysts
Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma.
Deafness
Toxic deafness. II. The effect of arsenic, salicylates and quinine on choline esterase activity in the blood and temporal lobe of guinea pigs.
Dehydration
Combined effect of short-term dehydration and sublethal acute oral dicrotophos exposure confounds the diagnosis of anticholinesterase exposure in common quail (Coturnix coturnix) using plasma cholinesterase activity.
Dehydration
The effect of dehydration on the ultrastructure and cholinesterase activity of the subcommissural organ in the rat.
Delirium
A Review for Usefulness of Atypical Antipsychotics and Cholinesterase Inhibitors in Delirium.
Delirium
Acetylcholinesterase and butyrylcholinesterase in cardiosurgical patients with postoperative delirium.
Delirium
Cholinesterase alterations in delirium after cardiosurgery: a German monocentric prospective study.
Delirium
Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients.
Delirium
Cholinesterase inhibitor treatment in patients with delirium.
Delirium
Cholinesterases and Anticholinergic Medications in Postoperative Pediatric Delirium.
Delirium
Delirium in elderly hospitalised patients: protective effects of chronic rivastigmine usage.
Delirium
Diagnostic Value of Cholinesterase Activity for the Development of Postoperative Delirium after Cardiac Surgery.
Delirium
Donepezil improves symptoms of delirium in dementia: implications for future research.
Delirium
Effect of anticholinergic burden on treatment modification, delirium and mortality in newly diagnosed dementia patients starting a cholinesterase inhibitor: A population-based study.
Delirium
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
Delirium
Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled trial.
Delirium
Incidence of cholinesterase inhibitor therapy initiation among hospitalized patients.
Delirium
Is Lower Plasma Cholinesterase Activity Really a Candidate Biomarker for Postoperative Delirium After Noncardiac Surgery?
Delirium
Low cholinesterase activity is a risk factor for delirium after cardiac surgery: A prospective cohort study.
Delirium
Low Plasma Cholinesterase Activity is Associated With Postoperative Delirium After Noncardiac Surgery in Elderly Patients: A Prospective Observational Study.
Delirium
Low preoperative plasma cholinesterase activity as a risk marker of postoperative delirium in elderly patients.
Delirium
Pharmacological management of anticholinergic delirium - theory, evidence and practice.
Delirium
Pharmacological Management of Delirium in Hospitalized Adults - A Systematic Evidence Review.
Delirium
Prevention of Post-operative Delirium in the Elderly Using Pharmacological Agents.
Delirium
Relevance of peripheral cholinesterase activity on postoperative delirium in adult surgical patients (CESARO): A prospective observational cohort study.
Delirium
Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial.
Delirium
Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor.
Delirium
The Cholinergic System and Inflammation: Common Pathways in Delirium Pathophysiology.
Delirium
Treatment of post-electroconvulsive therapy delirium and agitation with donepezil.
Delirium
Usefulness of atypical antipsychotics and choline esterase inhibitors in delirium: a review.
Delirium
[Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine]
Dementia
A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan.
Dementia
A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase.
Dementia
A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor.
Dementia
A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease.
Dementia
A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances.
Dementia
A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.
Dementia
A Randomized Trial of Oral and Transdermal Rivastigmine for Postural Instability in Parkinson Disease Dementia.
Dementia
A retrospective study of cholinesterase inhibitors for Alzheimer's disease: cerebrovascular disease as a predictor of patient outcomes.
Dementia
A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.
Dementia
A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care, and research.
Dementia
A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia.
Dementia
A versatile equation to describe reversible enzyme inhibition and activation kinetics: modeling beta-galactosidase and butyrylcholinesterase.
Dementia
Abnormalities in muscarinic cholinergic receptors and their G-protein coupling systems in the cerebral frontal cortex in Alzheimer's disease.
Dementia
Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease.
Dementia
Acetylcholinesterase activities and monoamine metabolite levels in the cerebrospinal fluid of patients with Alzheimer's disease.
Dementia
Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
Dementia
ACP Journal Club. Review: cholinesterase inhibitors but not memantine increase syncope in older adults with mild cognitive impairment or dementia.
Dementia
ACP Journal Club. Review: Cholinesterase inhibitors do not prevent dementia in patients with mild cognitive impairment.
Dementia
ACP Journal Club. Review: cholinesterase inhibitors do not reduce progression to dementia from mild cognitive impairment.
Dementia
Activities and kinetic properties of lumbar cerebrospinal fluid cholinesterases in relation to clinical diagnosis, severity, and progression of Alzheimer's disease.
Dementia
Acute effects of oral pyridostigmine bromide on conditioned operant performance in rats.
Dementia
Acute treatment of psychotic symptoms in a newly diagnosed Lewy body dementia patient with an accelerated titration schedule of rivastigmine and de-escalation of antipsychotics.
Dementia
Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada.
Dementia
Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats.
Dementia
Alendronate reduces the cognitive and neurological disturbances induced by combined doses of d-galactose and aluminum chloride in mice.
Dementia
Allium cepa fraction attenuates STZ-induced dementia via cholinesterase inhibition and amelioration of oxidative stress in mice.
Dementia
Altered Nucleus Basalis Connectivity Predicts Treatment Response in Mild Cognitive Impairment.
Dementia
Alzheimer's dementia: budget impact and cost-utility analysis of a combination treatment of a cholinesterase inhibitor and memantine in Switzerland.
Dementia
An audit of a specialist old age psychiatry liaison service to a medium and a high secure forensic psychiatry unit.
Dementia
An observational study of the needs and quality of life amongst patients in the treatment of Alzheimer's dementia with cholinesterase inhibitors.
Dementia
Anti-amnestic Effect of Curcumin in Combination with Donepezil, an Anticholinesterase Drug: Involvement of Cholinergic System.
Dementia
Anticholinergic Drug Burden in Persons with Dementia Taking a Cholinesterase Inhibitor: The Effect of Multiple Physicians.
Dementia
Antidementia drugs: prescription by level of cognitive impairment or by socio-economic group?
Dementia
Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia.
Dementia
Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study.
Dementia
Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
Dementia
Assessing capacity to consent to treatment with cholinesterase inhibitors in dementia using a specific and standardized version of the MacArthur Competence Assessment Tool (MacCAT-T).
Dementia
Assessing cognitive change in Parkinson's disease: development of practice effect-corrected reliable change indices.
Dementia
Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Dementia
Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors.
Dementia
Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia.
Dementia
Bioactive Compounds and Traditional Herbal Medicine: Promising Approaches for the Treatment of Dementia.
Dementia
Blood cells cholinesterase activity in early stage Alzheimer's disease and vascular dementia.
Dementia
Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia.
Dementia
BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia.
Dementia
Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies.
Dementia
Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.
Dementia
Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could BCHE Genotyping Be Helpful in Alzheimer's Therapy?
Dementia
Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia.
Dementia
Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment.
Dementia
Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
Dementia
Cardiovascular Outcomes of Cholinesterase Inhibitors in Individuals with Dementia: A Meta-Analysis and Systematic Review.
Dementia
CDR State Transition Probabilities in Alzheimer's Disease with and without Cholinesterase Inhibitor Intervention in an Observational Cohort.
Dementia
Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study.
Dementia
Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.
Dementia
Changes in cerebral glucose metabolism in patients with Parkinson disease with dementia after cholinesterase inhibitor therapy.
Dementia
Characterization of binding of antipsychotics to muscarinic receptors using mouse cerebral cortex.
Dementia
Chlorpyrifos shares stimulus properties with pentylenetetrazol as evaluated by an operant drug discrimination task.
Dementia
Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson's disease related dementia.
Dementia
Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Dementia
Cholinesterase activity in plasma, erythrocytes, and cerebrospinal fluid of patients with dementia of the Alzheimer type.
Dementia
Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
Dementia
Cholinesterase inhibitor and memantine use in newly admitted nursing home residents with dementia.
Dementia
Cholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use in older adults with end-stage dementia: a survey of hospice medical directors.
Dementia
Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
Dementia
Cholinesterase Inhibitor Use in Patients With Dementia Admitted to a Palliative Care Unit.
Dementia
Cholinesterase Inhibitor Use in U.S. Nursing Homes: Results from the National Nursing Home Survey.
Dementia
Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation.
Dementia
Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study.
Dementia
Cholinesterase Inhibitors and Behavioral & Psychological Symptoms of Alzheimer's Disease.
Dementia
Cholinesterase inhibitors and Gingko extracts--are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration.
Dementia
Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.
Dementia
Cholinesterase Inhibitors and Incidence of Bradycardia in Patients with Dementia in the Veterans Affairs New England Healthcare System.
Dementia
Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis.
Dementia
Cholinesterase inhibitors and the risk of pulmonary disorders in hospitalized dementia patients.
Dementia
Cholinesterase inhibitors and use of psychotropic medications in a sample of patients with dementia.
Dementia
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Dementia
Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
Dementia
Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease.
Dementia
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
Dementia
Cholinesterase inhibitors from Sargassum and Gracilaria gracilis: seaweeds inhabiting South Indian coastal areas (Hare Island, Gulf of Mannar).
Dementia
Cholinesterase inhibitors in advanced Dementia with Lewy bodies: increase or stop?
Dementia
Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry.
Dementia
Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
Dementia
Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
Dementia
Cholinesterase inhibitors modulate autonomic function in patients with Alzheimer´s disease and mixed dementia.
Dementia
Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Dementia
Cholinesterase inhibitors slow decline in executive functions, rather than memory, in Alzheimer's disease: a 1-year observational study in the sunnybrook dementia cohort.
Dementia
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Dementia
Cholinesterase inhibitors were associated with increased risk for syncope and its consequences in older persons with dementia.
Dementia
Cholinesterase-inhibitor therapy for dementia: novel clinical substrates and mechanisms for treatment response.
Dementia
Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease.
Dementia
Clinical and analytical considerations in the utilization of cholinesterase measurements.
Dementia
Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study*
Dementia
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
Dementia
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.
Dementia
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
Dementia
Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease.
Dementia
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study.
Dementia
Cognitive correlates of ?4?2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
Dementia
Cognitive stimulation therapy as a sustainable intervention for dementia in sub-Saharan Africa: feasibility and clinical efficacy using a stepped-wedge design.
Dementia
Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.
Dementia
Combination Therapy of Anti-Tau and Anti-Amyloid Drugs for Disease Modification in Early-stage Alzheimer's Disease: Socio-economic Considerations Modeled on Treatments for Tuberculosis, HIV/AIDS and Breast Cancer.
Dementia
Comparative efficacy of interventions for reducing symptoms of depression in people with dementia: systematic review and network meta-analysis.
Dementia
Comparing treatment effects in a clinical sample of patients with probable Alzheimer's disease treated with two different cholinesterase inhibitors.
Dementia
Comparison of prescribing practices for older adults treated by female versus male physicians: A retrospective cohort study.
Dementia
Compression or expansion of dementia in Germany? An observational study of short-term trends in incidence and death rates of dementia between 2006/07 and 2009/10 based on German health insurance data.
Dementia
Concomitant use of anticholinergics with acetylcholinesterase inhibitors in Medicaid recipients with dementia and residing in nursing homes.
Dementia
Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II.
Dementia
Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM).
Dementia
Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB.
Dementia
Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
Dementia
CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients.
Dementia
Cytotoxic and genotoxic effects of ss-(triphenylpho-s-phonio)ethyl carboxylate and of N,N'-bis(dihexylphos-phinoylmethyl)-1,4-diaminocyclohexane.
Dementia
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation.
Dementia
Delirium in elderly hospitalised patients: protective effects of chronic rivastigmine usage.
Dementia
Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Dementia
Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia.
Dementia
Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.
Dementia
Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey.
Dementia
Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
Dementia
Differentiation Between Dementia With Lewy Bodies And Alzheimer's Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter Study.
Dementia
Discontinuation of cholinesterase inhibitor treatment in institutionalised patients with advanced dementia.
Dementia
Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts.
Dementia
Dissociating cholinergic influence on alertness and temporal attention in primates in a simple reaction time paradigm.
Dementia
Do caregivers' experiences correspond with the concerns raised in the literature? Ethical issues relating to anti-dementia drugs.
Dementia
Donepezil and cognitive remediation therapy to augment treatment of alcohol use disorder related mild cognitive impairment (AUD-MCI): An open label pilot study with historical controls.
Dementia
Donepezil as add-on treatment of psychotic symptoms in patients with dementia of the Alzheimer's type.
Dementia
Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.
Dementia
Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial.
Dementia
Donepezil improves symptoms of delirium in dementia: implications for future research.
Dementia
Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury.
Dementia
Drug persistency of cholinesterase inhibitors for patients with dementia of Alzheimer type in Korea.
Dementia
Duration of therapy with acetylcholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease as reported in the literature.
Dementia
Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
Dementia
Education and use of dementia drugs: a register-based study of over 600,000 older people.
Dementia
Effect of anticholinergic burden on treatment modification, delirium and mortality in newly diagnosed dementia patients starting a cholinesterase inhibitor: A population-based study.
Dementia
Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats.
Dementia
Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study.
Dementia
Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
Dementia
Effect of rivastigmine on plasma butyrylcholine esterase activity and plasma ghrelin levels in patients with dementia in Alzheimer's disease.
Dementia
Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors.
Dementia
Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.
Dementia
Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: a review.
Dementia
Effects of 21 months of cholinesterase inhibitors on cognitive and functional decline in demented patients.
Dementia
Effects of antidepressants on longevity and dementia onset among adults with Down syndrome: a retrospective study.
Dementia
Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical Data.
Dementia
Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data.
Dementia
Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
Dementia
Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies.
Dementia
Effects of donepezil on sleep disturbances in patients with dementia with Lewy bodies: An open-label study with actigraphy.
Dementia
Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression.
Dementia
Effects of Ginkgo biloba Extract EGb 761, Donepezil and their Combination on Central Cholinergic Function in Aged Rats.
Dementia
Effects of rivastigmine and memantine alone and in combination on learning and memory in rats with scopolamine-induced amnesia.
Dementia
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
Dementia
Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies.
Dementia
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
Dementia
Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis.
Dementia
Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis.
Dementia
Efficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer's Dementia after Failure to Respond to Donepezil.
Dementia
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.
Dementia
Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies.
Dementia
Enhancing attention in neurodegenerative diseases: current therapies and future directions.
Dementia
Epidemiology of Dementia in Elderly Chronic Obstructive Pulmonary Disease Patients Living in China's Northwestern High-Elevation Area.
Dementia
Etiology and predictors of urinary incontinence and its effect on quality of life.
Dementia
Evaluation of cholinergic treatment in demented patients by P300 evoked related potentials.
Dementia
Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase.
Dementia
Exploring dementia management attitudes in primary care: a key informant survey to primary care physicians in 25 European countries.
Dementia
Factors associated with use of medications with potential to impair cognition or cholinesterase inhibitors among Alzheimer's disease patients.
Dementia
Fall-Related Hospitalizations in Nursing Home Residents Co-Prescribed a Cholinesterase Inhibitor and Beta-Blocker.
Dementia
Feeling the need ... the need for speed (of processing training) in Parkinson disease.
Dementia
Five-year risk of admission to long-term care home and death for older adults given a new diagnosis of dementia: a population-based retrospective cohort study.
Dementia
Generation and validation of algorithms to identify subjects with dementia using administrative data.
Dementia
Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders.
Dementia
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
Dementia
Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration.
Dementia
Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial.
Dementia
Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider.
Dementia
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review.
Dementia
How long can patients with mild or moderate Alzheimer's dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population-based study.
Dementia
How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis.
Dementia
Immunomodulation by 9-amino-1,2,3,4-tetrahydroacridine (THA): 1. Down-regulation of natural cell-mediated cytotoxicity in vitro.
Dementia
Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer's disease: a meta-analysis.
Dementia
Impact of cholinesterase inhibitors or memantine on survival in adults with Down syndrome and dementia: clinical cohort study.
Dementia
Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.
Dementia
In vivo and in vitro metabolism and pharmacokinetics of cholinesterase inhibitor deoxyvasicine from aerial parts of Peganum harmala Linn in rats via UPLC-ESI-QTOF-MS and UPLC-ESI-MS/MS.
Dementia
Increased cholinergic activity under conditions of low estrogen leads to adverse cardiac remodeling.
Dementia
Individualized evaluation of cholinesterase inhibitors effects in dementia with adaptive cognitive testing.
Dementia
Innovations: geriatric psychiatry: diagnosis and treatment of neuropsychiatric symptoms in Alzheimer's disease.
Dementia
Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
Dementia
Intermittent Stimulation of the Nucleus Basalis of Meynert Improves Working Memory in Adult Monkeys.
Dementia
Is donepezil effective for multiple sclerosis-related cognitive dysfunction? A critically appraised topic.
Dementia
Late life depression and dementia: a mental health literacy survey of Australian general practitioners.
Dementia
Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease?
Dementia
Little evidence that cholinesterase inhibitors prevent progression of mild cognitive impairment to dementia, but they are associated with adverse effects.
Dementia
Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study.
Dementia
Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality.
Dementia
Long-term efficacy of donepezil for relapse of visual hallucinations in patients with dementia with Lewy bodies.
Dementia
Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy.
Dementia
Mania after administration of cholinesterase inhibitors in patients with dementia and comorbid bipolar disorder: two case reports.
Dementia
Measuring Alzheimer's disease progression with transition probabilities in the Taiwanese population.
Dementia
Memantine and donepezil: a fixed drug combination for the treatment of moderate to severe Alzheimer's dementia.
Dementia
Memantine extended release (28 mg once daily): a review of its use in Alzheimer's disease.
Dementia
Mental health economics, health service provision, and the practice of geriatric psychiatry.
Dementia
Monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of progressive dementia patients: relation to clinical parameters.
Dementia
Muscarinic, Ca(++) antagonist and specific butyrylcholinesterase inhibitory activity of dried ginger extract might explain its use in dementia.
Dementia
N-[3,5-Bis(trifluoromethyl)phenyl]-5-bromo-2-hydroxybenzamide Analogues: Novel Acetyl- and Butyrylcholinesterase Inhibitors.
Dementia
Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update.
Dementia
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.
Dementia
Neuropsychological rehabilitation program and behavioral disturbances in early-stage Alzheimer patients.
Dementia
New perspectives on the role of tau in Alzheimer's disease. Implications for therapy.
Dementia
Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review.
Dementia
Novel Iodinated Hydrazide-hydrazones and their Analogues as Acetyl- and Butyrylcholinesterase Inhibitors.
Dementia
Parkinson's disease dementia: clinical correlates of brain spect perfusion and treatment.
Dementia
Parkinson's disease-related visual hallucinations unresponsive to atypical antipsychotics treated with cholinesterase inhibitors: a case series.
Dementia
Patient and companion shared decision making and satisfaction with decisions about starting cholinesterase medication at dementia diagnosis.
Dementia
Patients characteristics with cholinesterase inhibitor resistant hallucinations in dementia with Lewy bodies.
Dementia
Patients with dementia syndrome in public and private services in southern Brazil.
Dementia
Patterns of Potentially Inappropriate Bladder Antimuscarinic Use in People with Dementia: A Retrospective Cohort Study.
Dementia
Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia.
Dementia
Persistence of cholinesterase inhibitor treatment in dementia: insights from a naturalistic study.
Dementia
Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database study.
Dementia
Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
Dementia
Pharmacoeconomics of Alzheimer's disease (AD) treatment with cholinesterase inhibitors.
Dementia
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.
Dementia
Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review.
Dementia
Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease.
Dementia
Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics.
Dementia
Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration.
Dementia
Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
Dementia
Plasma acetylcholinesterase activity correlates with intracerebral ?-amyloid load.
Dementia
Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies?
Dementia
Posttraumatic stress disorder exacerbation with cholinesterase inhibitor in a patient with dementia.
Dementia
Potentially inappropriate prescribing in dementia: a state-of-the-art review since 2007.
Dementia
Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Dementia
Pre-Stroke Cholinesterase Inhibitor Treatment Is Beneficially Associated with Functional Outcome in Patients with Acute Ischemic Stroke and Pre-Stroke Dementia: The Fukuoka Stroke Registry.
Dementia
Predictive Factors of Clinical Response to Cholinesterase Inhibitors in Mild and Moderate Alzheimer's Disease and Mixed Dementia: A One-Year Naturalistic Study.
Dementia
Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission.
Dementia
Predictors of mortality in M?ori, Pacific Island, and European patients diagnosed with dementia at a New Zealand Memory Service.
Dementia
Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.
Dementia
Prescription patterns and efficacy of drugs for patients with dementia: physicians' perspective in Italy.
Dementia
Primary care physician volume and quality of care for older adults with dementia: a retrospective cohort study.
Dementia
Propentofylline prevents neuronal dysfunction induced by infusion of anti-nerve growth factor antibody into the rat septum.
Dementia
Prophylactic cognitive enhancers for improvement of cognitive function in patients undergoing electroconvulsive therapy: A systematic review and meta-analysis.
Dementia
Published randomized controlled trials of drug therapy for dementia often lack complete data on harm.
Dementia
Real-world effectiveness, its predictors and onset of action of cholinesterase inhibitors and memantine in dementia: retrospective health record study.
Dementia
Reassessment of the dementia diagnosis of Alzheimer's disease in patients enrolled on the cholinesterase inhibitors dispensation program.
Dementia
Recent Knowledge on Medicinal Plants as Source of Cholinesterase Inhibitors for the Treatment of Dementia.
Dementia
Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
Dementia
Regulation of attention and response to therapy in dementia by butyrylcholinesterase.
Dementia
Relationship and stage of dementia differences in caregiver perspectives on the meaning of activity.
Dementia
Reports in pharmacological treatments in geriatric psychiatry: is there anything new or just adding to old evidence?
Dementia
Review: cholinesterase inhibitors and memantine consistently but marginally improve symptoms of dementia.
Dementia
Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures.
Dementia
Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study.
Dementia
Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
Dementia
Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis.
Dementia
Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia.
Dementia
Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand.
Dementia
Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.
Dementia
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.
Dementia
Role of cholinesterase inhibitors in dementia care: memory clinics and cholinesterase inhibitors have their place.
Dementia
Role of cholinesterase inhibitors in dementia care: NICE's economic analysis has limitations.
Dementia
Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies.
Dementia
Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies.
Dementia
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
Dementia
Screening for Adverse Drug Reactions in Dementia Patients on Cholinesterase Inhibitor Therapy.
Dementia
Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force.
Dementia
Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.
Dementia
Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia.
Dementia
Serum Butyrylcholinesterase Activity: A Biomarker for Parkinson's Disease and Related Dementia.
Dementia
Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer's Dementia Are Frequently Below the Recommended Levels.
Dementia
Serum Level and Activity of Butylcholinesterase: A Biomarker for Post-Stroke Dementia.
Dementia
Sex Differences in the Prevalent Use of Oral Formulations of Cholinesterase Inhibitors in Older Adults with Dementia.
Dementia
Short- and long-term efficacy of cholinesterase inhibitors in older adults with alzheimer's disease and mixed dementia: results of a 21-month observational study.
Dementia
Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease.
Dementia
SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties.
Dementia
Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.
Dementia
Structure-activity relationship, in vitro and in vivo evaluation of novel dienyl sulphonyl fluorides as selective BuChE inhibitors for the treatment of Alzheimer's disease.
Dementia
Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives.
Dementia
Successful treatment of behavioural problems in dementia using a cholinesterase inhibitor: the ethical questions.
Dementia
Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.
Dementia
Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.
Dementia
Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias.
Dementia
Systematic Review of Cholinesterase Inhibitors on Cognition and Behavioral Symptoms in Patients of Chinese Descent with Alzheimer's Disease, Vascular Dementia, or Mixed Dementia.
Dementia
Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia.
Dementia
Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography.
Dementia
Tacrine therapy is associated with reduced mortality in nursing home residents with dementia.
Dementia
Tetrahydroaminoacridine (THA) in Alzheimer's disease: an assessment of attentional and mnemonic function using CANTAB.
Dementia
The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias.
Dementia
The age gap between patients in clinical studies and in the general population: a pitfall for dementia research.
Dementia
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.
Dementia
The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia.
Dementia
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
Dementia
The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patients.
Dementia
The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach.
Dementia
The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort.
Dementia
The effect of cholinesterase inhibitors on risk of nursing home placement among medicaid beneficiaries with dementia.
Dementia
The effect of donepezil on increased regional cerebral blood flow in the posterior cingulate cortex of a patient with Parkinson's disease dementia.
Dementia
The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia.
Dementia
The effects of repetitive transcranial magnetic stimulation in older adults with mild cognitive impairment: a protocol for a randomized, controlled three-arm trial.
Dementia
The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
Dementia
The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Dementia
The impact of Medicare prescription drug coverage on the use of antidementia drugs.
Dementia
The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada.
Dementia
The interplay of cholinergic function, attention, and falls in Parkinson's disease.
Dementia
The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients.
Dementia
The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.
Dementia
The use of medications with known or potential anticholinergic activity in patients with dementia receiving cholinesterase inhibitors.
Dementia
The Use of Transdermal Therapeutic Systems in Psychiatric Care: A Primer on Patches.
Dementia
The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available?
Dementia
Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching.
Dementia
Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.
Dementia
Transdermal rivastigmine: management of cutaneous adverse events and review of the literature.
Dementia
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
Dementia
Treatment guidelines for Alzheimer's disease: redefining perceptions in primary care.
Dementia
Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings.
Dementia
Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia.
Dementia
Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage.
Dementia
Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer's disease dispensed by the Brazilian public health system - 2008 to 2014: a nation-wide analysis.
Dementia
Trends in Drug Prescription Rates for Dementia: An Observational Population-Based Study in France, 2006-2014.
Dementia
Upper gastrointestinal bleeding in elderly adults with dementia receiving cholinesterase inhibitors: a population-based cohort study.
Dementia
Use of a novel radiometric method to assess the inhibitory effect of donepezil on acetylcholinesterase activity in minimally diluted tissue samples.
Dementia
Use of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany.
Dementia
Use of cognitive enhancers and associated medical care costs among patients with dementia: a nationwide study in Taiwan.
Dementia
Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland.
Dementia
Using a distribution-based approach and systematic review methods to derive minimum clinically important differences.
Dementia
Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.
Dementia
Weight Loss Associated with Cholinesterase Inhibitors in Individuals with Dementia in a National Healthcare System.
Dementia
Who will be eligible? An investigation of the dementia population eligible for cholinesterase treatment following the change in NICE guidance.
Dementia
Withanolides: Biologically Active Constituents in the Treatment of Alzheimer Disease.
Dementia
Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration.
Dementia
[Cholinergic deficiency syndrome as an indicator for the cholinesterase inhibitors]
Dementia
[Cholinesterase inhibitor and ginkgo extracts in therapy of dementia. A comparison of effectiveness based on controlled studies]
Dementia
[Cholinesterase inhibitors in dementia: the precarious balance between efficacy and safety]
Dementia
[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]
Dementia
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine]
Dementia
[Diagnosis and treatment of Parkinson's syndrome. What is important for the general practitioner?]
Dementia
[Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient]
Dementia
[Doubtful evidence for the use of the cholinesterase inhibitor donepezil in patients with dementia -- a systematic review]
Dementia
[Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina].
Dementia
[Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing]
Dementia
[Metabolic syndrome in Alzheimer's disease: clinical and developmental influences]
Dementia
[Role of secondary care too small in Dutch College of General Practitioners' (NHG) practice guideline 'Dementia'].
Dementia
[Severe bradycardia in general anaesthesia in a patient treated with cholinesterase inhibitors for dementia.]
Dementia
[Treatment for dementia in parkinsonian syndromes. Efficacy of cholinesterase inhibitors]
Dementia
[Treatment of Alzheimer's disease according to the S3 guidelines on dementia. Choline esterase inhibitors for all and for ever?].
Dementia, Multi-Infarct
CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients.
Dementia, Vascular
Blood cells cholinesterase activity in early stage Alzheimer's disease and vascular dementia.
Dementia, Vascular
Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Dementia, Vascular
Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients.
Dementia, Vascular
Cholinesterase inhibitors and vascular dementia: another string to their bow?
Dementia, Vascular
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
Dementia, Vascular
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
Dementia, Vascular
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
Dementia, Vascular
Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM).
Dementia, Vascular
Correlations Between Cholinesterase Activity and Cognitive Scores in Post-Ischemic Rats and Patients with Vascular Dementia.
Dementia, Vascular
Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia.
Dementia, Vascular
Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
Dementia, Vascular
Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: A meta-analysis.
Dementia, Vascular
Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
Dementia, Vascular
Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
Dementia, Vascular
Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis.
Dementia, Vascular
Evaluating the Memory Enhancing Effects of Angelica gigas in Mouse Models of Mild Cognitive Impairments.
Dementia, Vascular
Feasibility of vascular dementia treatment with cholinesterase inhibitors.
Dementia, Vascular
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review.
Dementia, Vascular
Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients.
Dementia, Vascular
Prescription patterns and efficacy of drugs for patients with dementia: physicians' perspective in Italy.
Dementia, Vascular
Review: Cerebral microvascular pathology in aging and neurodegeneration.
Dementia, Vascular
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.
Dementia, Vascular
Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia.
Dementia, Vascular
Systematic Review of Cholinesterase Inhibitors on Cognition and Behavioral Symptoms in Patients of Chinese Descent with Alzheimer's Disease, Vascular Dementia, or Mixed Dementia.
Dementia, Vascular
Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia.
Dementia, Vascular
Systematic review on the efficacy and safety of herbal medicines for vascular dementia.
Dementia, Vascular
The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia.
Dementia, Vascular
Twin drug design, synthesis and evaluation of diosgenin derivatives as multitargeted agents for the treatment of vascular dementia.
Dementia, Vascular
Vascular cognitive impairment: epidemiology, subtypes, diagnosis and management.
Dementia, Vascular
[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]
Demyelinating Diseases
Butyrylcholinesterase activity in multiple sclerosis neuropathology.
Demyelinating Diseases
Cysteine thioesters as myelin proteolipid protein analogues to examine the role of butyrylcholinesterase in myelin decompaction.
Dermatitis
Ataxia, depression, and dermatitis associated with the use of dichlorvos-impregnated collars in the laboratory cat.
Dermatitis
[Differences in blood cholinesterase activity as a possible differential diagnostic criterion of eczema, atopic dermatosis and allergic eczema-like dermatitis]
Dermatitis
[Effects of glutathione on serum cholinesterase activity in so-called allergic dermatitis]
Dermatitis, Atopic
Studies in the transaminase, cholinesterase, and alkaline phosphatase activity in the serum of patients with disseminated neurodermatitis.
Dermatomycoses
[Changes in cholinesterase activity and catecholamine content in the blood plasma in dermatomycoses]
Diabetes Mellitus
A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation.
Diabetes Mellitus
Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation.
Diabetes Mellitus
Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?
Diabetes Mellitus
Butyrylcholinesterase activity in women with diabetes mellitus in pregnancy: correlation with antioxidant activity.
Diabetes Mellitus
Butyrylcholinesterase and diabetes mellitus in the CHE2 C5- and CHE2 C5+ phenotypes.
Diabetes Mellitus
Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry.
Diabetes Mellitus
Determination of inhibitory activities of enzymes, related to Alzheimer's disease and diabetes mellitus of plane tree (Platanus orientalis L.) extracts and their antioxidant, antimicrobial and anticancer activities.
Diabetes Mellitus
Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease.
Diabetes Mellitus
Evaluation of the neuroprotective and antidiabetic potential of phenol-rich extracts from virgin olive oils by in vitro assays.
Diabetes Mellitus
Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study.
Diabetes Mellitus
Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids.
Diabetes Mellitus
Hepaticojejunostomy--analysis of risk factors for postoperative bile leaks and surgical complications.
Diabetes Mellitus
Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and ?-glucosidase inhibitors.
Diabetes Mellitus
Plasma 25-hydroxyvitamin d is independently associated with hemoglobin concentration in male subjects with type 2 diabetes mellitus.
Diabetes Mellitus
Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast ?-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Diabetes Mellitus
Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus.
Diabetes Mellitus
Relationship between serum pseudocholinesterase and triglycerides in experimentally induced diabetes mellitus in rats.
Diabetes Mellitus
Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus.
Diabetes Mellitus
Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach.
Diabetes Mellitus
Serum cholinesterase activity and proteosynthetic function of liver in patients with diabetes mellitus.
Diabetes Mellitus
Serum cholinesterase activity in the diagnosis of nonalcoholic fatty liver disease in type 2 diabetic patients.
Diabetes Mellitus
Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.
Diabetes Mellitus
Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and ?-glycosidase inhibitors.
Diabetes Mellitus
Synthesis, Characterization, and Inhibition Study of Novel Substituted Phenylureido Sulfaguanidine Derivatives as ?-Glycosidase and Cholinesterase Inhibitors.
Diabetes Mellitus
The results of the "essential laboratory tests" applied to new outpatients--re-evaluation of diagnostic efficiencies of the test items.
Diabetes Mellitus
Variant K of butyrylcholinesterase and risk of early-onset type 1 diabetes mellitus in Euro-Brazilians.
Diabetes Mellitus
Variant K of butyrylcholinesterase and types 1 and 2 of diabetes mellitus.
Diabetes Mellitus
[Assessment of the guidelines for efficacious utilization of laboratory tests in primary care medicine]
Diabetes Mellitus
[Serum cholinesterase determination in diabetes mellitus patients, using indicator paper]
Diabetes Mellitus
[Significance of serum pseudocholinesterase activity in diabetes mellitus]
Diabetes Mellitus
[Transaminase, lactic dehydrogenase and pseudocholinesterase activity of the blood in diabetes mellitus.]
Diabetes Mellitus, Type 1
Assessment of the platelet parameters and serum butyrylcholinesterase activity in type 1 diabetes patients with ketoacidosis.
Diabetes Mellitus, Type 1
Osmotic stress due to changes in plasma glucose and its regulation in IDDM patients.
Diabetes Mellitus, Type 1
Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus.
Diabetes Mellitus, Type 1
Variant K of butyrylcholinesterase and risk of early-onset type 1 diabetes mellitus in Euro-Brazilians.
Diabetes Mellitus, Type 2
A study of measurement of serum cholinesterase in type 2 diabetes and hypertension.
Diabetes Mellitus, Type 2
Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?
Diabetes Mellitus, Type 2
Butyrylcholinesterase activity in women with diabetes mellitus in pregnancy: correlation with antioxidant activity.
Diabetes Mellitus, Type 2
Effects of Coenzyme Q10 Supplementation on Serum Values of Gamma-glutamyl transferase, Pseudocholinesterase, Bilirubin, Ferritin, and High-Sensitivity C-Reactive Protein in Women with Type 2 Diabetes.
Diabetes Mellitus, Type 2
Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease.
Diabetes Mellitus, Type 2
Focus on the Correlations between Alzheimer's Disease and Type 2 Diabetes.
Diabetes Mellitus, Type 2
Influence of different extraction techniques on the chemical profile and biological properties of Anthemis cotula L.: Multifunctional aspects for potential pharmaceutical applications.
Diabetes Mellitus, Type 2
Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion.
Diabetes Mellitus, Type 2
Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus.
Diabetes Mellitus, Type 2
Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Serum butyrylcholinesterase and the risk of future type 2 diabetes: The Kansai Healthcare Study.
Diabetes Mellitus, Type 2
Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach.
Diabetes Mellitus, Type 2
Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance.
Diabetes Mellitus, Type 2
Serum cholinesterase activity correlates with serum insulin, C-peptide and free fatty acids levels in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Serum cholinesterase activity in the diagnosis of nonalcoholic fatty liver disease in type 2 diabetic patients.
Diabetes Mellitus, Type 2
Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders.
Diabetes Mellitus, Type 2
Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.
Diabetes, Gestational
Acylated ghrelin concentrations are markedly decreased during pregnancy in mothers with and without gestational diabetes: relationship with cholinesterase.
Diabetes, Gestational
Butyrylcholinesterase activity in gestational diabetes: correlation with lymphocyte subpopulations in peripheral blood.
Diabetes, Gestational
Butyrylcholinesterase activity in women with diabetes mellitus in pregnancy: correlation with antioxidant activity.
Diabetes, Gestational
Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids.
Diabetes, Gestational
Maternal circulating levels of some metabolic syndrome biomarkers in gestational diabetes mellitus.
Diabetes, Gestational
Pseudocholinesterase in gestational diabetes: positive correlation with LDL and negative correlation with triglyceride.
Diabetes, Gestational
[Application of Bayes Probability Model in Differentiation of Yin and Yang Jaundice Syndromes in Neonates].
Diabetic Ketoacidosis
Assessment of platelets morphological changes and serum butyrylcholinesterase activity in children with diabetic ketoacidosis: a case control study.
Digestive System Diseases
Changes in high density lipoproteins in patients with hepatobiliary diseases. Levels and lipid composition of HDL2 and HDL3 and LCAT reaction.
Disseminated Intravascular Coagulation
Clinical studies on plasma protein C. Correlation with serum cholinesterase.
Disseminated Intravascular Coagulation
Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
Down Syndrome
Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome.
Down Syndrome
An Overview on Natural Cholinesterase Inhibitors - A Multi-Targeted Drug Class - and Their Mass Production.
Down Syndrome
Clinical trials in children with Down syndrome: Issues from a cognitive research perspective.
Down Syndrome
Determination of cholinesterase and acetylcholinesterase in amniotic fluid. Uses in prenatal diagnosis and quality control.
Down Syndrome
Effects of antidepressants on longevity and dementia onset among adults with Down syndrome: a retrospective study.
Down Syndrome
Impact of cholinesterase inhibitors or memantine on survival in adults with Down syndrome and dementia: clinical cohort study.
Down Syndrome
Pseudocholinesterase activity and E1 phenotypes in Down's syndrome and mental retardation.
Down Syndrome
Serum cholinesterase (pseudocholinesterase) in Down's syndrome: 1. Phenotype frequencies at the E1 and E2 loci.
Down Syndrome
Serum cholinesterase (pseudocholinesterase) in Down's syndrome: 2. Quantitative levels.
Down Syndrome
The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome.
Drug-Related Side Effects and Adverse Reactions
Adverse Drug Reactions Associated With Cholinesterase Inhibitors-Sequence Symmetry Analyses Using Prescription Claims Data.
Drug-Related Side Effects and Adverse Reactions
Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.
Drug-Related Side Effects and Adverse Reactions
Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer's Disease.
Drug-Related Side Effects and Adverse Reactions
Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting.
Drug-Related Side Effects and Adverse Reactions
Memantine in everyday clinical practice: a comparison of studies in Germany and Greece.
Drug-Related Side Effects and Adverse Reactions
Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study.
Drug-Related Side Effects and Adverse Reactions
Potential Nutraceutical Properties of Leaves from Several Commonly Cultivated Plants.
Drug-Related Side Effects and Adverse Reactions
Screening for Adverse Drug Reactions in Dementia Patients on Cholinesterase Inhibitor Therapy.
Duodenal Ulcer
THE CONCENTRATION OF ACETYLCHOLINE AND THE LEVEL CHOLINESTERASE ACTIVITY IN THE SERUM OF PATIENTS WITH GASTRIC ULCER, DUODENAL ULCER AND ALCOHOLIC CHRONIC PANCREATITIS.
Duodenal Ulcer
[DUODENAL ULCER AND PROTRACTED CHOLINESTERASE INHIBITION. OBSERVATION OF 2 PATIENTS WITH MYASTHENIA GRAVIS.]
Duodenal Ulcer
[Problems in the genetics of peptic ulcer. II. An analysis of the associations of the disease with certain simply heritable traits]
Dysentery
[Activity of serum cholinesterase and catalase in patients with typhoid and dysentery]
Dysentery
[On the problem of the relationship between vitamin B1 metabolism and cholinesterase activity in dysentery in children.]
Dyskinesias
A Case Report on Dyskinesia Following Rivastigmine Patch 13.3 mg/24 hours for Alzheimer's Disease: Perspective in the Movement Disorders Spectrum Following Use of Cholinesterase Inhibitors.
Dyskinesias
Chronic Neurological Disorders: Genetic and Epigenetic Markers for Monitoring of Pharmacotherapy.
Dyslipidemias
Fish Oil and Primrose Oil Suppress the Progression of Alzheimer's Like Disease Induced by Aluminum in Rats.
Dyslipidemias
Longitudinal lipid profile variations and clinical change in Alzheimer's disease dementia.
Dyspnea
Anticholinesterase-induced symptoms improved by pacemaker implantation in patients with Alzheimer's disease: analysis of 6 cases.
Dyspnea
Effects of subchronic inhalation exposure to an organophosphorus insecticide compound containing dichlorvos on wistar rats' otoacoustic emissions.
Dyspnea
Poisoning of an urban family due to misapplication of household organophosphate and carbamate pesticides.
Dyspnea
The possible role of intravenous lipid emulsion in the treatment of chemical warfare agent poisoning.
Dyspnea
[A patient with facioscapulohumeral muscular dystrophy accompanied by myasthenia gravis]
Dyspnea
[Clinical analysis of patients with community-acquired pneumonia requiring hospitalization classified by age group]
Dystonia
Acetylcholinesterase and butyrylcholinesterase in cerebrospinal fluid from patients with dystonia.
Dystonia
Donepezil-induced cervical dystonia in Alzheimer's disease: a case report and literature review of dystonia due to cholinesterase inhibitors.
Ectopia Cordis
Determination of cholinesterase and acetylcholinesterase in amniotic fluid. Uses in prenatal diagnosis and quality control.
Eczema
[Differences in blood cholinesterase activity as a possible differential diagnostic criterion of eczema, atopic dermatosis and allergic eczema-like dermatitis]
Ehrlichiosis
Butyrylcholinesterase as a marker of inflammation and liver injury in the acute and subclinical phases of canine ehrlichiosis.
Encephalitis
Evaluation of cholinergic functions in patients with Japanese encephalitis and Herpes simplex encephalitis.
Encephalitis, Herpes Simplex
Evaluation of cholinergic functions in patients with Japanese encephalitis and Herpes simplex encephalitis.
Encephalitis, Japanese
Evaluation of cholinergic functions in patients with Japanese encephalitis and Herpes simplex encephalitis.
Encephalitis, Japanese
Japanese Encephalitis Virus Infection Results in Transient Dysfunction of Memory Learning and Cholinesterase Inhibition.
Encephalocele
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
End Stage Liver Disease
Changes of plasma cholinesterase activity during orthotopic liver transplantation in man.
End Stage Liver Disease
Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D.
End Stage Liver Disease
[Reevaluation of the typing criteria for patients with chronic severe hepatitis]
End Stage Liver Disease
[The therapeutic value of alpha-fetoprotein and cholinesterase in patients with hepatitis B virus related acute onset chronic liver failure].
Endometriosis
[Genetic aspects of endometriosis: features of the distribution of polymorphic gene frequencies]
Endotoxemia
Physostigmine reverses disturbances of the intestinal microcirculation during experimental endotoxemia.
Endotoxemia
Serum butyrylcholinesterase and paraoxonase 1 in a canine model of endotoxemia: Effects of choline administration.
Endotoxemia
Serum choline and butyrylcholinesterase changes in response to endotoxin in calves receiving intravenous choline administration.
Entamoebiasis
Serum cholinesterase and alkaline phosphatase levels and serum protein fractions in Entamoeba histolytica infections.
Enteritis
Anti-foodborne enteritis effect of galantamine potentially via acetylcholine anti-inflammatory pathway in fish.
Enteritis
Inflammatory and oxidative biomarkers of disease severity in dogs with parvoviral enteritis.
Environmental Illness
Environmental illness: fatigue and cholinesterase activity in patients reporting hypersensitivity to electricity.
Epilepsies, Partial
[A hypothesis based on histochemical data regarding the site from which originate the automatic movements present in rhinencephalic epilepsy and an added note concerning the distribution of cholinesterase activity in the amygdaloid complex of man.]
Epilepsy
High-performance counter-current chromatography isolation and initial neuroactivity characterization of furanocoumarin derivatives from Peucedanum alsaticum L (Apiaceae).
Epilepsy
Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment.
Epilepsy
Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations.
Epilepsy
Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and ?-glycosidase inhibitors.
Epilepsy
[Action of cholinesterase & electrophoretic blood protein fractions in epilepsy & paresis.]
Epilepsy
[Decrease of cholinesterase in areas of the cerebral cortex "isolated" for a long period and hypersensitive to epilepsy.]
Epilepsy, Reflex
[Electrographic observations on the "antidisposition" mechanism of action toward reflex epilepsy on the cholinesterase treatment.]
Erythema
Clinical factors that affect blood gases in non-smoking women with chronic liver disease.
Erythema
Skin decontamination efficacy of sulfur mustard and VX in the pig model: A comparison between Fuller's earth and RSDL.
Esophageal Achalasia
Esophageal aperistalsis and achalasia produced in dogs by prolonged cholinesterase inhibition.
Esophageal and Gastric Varices
A conundrum: general or neuraxial anesthesia and the use of ROTEM.
Esophageal and Gastric Varices
Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi).
Esophageal and Gastric Varices
Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosis.
Esophageal and Gastric Varices
Survival and prognostic indicators in compensated and decompensated cirrhosis.
Esophageal and Gastric Varices
Survival in alcoholic liver cirrhosis: prognostic value of portal pressure, size of esophageal varices and biochemical data. Comparison with Child classification.
Esophageal Spasm, Diffuse
Symptomatic diffuse esophageal spasm. Manometric follow-up and response to cholinergic stimulation and cholinesterase inhibition.
Essential Hypertension
[Association of mutant alleles of serum cholinesterase with various multi-factorial and infectious diseases]
Essential Hypertension
[Effects of A.T.P. (adenosinetriphosphoric acid) on the blood cholinesterase of patients with essential hypertension and hyperthyroidism; preliminary report.]
Fasciculation
Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats.
Fasciculation
Fresh frozen plasma as a successful antidotal supplement in acute organophosphate poisoning.
Fasciculation
Letter: Absence of suxamethonium fasciculations in patients with atypical plasma cholinesterase.
Fasciculation
Letter: Absence of suxamethonium fasciculations in patients with atypical pseudocholinesterase.
Fasciculation
Pathophysiology of fasciculations in ALS as studied by electromyography of single motor units.
Fasciculation
Potential of memantine, D-tubocurarine, and atropine in preventing acute toxic myopathy induced by organophosphate nerve agents: soman, sarin, tabun and VX.
Fasciculation
Presence of suxamethonium fasciculations in patients with atypical plasma cholinesterase.
Fasciculation
Pulmonary function changes induced by experimental dichlorvos toxicosis in calves.
Fasciculation
Striatal neurochemical changes and motor dysfunction in mipafox-treated animals.
Fasciculation
Violent fasciculations after small dose succinylcholine infusion as a first sign of atypical pseudocholinesterase.
Fasciculation
[Myasthenia gravis with anti-acetylcholine receptor antibody or anti-muscle specific kinase antibody].
Fatigue Syndrome, Chronic
Peripheral cholinergic function in humans with chronic fatigue syndrome, Gulf War syndrome and with illness following organophosphate exposure.
Fatty Liver
Abnormal blood chemistry data in Cushing's syndrome: comparison with those for fatty liver.
Fatty Liver
Acetylcholinesterase (AChE) inhibition aggravates fasting-induced triglyceride accumulation in the mouse liver.
Fatty Liver
Changes in high density lipoproteins in patients with hepatobiliary diseases. Levels and lipid composition of HDL2 and HDL3 and LCAT reaction.
Fatty Liver
Development and application of serum cholinesterase activity measurement using benzoylthiocholine iodide.
Fatty Liver
Fatty liver and serum cholinesterase are independently correlated with HbA1c levels: Cross-sectional analysis of 5384 people.
Fatty Liver
Idiopathic fatty liver of pregnancy with a subsequent uncomplicated pregnancy and a progressive increase in serum cholinesterase activity during the third trimester. A case report.
Fatty Liver
Prolonged neuromuscular block associated with acute fatty liver of pregnancy and reduced plasma cholinesterase.
Fatty Liver
Relationship between content of hepatic glutathione S-transferases and the kinetics of indocyanine green elimination in various liver diseases.
Fatty Liver
Relationship between serum leptin and fatty liver in Japanese male adolescent university students.
Fatty Liver
Serum butyrylcholinesterase and the risk of future type 2 diabetes: The Kansai Healthcare Study.
Fatty Liver
Serum butyrylcholinesterase/HDL-cholesterol ratio and atherogenic index of plasma in patients with fatty liver disease.
Fatty Liver
Serum cholinesterase activity and proteosynthetic function of liver in patients with diabetes mellitus.
Fatty Liver
The results of the "essential laboratory tests" applied to new outpatients--re-evaluation of diagnostic efficiencies of the test items.
Fatty Liver
[Assessment of the guidelines for efficacious utilization of laboratory tests in primary care medicine]
Fatty Liver
[ON THE DIFFERENTIAL DIAGNOSIS OF CHRONIC HEPATITIS AND FATTY LIVER. THE SIGNIFICANCE OF PERCUTANEOUS LIVER BIOPSY AND SERUM CHOLINESTERASE ACTIVITY.]
Fatty Liver
[Serum cholinesterase activity in non-alcoholic fatty liver. Effect of obesity on the activity and role of its measurement in the differential diagnosis in chronic hepatitis]
Fetal Death
Determination of cholinesterase and acetylcholinesterase in amniotic fluid. Uses in prenatal diagnosis and quality control.
Fetal Death
[CHOLINESTERASE ACTIVITY OF THE BLOOD SERUM IN FETAL DEATH, ASPHYXIA NEONATORUM AND FETAL DEFORMITIES.]
Fetal Hypoxia
[Effect of acute fetal anoxia during labor on enzyme activity of some transaminases and cholinesterase]
Frontotemporal Dementia
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.
Frontotemporal Dementia
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
Frontotemporal Dementia
Reports in pharmacological treatments in geriatric psychiatry: is there anything new or just adding to old evidence?
Frontotemporal Dementia
[Rivastigmine in a case of autopsy proved frontotemporal dementia (Pick's disease)]
Frontotemporal Lobar Degeneration
Prescription patterns and efficacy of drugs for patients with dementia: physicians' perspective in Italy.
Frontotemporal Lobar Degeneration
[New therapeutic strategies for behavioral and psychological symptoms of dementia]
Ganglion Cysts
[Effect of Alternanthera philoxeroides on enzymic histochemistry of oncomelania hupensis]
Ganglion Cysts
[Protective effect of exogenous glial cell line derived neurotrophic factor on neurons after sciatic nerve injury in rats]
Gastrointestinal Diseases
[Activity of non-specific cholinesterase in acute gastrointestinal diseases in infants]
Gastroschisis
Ratio of amniotic fluid acetylcholinesterase to pseudocholinesterase as an antenatal diagnostic test for exomphalos and gastroschisis.
Gestational Trophoblastic Disease
Plasma cholinesterase and trophoblastic disease. Gestational trophoblastic disease and reduced activity of plasma cholinesterase.
Gilbert Disease
Relationship between content of hepatic glutathione S-transferases and the kinetics of indocyanine green elimination in various liver diseases.
Glaucoma
An Overview on Natural Cholinesterase Inhibitors - A Multi-Targeted Drug Class - and Their Mass Production.
Glaucoma
Blood cholinesterase activity of glaucoma patients treated with phospholine iodide.
Glaucoma
Cholinesterase activities in plasma and erythrocytes in glaucoma patients treated with substances without any anticholin-esterase effect.
Glaucoma
CHOLINESTERASE ACTIVITY IN PLASMA AND ERYTHROCYTES. A CLINICO-HAEMATOLOGICAL STUDY BASED ON NORMAL SUBJECTS AND ON PATIENTS WITH GLAUCOMA, OF WHOM SOME NOT TREATED WITH AND SOME TREATED WITH ANTICHOLINESTERASES.
Glaucoma
Cholinesterase inhibitors: pharmacology, symptoms of poisoning, and treatment. Studies on the cholinesterase activities in glaucoma patients.
Glaucoma
EFFECT OF PHOSPHOLINE IODIDE ON BLOOD CHOLINESTERASE LEVELS OF NORMAL AND GLAUCOMA SUBJECTS.
Glaucoma
Effects of Distigmine on Electrical Field Stimulation-Induced Contraction of Mouse Urinary Bladder Smooth Muscles.
Glaucoma
Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and ?-glycosidase inhibitors.
Glaucoma
The effect of phospholine iodide eye drops on blood cholinesterase in glaucoma patients.
Glaucoma
[Cholinesterase activity in the humor of the anterior chamber and in the blood in patients with glaucoma and cataract]
Glaucoma
[Cholinesterase inhibitors. Pharmacology, symptoms and treatment of poisoning. Investigation of cholinesterase activities in glaucoma patients]
Glaucoma
[Clinical evaluation of the effectiveness of cholinesterase inhibition with neuromidin in the treatment of primary glaucoma patients].
Glaucoma
[Examination of cholinesterase activity of the serum and aqueous humor in glaucoma.]
Glioblastoma
Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors.
Glioma
A histochemical study of the activity of nonspecific cholinesterase in C6 glioma cells in culture.
Glioma
Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors.
Glioma
Characterization of activities and forms of cholinesterases in human primary brain tumors.
Glioma
Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma.
Glioma
Observation of the Elevation of Cholinesterase Activity in Brain Glioma by a Near-Infrared Emission Chemsensor.
Glucose Intolerance
Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders.
Glucose Metabolism Disorders
Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders.
glucose-6-phosphate dehydrogenase (nadp+) deficiency
Beta-thalassaemia, G-6-PD deficiency, and atypical cholinesterase in Cyprus.
Glycogen Storage Disease Type VI
Hypercholinesterasemia with isoenzymic alteration in a family.
Goiter
Prevalence of goiter and its associated factors among primary school children in Chole District, Arsi Zone, Ethiopia: a cross- sectional study.
Goiter
[Changes in the acetylcholine concentration and acetylcholinesterase activity in the thyroid gland tissues and in serum cholinesterase activity in goiter]
Goiter
[Studies on the thyroid gland. 3. Cholinesterase activity of the blood and serum in patients before and after resection of the goiter]
Goldenhar Syndrome
Airway management using the pediatric GlideScope in a child with Goldenhar syndrome and atypical plasma cholinesterase.
Guillain-Barre Syndrome
The impact of aerial application of organophosphates on the cholinesterase levels of rural residents in the Vaalharts district, Northern Cape Province, South Africa.
Guillain-Barre Syndrome
[Electrophoresis of cholinesterases of the cerebrospinal fluid in the Guillain-Barré syndrome]
Hallucinations
Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies.
Hallucinations
Cholinesterase inhibitors might alleviate methamphetamine-induced delusions, hallucinations and cognitive impairment, while reducing craving and addiction.
Hallucinations
Chronic Neurological Disorders: Genetic and Epigenetic Markers for Monitoring of Pharmacotherapy.
Hallucinations
Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease.
Hallucinations
Compensatory shifts in visual perception are associated with hallucinations in Lewy body disorders.
Hallucinations
Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB.
Hallucinations
Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease.
Hallucinations
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
Hallucinations
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease.
Hallucinations
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
Hallucinations
Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies.
Hallucinations
Imagine that: cholinesterase inhibitor treatment of complex visual hallucinations of unknown aetiology.
Hallucinations
Measuring Alzheimer's disease progression with transition probabilities in the Taiwanese population.
Hallucinations
Neuropsychiatric symptoms in patients with dementias associated with cortical lewy bodies: pathophysiology, clinical features, and pharmacological management.
Hallucinations
New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins.
Hallucinations
Parkinson's disease-related visual hallucinations unresponsive to atypical antipsychotics treated with cholinesterase inhibitors: a case series.
Hallucinations
Patients characteristics with cholinesterase inhibitor resistant hallucinations in dementia with Lewy bodies.
Hallucinations
THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO LYSERGIC ACID TARTRATE (BOL-148) ON SPECIFIC CHOLINESTERASE AND MONOAMINE OXIDASE OF RAT LIVER AS POSSIBLE FACTORS IN THE MECHANISM OF HALLUCINATION. A HISTOCHEMICAL STUDY.
Hallucinations
Treatment of Visual Hallucinations in Schizophrenia by Acetylcholinesterase Inhibitors: a case report.
Hallucinations
Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine.
Hallucinations
Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas.
Hallucinations
[New therapeutic strategies for behavioral and psychological symptoms of dementia]
Hand, Foot and Mouth Disease
Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.
Head and Neck Neoplasms
Prognostic and diagnostic value of serum pseudocholinesterase, serum aspartate transaminase, and serum alinine transaminase in malignancies treated by radiotherapy.
Headache Disorders
Light therapy modulates serotonin levels and blood flow in women with headache. A preliminary study.
Hearing Loss
Hearing screening and cholinesterase activity among rural workers exposed to pesticides.
Heart Block
Correlative electrophysiological and anatomical studies concerning the site of origin of escape rhythm during complete atrioventricular block in the dog.
Heart Block
[Severe bradycardia in general anaesthesia in a patient treated with cholinesterase inhibitors for dementia.]
Heart Defects, Congenital
[Blood cholinesterase activity in children with congenital heart defects]
Heart Diseases
Cholinesterase inhibition reduces arrhythmias in asymptomatic Chagas disease.
Heart Diseases
[Acute poisoning by an organophosphoric compound. Effects of pralidoxime on cardiac disorders and serum, erythrocyte and tissue cholinesterase activity]
Heart Diseases
[Mortality rates in patients with Alzheimer's disease treated with atypical neuroleptic drugs]
Heart Failure
A patient with Churg-Strauss syndrome who underwent endoscopic sinus surgery under general anesthesia -A case report-.
Heart Failure
Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
Heart Failure
Effect of the cholinesterase inhibitor donepezil on cardiac remodeling and autonomic balance in rats with heart failure.
Heart Failure
Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
Heart Failure
Manifestations of and risk factors for acute myocardial injury after acute organophosphorus pesticide poisoning.
Heart Failure
Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy.
Heart Failure
Prognostic nomogram for the severity of acute organophosphate insecticide self-poisoning: a retrospective observational cohort study.
Heart Failure
Prognostic significance of serum cholinesterase in patients with acute decompensated heart failure: a prospective comparative study with other nutritional indices.
Heart Failure
Prognostic Significance of Serum Cholinesterase Level in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-HFpEF Registry.
Heart Failure
Serum cholinesterase activity and its diagnostic and prognostic significance in patients with chronic cardiac failure.
Heart Failure
Serum cholinesterase is an important prognostic factor in chronic heart failure.
Heart Failure
Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.
Heart Failure
The acetylcholine content and cholinesterase activities in the rabbit heart in experimental heart failure and the effect of g-strophanthin treatment upon them.
Hematologic Diseases
A study of cholinesterase activity in the blood of patients with hematologic disease.
Hematologic Neoplasms
Serum cholesterol and apoprotein B levels and serum cholinesterase activity in selected hematologic malignancies.
Hemorrhagic Fever with Renal Syndrome
[On blood serum cholinesterase activity in patients with hemorrhagic fever with renal syndrome]
Hepatic Encephalopathy
Choline acetyltransferase and acetylcholinesterase activities are unchanged in brain in human and experimental portal-systemic encephalopathy.
Hepatic Encephalopathy
Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy.
Hepatic Encephalopathy
Nucleos(t)ide analogs improve long-term prognosis in patients with chronic hepatitis B-associated liver failure.
Hepatic Encephalopathy
Prognostic factors for chronic severe hepatitis and construction of a prognostic model.
Hepatic Encephalopathy
Serum levels of C3 and cholinesterase in various diseases of the liver.
Hepatic Encephalopathy
Severe depression of serum cholinesterase activity associated with two cases of hepatic encephalopathy.
Hepatic Encephalopathy
[Effectiveness of nutritional support for the liver-cell deficiency in the liver cirrhosis]
Hepatic Encephalopathy
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
Hepatic Insufficiency
[Management of children with fatal liver diseases with reference to eventual liver transplantation]
Hepatic Insufficiency
[Prolonged apnea after suxamethonium administration during staphylococcal toxic shock]
Hepatitis
Changes in ultrastructure of hepatocytes and liver test results before, during, and after treatment with interferon-beta in patients with HB(e)Ag-positive chronic active hepatitis.
Hepatitis
Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
Hepatitis
Dynamic relationship between infantile hepatitis syndrome and cytomegalovirus infection.
Hepatitis
Measurement of serum cholinesterase activity: a useful test in the management of acute hepatitis.
Hepatitis
Serum cholinesterase (pseudocholinesterase) in Down's syndrome: 2. Quantitative levels.
Hepatitis
Studies of cholinesterase activity. II. Serum cholinesterase in hepatitis and cirrhosis.
Hepatitis
The behavior of aspartic and alanine aminotransferases, lactic dehydrogenase, cholinesterase, prothrombin, beta-glucuronidase, bilirubin, thymol turbidity test and serum proteinograms under the influence of corticotherapy in the course of viral hepatitis in children.
Hepatitis
The pharmacodynamics of mivacurium in the rabbit with carbon tetrachloride-induced liver disease.
Hepatitis
[Activity of aldolase, pseudocholinesterase and transaminases in the blood serum in epidemic hepatitis.]
Hepatitis
[Activity of serum cholinesterase in certain liver diseases, particularly in virus hepatitis]
Hepatitis
[Cholinesterase activity in the blood and liver of mice with mouse hepatitis virus infection]
Hepatitis
[Cholinesterase, iron & transaminase in blood serum: comparative study in acute hepatitis, chronic liver diseases & extrahepatic obstructive jaundice.]
Hepatitis
[Clinical value of measuring the activity of serum cholinesterase and its isoenzyme in chronic hepatitis and liver cirrhosis]
Hepatitis
[Comparative studies on the behavior of serum cholinesterase activity, transaminases (SGOT and SGPT) and the serum albumin picture during the treatment of epidemic hepatitis with glucocorticoids (prednisone) and anabolic steroids (methandrostenolone) in childhood]
Hepatitis
[Determination of cholinesterase in obstructive jaundice and in the course of virus hepatitis]
Hepatitis
[Relationship between cholinesterase, prothrombin activity and albumin and the pathology of the liver]
Hepatitis
[Serum cholinesterase activity in non-alcoholic fatty liver. Effect of obesity on the activity and role of its measurement in the differential diagnosis in chronic hepatitis]
Hepatitis
[Serum cholinesterase level in patients with viral hepatitis treated with prednisolone]
Hepatitis
[Serum cholinesterase synthesis in children with liver diseases with special reference to acute icteric and anicteric hepatitis]
Hepatitis
[Some features specific of the spectrum of proteins, cholinesterase and peroxidase isoenzymes of the blood serum in viral hepatitis]
Hepatitis
[The cause of serum cholinesterase activity decrease in hepatitis and liver cirrhosis.]
Hepatitis
[Usefulness of serum pseudocholinesterase isoenzymes in acute and chronic liver diseases and neoplasms (experimental and clinical study)]
Hepatitis A
An ultramicro technique for the assay of serum cholinesterase: results in normal children and in children with infectious hepatitis.
Hepatitis A
Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study.
Hepatitis A
PLASMA ESTERASE ACTIVITY IN PATIENTS WITH LIVER DISEASE AND THE NEPHROTIC SYNDROME.
Hepatitis A
[Clinical value of determining the serum cholinesterase level in infectious hepatitis treated with prednisolone]
Hepatitis A
[Course of activity of serum cholinesterase in various liver diseases especially in infectious hepatitis of adults]
Hepatitis B
Changes in ultrastructure of hepatocytes and liver test results before, during, and after treatment with interferon-beta in patients with HB(e)Ag-positive chronic active hepatitis.
Hepatitis B
Immunohistological investigations of PAS-negative globular intracisternal hyalin in human liver biopsy specimens.
Hepatitis B
Plasma cholinesterase: double-edged parameter in the diagnosis of acute organophosphorus poisoning.
Hepatitis B
[The therapeutic value of alpha-fetoprotein and cholinesterase in patients with hepatitis B virus related acute onset chronic liver failure].
Hepatitis B, Chronic
Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy.
Hepatitis B, Chronic
Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis B.
Hepatitis C
Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis.
Hepatitis C, Chronic
Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C.
Hepatitis C, Chronic
[Relationship between the level of serum TNF-alpha of patients with chronic hepatitis C and treatment with interferon-alpha and the influencing factors]
Hepatitis D
Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D.
Hepatitis D, Chronic
Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D.
Hepatitis, Chronic
Changes in ultrastructure of hepatocytes and liver test results before, during, and after treatment with interferon-beta in patients with HB(e)Ag-positive chronic active hepatitis.
Hepatitis, Chronic
Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
Hepatitis, Chronic
Discrimination of liver cirrhosis from chronic hepatitis by analysis of serum cholinesterase isozymes using affinity electrophoresis with concanavalin A or wheat germ agglutinin.
Hepatitis, Chronic
Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein.
Hepatitis, Chronic
Enzyme-linked immunosorbent assay (ELISA) for Aleuria aurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronic hepatitis.
Hepatitis, Chronic
High plasma concentration of myeloperoxidase in cirrhosis: a possible marker of hypersplenism.
Hepatitis, Chronic
[Clinical value of measuring the activity of serum cholinesterase and its isoenzyme in chronic hepatitis and liver cirrhosis]
Hepatitis, Chronic
[ON THE DIFFERENTIAL DIAGNOSIS OF CHRONIC HEPATITIS AND FATTY LIVER. THE SIGNIFICANCE OF PERCUTANEOUS LIVER BIOPSY AND SERUM CHOLINESTERASE ACTIVITY.]
Hepatitis, Chronic
[Place of serum cholinesterase in the diagnosis of chronic liver diseases]
Hepatitis, Chronic
[Serum cholinesterase activity in non-alcoholic fatty liver. Effect of obesity on the activity and role of its measurement in the differential diagnosis in chronic hepatitis]
Hepatolenticular Degeneration
Oral zinc therapy normalizes serum uric acid level in Wilson's disease patients.
Hepatomegaly
Factors Influencing Cyst Infection in Autosomal Dominant Polycystic Kidney Disease.
Hepatomegaly
[Serum cholinesterase and arylesterase in cirrhosis and steatosic hepatomegaly]
Hepatorenal Syndrome
[Reevaluation of the typing criteria for patients with chronic severe hepatitis]
Hernia, Umbilical
Diagnosis of neural tube defects by estimation of amniotic fluid acetylcholinesterase.
Hernia, Umbilical
Ratio of amniotic fluid acetylcholinesterase to pseudocholinesterase as an antenatal diagnostic test for exomphalos and gastroschisis.
Herpes Zoster
Evaluation of the developmental and reproductive toxicity of chlorpyrifos in the rat.
Hirschsprung Disease
Autonomic nerves in rectum and colon in Hirschsprung's disease. A cholinesterase and catecholamine histochemical study.
Hirschsprung Disease
Cholinesterase activities in resected bowel specimens from children with Hirschsprung's disease.
Hirschsprung Disease
Congenital megacolon; a comparison of the spastic and hypertrophied segments with respect to Cholinesterase activities and sensitivities to Acetylcholine, DFP and the barium ion.
Hirschsprung Disease
Experience with a cholinesterase histochemical technique for rectal suction biopsies in the diagnosis of Hirschsprung's disease.
Hirschsprung Disease
Histologic diagnosis of Hirschsprung's disease. The value of concurrent hematoxylin and eosin and cholinesterase staining of rectal biopsies.
Hirschsprung Disease
The determination of total cholinesterase in rectal biopsy tissue from patients with Hirschsprung's disease.
Hirschsprung Disease
[Diagnostic value of cholinesterase activity in superficial biopsies of the rectum]
Hirschsprung Disease
[Value of the assay of cholinesterase activity in superficial biopsies of the rectum in the diagnosis of Hirschsprung's disease]
HIV Infections
The association of the platelet count and the peripheral CD8+ cell count in Japanese HIV-infected hemophiliacs.
Hodgkin Disease
Hodgkin's lymphoma presenting in two siblings with atypical pseudocholinesterase.
Homocystinuria
In vitro homocysteine inhibits platelet Na+,K+-ATPase and serum butyrylcholinesterase activities of young rats.
Homocystinuria
Lipid, Oxidative and Inflammatory Profile and Alterations in the Enzymes Paraoxonase and Butyrylcholinesterase in Plasma of Patients with Homocystinuria Due CBS Deficiency: The Vitamin B12 and Folic Acid Importance.
Homocystinuria
Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia.
Hookworm Infections
Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study.
Hydrocephalus
Determination of cholinesterase and acetylcholinesterase in amniotic fluid. Uses in prenatal diagnosis and quality control.
Hydrocephalus
Early Serum Biomarkers for Intensive Care Unit Treatment within the First 24 Hours in Patients with Intracerebral Hemorrhage.
Hydronephrosis
Determination of cholinesterase and acetylcholinesterase in amniotic fluid. Uses in prenatal diagnosis and quality control.
Hydrophthalmos
[On the problem of pseudocholinesterase deficiency syndrome. Anesthesia accident in a 4-months-old infant during an ophthalmological operation in congenital buphthalmos.]
Hyperalgesia
The antiallodynic effects of intrathecal cholinesterase inhibitors in a rat model of neuropathic pain.
Hyperalgesia
The interaction between intrathecal neostigmine and GABA receptor agonists in rats with nerve ligation Injury.
Hypercholesterolemia
Influence of APOE gene polymorphisms on interferon-beta treatment response in multiple sclerosis.
Hyperemia
Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
Hypergammaglobulinemia
Horseshoe kidney and membranous glomerulonephritis with cold activation of complement.
Hyperglycemia
Acute toxicity of methyl isocyanate in mammals. II. Induction of hyperglycemia, lactic acidosis, uraemia, and hypothermia in rats.
Hyperglycemia
Antihyperglycemic Effect of Quercetin in Ovariectomized Rats Treated with Tamoxifen.
Hyperglycemia
Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3.
Hyperglycemia
Methyl parathion and fenvalerate toxicity in American kestrels: acute physiological responses and effects of cold.
Hyperglycemia
Suspected chlorpyrifos toxicosis in a llama, and plasma pseudocholinesterase activity in llamas given chlorpyrifos.
Hyperglycemia
The Neuroprotective Effect of Dark Chocolate in Monosodium Glutamate-Induced Nontransgenic Alzheimer Disease Model Rats: Biochemical, Behavioral, and Histological Studies.
Hyperglycemia
[Iodine 131 with autography, hyperglycemia, cholinesterase, metabolism, thiomidil, anaphylactic shock, immunisation in hibernation.]
Hyperglycemia
[Iodine 131 with radioautography hyperglycemia, cholinesterase, metabolism, thiomidil, in hibernation.]
Hyperglycemia
[Radioactive iodine with autography, hyperglycemia, cholinesterase, metabolism, thiomidil, anaphylactic shock, and immunization in hibernation.]
Hyperhidrosis
Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management.
Hyperhomocysteinemia
A versatile equation to describe reversible enzyme inhibition and activation kinetics: modeling beta-galactosidase and butyrylcholinesterase.
Hyperhomocysteinemia
Butyrylcholinesterase activity is reduced in haemodialysis patients: is there association with hyperhomocysteinemia and/or oxidative stress?
Hyperhomocysteinemia
Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE epsilon4, and hyperhomocysteinemia in neurodegenerative dementias.
Hyperhomocysteinemia
Folic acid pretreatment prevents the reduction of Na(+),K(+)-ATPase and butyrylcholinesterase activities in rats subjected to acute hyperhomocysteinemia.
Hyperhomocysteinemia
Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia.
Hyperkalemia
Synergistic effect of acidosis and succinylcholine-induced hyperkalemia in spinal cord transected rats.
Hyperlipidemias
Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation.
Hyperlipidemias
Cholinesterase in serum and low density lipoprotein of hyperlipidemic patients.
Hyperlipidemias
Effect of simian virus 40 subcutaneous tumors on circulating lipids and lipoproteins in the Syrian hamster.
Hyperlipidemias
Hereditary serum cholinesterase deficiency associated with severe lipid deposition in the kidney.
Hyperlipidemias
Serum butyrylcholinesterase and the risk of future type 2 diabetes: The Kansai Healthcare Study.
Hyperlipidemias
Serum cholinesterase activity in hyperlipidemia and the in vitro effect of isoniazid on serum cholinesterase.
Hyperlipidemias
[The preanalytical stage of under measuring of concentration of catalytic activity of enzymes: the characteristics and tasks of standardization].
Hyperlipoproteinemia Type II
Alpha 2-antiplasmin, plasminogen activator inhibitor (PAI) and dilute blood clot lysis time in selected disease states.
Hyperlipoproteinemia Type II
Clinical studies on plasma fibronectin and factor XIII; with special reference to hyperlipoproteinemia.
Hyperlipoproteinemia Type II
Clinical study on the effect of simvastatin on butyrylcholinesterase activity.
Hyperlipoproteinemia Type II
[Evaluation of the pseudocholinesterase activity in hyperlipoproteinemia type II and type IV]
Hyperlipoproteinemia Type IV
[Evaluation of the pseudocholinesterase activity in hyperlipoproteinemia type II and type IV]
Hyperlipoproteinemias
Alpha 2-antiplasmin, plasminogen activator inhibitor (PAI) and dilute blood clot lysis time in selected disease states.
Hyperlipoproteinemias
Clinical studies on plasma fibronectin and factor XIII; with special reference to hyperlipoproteinemia.
Hyperlipoproteinemias
Clinical study on the effect of simvastatin on butyrylcholinesterase activity.
Hyperlipoproteinemias
Serum pseudocholinesterase and ceruloplasmin in various types of hyperlipoproteinemia.
Hyperlipoproteinemias
Similar behaviour of lecithin:cholesterol acyltransferase and pseudocholinesterase in liver disease and hyperlipoproteinemia.
Hyperlipoproteinemias
[Cholinesterase activity in hyperlipoproteinemia patients in middle age]
Hyperlipoproteinemias
[Evaluation of the pseudocholinesterase activity in hyperlipoproteinemia type II and type IV]
Hyperparathyroidism
Bilateral Forearm Fractures During Modified Electroconvulsive Therapy in a Male Patient With a History of Hyperparathyroidism and Elevated Pseudocholinesterase Activity.
Hyperpigmentation
Characterization of phytochemical components of Ferula halophila extracts using HPLC-MS/MS and their pharmacological potentials: a multi-functional insight.
Hyperpigmentation
Exploring the halophyte Cistanche phelypaea (L.) Cout as a source of health promoting products: In vitro antioxidant and enzyme inhibitory properties, metabolomic profile and computational studies.
Hyperpigmentation
Influence of different extraction techniques on the chemical profile and biological properties of Anthemis cotula L.: Multifunctional aspects for potential pharmaceutical applications.
Hypersensitivity
Allergic reaction to suxamethonium during emergency caesarean section and pseudocholinesterase deficiency in the same patient.
Hypersensitivity
Deep neuromuscular blockade and surgical conditions during laparoscopic ventral hernia repair: A randomised, blinded study.
Hypersensitivity
Dexmedetomidine decreases hyperalgesia in neuropathic pain by increasing acetylcholine in the spinal cord.
Hypersensitivity
Effect of Delirium on Physical Function in Noncardiac Thoracic Surgery Patients.
Hypersensitivity
Environmental illness: fatigue and cholinesterase activity in patients reporting hypersensitivity to electricity.
Hypersensitivity
Hypersensitivity to the cholinesterase inhibitor di-iso-propoxy-phosphoryl fluoride (DFP). Cross-sensitization to related compounds.
Hypersensitivity
Increase in the activities of plasma pseudocholinesterase dependent on the blood glucose level and its relation to the hypersensitivity to acetylcholine in striated muscles of KK-CAy mice with diabetes.
Hypersensitivity
Oral donepezil reduces hypersensitivity after nerve injury by a spinal muscarinic receptor mechanism.
Hypersensitivity
Oral gabapentin activates spinal cholinergic circuits to reduce hypersensitivity after peripheral nerve injury and interacts synergistically with oral donepezil.
Hypersensitivity
Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury.
Hypersensitivity
[Acetylcholine and cholinesterase activity in experimental allergy in white rats]
Hypersensitivity
[Action of corticotropin on blood cholinesterase activity in normal subjects and respiratory allergy patients.]
Hypersensitivity
[Modifications in the action of cholinesterase in blood and tissue in allergy.]
Hypersensitivity
[Research on serum cholinesterase activity in hypersensitivity of the immediate type. I]
Hypersensitivity
[The behavior of serum cholinesterase in allergic diseases in childhood. (Contribution on the role of liver in allergies]
Hypersensitivity, Delayed
Immune and nutritional effects of early enteral nutrition after major abdominal operations.
Hypersensitivity, Delayed
Nutritional status, function of the small intestine and jejunal morphology after total gastrectomy for carcinoma of the stomach.
Hypersensitivity, Delayed
[Effect of the cholinesterase reactivator dipyroxime in various models of delayed hypersensitivity during acute intoxication by acrylonitrile]
Hypersensitivity, Delayed
[The mechanism of the effect of the cholinesterase reactivator diethyxime on different models of the development of delayed hypersensitivity in acute dichloroethane poisoning]
Hypertension
A study of measurement of serum cholinesterase in type 2 diabetes and hypertension.
Hypertension
A study of the cholinesterases of the canine pancreatic sphincters and the relationship between reduced butyrylcholinesterase activity and pancreatic ductal hypertension.
Hypertension
Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation.
Hypertension
Cognitive decline and survival in Alzheimer's disease according to education level.
Hypertension
Functional Analysis and Molecular Docking studies of Medicinal Compounds for AChE and BChE in Alzheimer's Disease and Type 2 Diabetes Mellitus.
Hypertension
Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease.
Hypertension
Identification of a point mutation associated with a silent phenotype of human serum butyrylcholinesterase--a case of familial cholinesterasemia.
Hypertension
Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia.
Hypertension
Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy.
Hypertension
Potential long-term effects of rivastigmine on disease progression may be linked to drug effects on vascular changes in Alzheimer brains.
Hypertension
Relationship between cardiac autonomic function and cognitive function in Alzheimer's disease.
Hypertension
The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada.
Hypertension
What are the benefits of cognitive enhancers for Alzheimer's Disease: use of Population Impact Measures.
Hypertension
[Modification of blood cholinesterase and effect of phosphacol on hypertension in dogs.]
Hypertension, Portal
[Usefulness of cholinesterase determination in ascitic fluid in the differential diagnosis of ascites]
Hypertension, Pregnancy-Induced
Butyrylcholinesterase activity and pregnancy-associated differences in immunologically relevant peripheral blood leukocyte populations.
Hypertension, Renal
[Acetylcholine-like substance concentration and cholinesterase activity during development of experimental renal hypertension]
Hypertension, Renal
[The effects of papaverine, tiphen and dibazol on the level of sympathomimetic amines and cholinesterase activity in the blood of dogs with experimentally induced renal hypertension]
Hyperthyroidism
Differential effects of developmental hypo- and hyperthyroidism on acetylcholinesterase and butyrylcholinesterase activity in the spinal cord of developing postnatal rat pups.
Hyperthyroidism
Relationship between butyrylcholinesterase activity and lipid parameters in workers occupationally exposed to pesticides.
Hyperthyroidism
Serum electrophoretic lipoprotein factors and pseudocholinesterase activity in thyroid disease.
Hyperthyroidism
[Blood coagulation, fibrinolysis and plasma esterase activity in hyperthyroidism treated conservatively and surgically]
Hyperthyroidism
[Effects of A.T.P. (adenosinetriphosphoric acid) on the blood cholinesterase of patients with essential hypertension and hyperthyroidism; preliminary report.]
Hyperthyroidism
[Studies on serum cholinesterase and on procaine esterase in hyperthyroidism.]
Hypertriglyceridemia
1914G variant of BCHE gene associated with enzyme activity, obesity and triglyceride levels.
Hypertriglyceridemia
Associations between serum cholinesterase and incident hyper-LDL cholesterolemia, hypertriglyceridemia and hypo-HDL cholesterolemia as well as changes in lipid levels in a health screening population.
Hypertriglyceridemia
Increased serum gamma-glutamyltransferase in hypertriglyceridemia: comparison with serum pseudocholinesterase.
Hypesthesia
Cholinesterase demonstration of dermal nerve endings in patients with impaired sensation. A clinical and pathologic study of 41 patients and 37 control subjects.
Hypoalbuminemia
Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion.
Hypoglycemia
Hypoglycemia During the Temporary Interruption of Parenteral Nutrition Infusion in Pediatric Hematopoietic Stem Cell Transplantation.
Hypoglycemia
Proximal subtotal pancreatectomy as an alternative to total pancreatectomy for malnourished patients.
Hypoglycemia
[Induced insulin hypoglycemia and pseudocholinesterase in peripheral vein blood in subjects with normal metabolism.]
Hypokinesia
[Blood and cardiac cholinesterase activity in rats of different sexes and ages during muscle loading and hypokinesia]
Hypotension
Clinical correlates of hypotension in patients with acute organophosphorus poisoning.
Hypotension
Inhibitory effect of fenthion and diazinon on the contraction of rat aorta, and its contribution to lethality.
Hypotension
Intrathecal cholinergic agonists lessen bupivacaine spinal-block-induced hypotension in rats.
Hypotension
[Clinical analysis of patients with community-acquired pneumonia requiring hospitalization classified by age group]
Hypothyroidism
Differential effects of developmental hypo- and hyperthyroidism on acetylcholinesterase and butyrylcholinesterase activity in the spinal cord of developing postnatal rat pups.
Hypothyroidism
Effects of thyroxin therapy on different analytes related to obesity and inflammation in dogs with hypothyroidism.
Hypothyroidism
Influence of neonatal hypothyroidism and of thyroxine on the acetylcholinesterase and cholinesterase activities in the developing central nervous system of the rat.
Hypothyroidism
Pseudo-internuclear ophthalmoplegia as a sign of overlapping myasthenia gravis in a patient with 'intractable' hypothyroidism.
Hypothyroidism
The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada.
Hypothyroidism
The relation between plasma lipid levels and pseudocholinesterase activity in hypothyroidism.
Hypothyroidism
[Blood cholinesterase in rats with experimental thyrotoxicosis and hypothyroidism]
Hypothyroidism
[Cholinesterase of the heart of rats with experimental thyrotoxicosis and hypothyroidism]
Hypoventilation
[Relation between serum cholinesterase polymorphism, long-term apnea and hypoventilation during surgery and in the postoperative period]
Hypoxia-Ischemia, Brain
Administration of Huperzia quadrifariata Extract, a Cholinesterase Inhibitory Alkaloid Mixture, has Neuroprotective Effects in a Rat Model of Cerebral Hypoxia-Ischemia.
Ileus
Postoperative ileus, pregnancy-related cholinesterase deficiency and suxamethonium after-pains. A case report.
Infections
A patient with Churg-Strauss syndrome who underwent endoscopic sinus surgery under general anesthesia -A case report-.
Infections
Assessment of hepatic oxidative damage, paraoxonase-1 activity, and lipid profile in cattle naturally infected with Ba7besia bigemina.
Infections
Changes on the activity of cholinesterase's in an immunomodulatory response of cattle infected by Listeria monocytogenes.
Infections
Cholinergic enzymes and inflammatory markers in rats infected by Sporothrix schenckii.
Infections
Cholinesterase as inflammatory markers in a experimental infection by Trypanosoma evansi in rabbits.
Infections
Cholinesterases as markers of the inflammatory process associated oxidative stress in cattle infected by Babesia bigemina.
Infections
Chronological changes in microbial profiles in external and middle ear diseases: a 20-year study in Korea.
Infections
Dynamic relationship between infantile hepatitis syndrome and cytomegalovirus infection.
Infections
Effects of reversible inhibition of cholinesterase and nicotine on mouse mortality and blood levels of proinflammatory cytokines during the early phase of sepsis.
Infections
Endogenous butyrylcholinesterase in SV40 transformed cell lines: COS-1, COS-7, MRC-5 SV40, and WI-38 VA13.
Infections
Evaluation of oxidative stress and antioxidant status, serum trace mineral levels and cholinesterases activity in cattle infected with Anaplasma marginale.
Infections
Evaluation of some acute phase proteins in cattle naturally infected with Babesia bigemina.
Infections
Experimental trichinosis: parasitological, electrophysiological and biochemical studies.
Infections
Factors Influencing Cyst Infection in Autosomal Dominant Polycystic Kidney Disease.
Infections
Immune and nutritional effects of early enteral nutrition after major abdominal operations.
Infections
Influence of Toxoplasma gondii Acute Infection on Cholinesterase Activities of Wistar Rats.
Infections
Influence of toxoplasmosis on acetylcholinesterase activity, nitric oxide levels and cellular lesion on the brain of mice.
Infections
Methicillin-resistant Staphylococcus aureus: colonization and development of infection in patients with haematological disorders.
Infections
Neospora caninum: Activity of cholinesterases during the acute and chronic phases of an experimental infection in gerbils.
Infections
Nippostrongylus brasiliensis: infection decreases plasma butyrylcholinesterase activity in rats.
Infections
Nucleos(t)ide analogs improve long-term prognosis in patients with chronic hepatitis B-associated liver failure.
Infections
Paraoxonase-1 activity is related to Trichinella spiralis-induced hepatitis in rats.
Infections
Pathological physiology of salmonellosis. II. Plasma cholinesterase in infections due to Enterobacteriaceae.
Infections
Potential association of reduced cholinesterase activity with Trypanosoma evansi pathogenesis in buffaloes.
Infections
Prognostic factors for chronic severe hepatitis and construction of a prognostic model.
Infections
Pseudomonas aeruginosa cholinesterase and phosphorylcholine phosphatase: two enzymes contributing to corneal infection.
Infections
Relationship of nematode cholinesterase activity and nematode burdens to the development of resistance to trichostrongyle infections in sheep.
Infections
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2?years of age - a multicenter retrospective study.
Infections
Serum cholinesterase and alkaline phosphatase levels and serum protein fractions in Entamoeba histolytica infections.
Infections
Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.
Infections
Studies on tissue cholinesterase in experimental trichinosis in albino rat. 1. Effect of T. spiralis infection.
Infections
The effect of Trypanosoma brucei infection of the localization of salivary gland cholinesterase in Glossina morsitans morsitans.
Infections
[Cholinesterase activity in muscle phase of Trichinella pseudospiralis Garkavi (1972) infection in mice]
Infections
[Decrease in plasmatic cholinesterase activity in severe bacterial infections: comparison with the decrease observed in severe liver cirrhosis]
Infections
[Erythocyte and plasma cholinesterase activity in swine: nutrition and infection.]
Infections
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
Infertility
Effect of Acetylcholinesterase and Butyrylcholinesterase on Intrauterine Insemination, Contribution to Inflammations, Oxidative Stress and Antioxidant Status; A Preliminary Report.
Infertility
[Cholinesterase and alkaline phosphatase activity and the SH group content of the blood in the pathogenesis of sterility in cows]
Inflammatory Bowel Diseases
A pregnant woman with genetic variants of butyrylcholinesterase and inflammatory bowel disease.
Inflammatory Bowel Diseases
Serum Cholinesterases, a Novel Marker of Clinical Activity in Inflammatory Bowel Disease: A Retrospective Case-Control Study.
Influenza, Human
Influenza vaccination and the activities of plasma acetylcholinesterase and butyrylcholinesterase in institutionalised elderly patients.
Influenza, Human
Primary care physician volume and quality of care for older adults with dementia: a retrospective cohort study.
Insulin Resistance
Abdominal Obesity Associated with Elevated Serum Butyrylcholinesterase Activity, Insulin Resistance and Reduced High Density Lipoprotein-Cholesterol Levels.
Insulin Resistance
Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation.
Insulin Resistance
aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease.
Insulin Resistance
Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?
Insulin Resistance
Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners.
Insulin Resistance
Cognition enhancing effect of the aqueous extract of Cinnamomum zeylanicum on non-transgenic Alzheimer's disease rat model: Biochemical, histological, and behavioural studies.
Insulin Resistance
Effects of high-fat diet and age on the blood lipidome and circulating endocannabinoids of female C57BL/6 mice.
Insulin Resistance
Liver Enzymes Correlate With Metabolic Syndrome, Inflammation, and Endothelial Dysfunction in Prepubertal Children With Obesity.
Insulin Resistance
Liver fat content measured by magnetic resonance spectroscopy at 3.0 tesla independently correlates with plasminogen activator inhibitor-1 and body mass index in type 2 diabetic subjects.
Insulin Resistance
Maternal circulating levels of some metabolic syndrome biomarkers in gestational diabetes mellitus.
Insulin Resistance
Pyridostigmine alleviates cardiac dysfunction via improving mitochondrial cristae shape in a mouse model of metabolic syndrome.
Insulin Resistance
Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus.
Insulin Resistance
Relationship between serum butyrylcholinesterase and the metabolic syndrome.
Insulin Resistance
Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance.
Insulin Resistance
Serum cholinesterase activity correlates with serum insulin, C-peptide and free fatty acids levels in patients with type 2 diabetes.
Insulin Resistance
The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies.
Intellectual Disability
Biochemical genetics and mental retardation: a study of hemoglobins, Australia antigen and the enzymes pseudocholinesterase and glucose-6-phosphate dehydrogenase.
Intellectual Disability
Pseudocholinesterase activity and E1 phenotypes in Down's syndrome and mental retardation.
Intestinal Pseudo-Obstruction
Paralytic ileus after discontinuation of cholinesterase inhibitor.
Intestinal Pseudo-Obstruction
Paralytic ileus as a complication of atropine therapy following severe organophosphate poisoning.
Intestinal Pseudo-Obstruction
Treatment of paralytic ileus with cholinesterase inhibitors in intravenous drip.
Irritable Bowel Syndrome
Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls.
Ischemic Stroke
Admission serum cholinesterase concentration for prediction of in-hospital mortality in very elderly patients with acute ischemic stroke: a retrospective study.
Ischemic Stroke
Pre-Stroke Cholinesterase Inhibitor Treatment Is Beneficially Associated with Functional Outcome in Patients with Acute Ischemic Stroke and Pre-Stroke Dementia: The Fukuoka Stroke Registry.
Ischemic Stroke
Serum butyrylcholinesterase activity and phenotype associations with lipid profile in stroke patients.
Ischemic Stroke
Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality.
Ischemic Stroke
[Changes in the acetylcholine level and cholinesterase activity in hemorrhagic and ischemic strokes]
Ischemic Stroke
[Secretion of melatonin and serum cholinesterase activity as biological markers of cognitive disorders in the acute stage of ischemic stroke].
Ketosis
Assessment of the platelet parameters and serum butyrylcholinesterase activity in type 1 diabetes patients with ketoacidosis.
Kidney Diseases
Plasma and red cell cholinesterase activity in uremic patterns (effects of hemodialysis and renal transplantation).
Kidney Diseases
Red blood cell and total blood acetylcholinesterase and plasma pseudocholinesterase in humans: observed variances.
Kidney Diseases
[Behavior of serum cholinesterase activity and its relation to the serum protein picture in various kidney diseases in childhood]
Kidney Failure, Chronic
Preoperative serum cholinesterase concentration in chronic renal failure. Clinical experience of suxamethonium in 81 patients undergoing renal transplant.
Kidney Failure, Chronic
Serum aspirin esterase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after haemodialysis.
Kwashiorkor
[Pseudocholinesterase in kwashiorkor. Importance of a simple test-paper method (Acholest)]
Lambert-Eaton Myasthenic Syndrome
Autoimmune Channelopathies: Well-Established and Emerging Immunotherapy-Responsive Diseases of the Peripheral and Central Nervous Systems.
Lambert-Eaton Myasthenic Syndrome
Two Lambert-Eaton Myasthenic Syndrome Patients with Ameliorated Activities of Daily Living Due to Cholinesterase Inhibitors.
Lambert-Eaton Myasthenic Syndrome
[Two cases of Lambert-Eaton syndrome with an increase of serum cholinesterase activity]
Language Disorders
Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease.
Laryngeal Neoplasms
[State of the liver after radiotherapy of cancer of the stomach and larynx with metronidazole radiosensitization]
Laryngismus
[Emergency from anesthesia in small children. From laryngospasm to prolonged apnea]
Leiomyoma
[Effects of the administration of estrogens on serum cholinesterase in women with uterine fibromas.]
Leishmaniasis, Visceral
Evaluation of cholinesterase level in an endemic population exposed to malathion suspension formulation as a vector control measure.
Leprosy
Investigation of Association between Susceptibility to Leprosy and SNPs inside and near the BCHE Gene of Butyrylcholinesterase.
Leprosy
Serum pseudocholinesterase variants in Mexican-born patients with lepromatous leprosy.
Leprosy, Lepromatous
Serum pseudocholinesterase variants in Mexican-born patients with lepromatous leprosy.
Lesch-Nyhan Syndrome
Effect of hypoxanthine, antioxidants and allopurinol on cholinesterase activities in rats.
Leukemia
Blood cholinesterase level and duration of life in the leukemias with notes on elevation of blood cholinesterase in certain leukemoid conditions.
Leukemia
Cholinesterase activity and acetylcholinesterase glycosylation are altered in human breast cancer.
Leukemia
Coamplification of human acetylcholinesterase and butyrylcholinesterase genes in blood cells: correlation with various leukemias and abnormal megakaryocytopoiesis.
Leukemia
Effect of L-asparaginase therapy upon serum pseudocholinesterase and ceruloplasmin levels in patients with acute leukemia.
Leukemia
Serum cholesterol and apoprotein B levels and serum cholinesterase activity in selected hematologic malignancies.
Leukemia
Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and ?-glycosidase inhibitors.
Leukemia
[Cholinesterase in the plasma, erythrocytes and whole blood in pernicious anemia and leukemia.]
Leukemia
[THE CLINICAL SIGNIFICANCE OF THE CHOLINESTERASE ACTIVITY OF THE ERYTHROCYTES IN ACUTE LEUKEMIA IN CHILDREN.]
Leukocytosis
Clinical manifestations, laboratory findings, treatment and outcome of acute organophosphate or carbamate intoxication in 102 dogs: A retrospective study.
Leukocytosis
Latrodectism in Italy: First report of successful treatment of L. tredecimguttatus envenomation using L. mactans antivenom from North America.
Leukocytosis
Second Line Chemotherapy in Biliary Tract Cancer: Outcome and Prognostic Factors.
Leukocytosis
[Action of fenitrothion (Agria 1050) on the development of a surgical infection with Corynebacterium pyogenes in sheep]
Lewy Body Disease
A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
Lewy Body Disease
A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing.
Lewy Body Disease
A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.
Lewy Body Disease
Acute treatment of psychotic symptoms in a newly diagnosed Lewy body dementia patient with an accelerated titration schedule of rivastigmine and de-escalation of antipsychotics.
Lewy Body Disease
An audit of a specialist old age psychiatry liaison service to a medium and a high secure forensic psychiatry unit.
Lewy Body Disease
Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor.
Lewy Body Disease
Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis.
Lewy Body Disease
Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.
Lewy Body Disease
Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Lewy Body Disease
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
Lewy Body Disease
Compensatory shifts in visual perception are associated with hallucinations in Lewy body disorders.
Lewy Body Disease
Individualized evaluation of cholinesterase inhibitors effects in dementia with adaptive cognitive testing.
Lewy Body Disease
Prescription patterns and efficacy of drugs for patients with dementia: physicians' perspective in Italy.
Lewy Body Disease
Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activation.
Lewy Body Disease
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
Lewy Body Disease
The neuroprotective mechanism of action of the multimodal drug ladostigil.
Lewy Body Disease
The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats.
Lewy Body Disease
[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]
Lewy Body Disease
[Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient]
Lewy Body Disease
[Posterior cortical atrophy. Pathology, diagnosis and treatment of a rare form of dementia].
Lipid Metabolism Disorders
[Behavior of cholinesterase activity in lipid metabolism disorders]
Liver Abscess, Amebic
LEFT-SIDED AMOEBIC LIVER ABSCESS WITH PULMONARY INVOLVEMENT, PERICARDITIS, AND PSEUDOCHOLINESTERASE DEFICIENCY.
Liver Abscess, Amebic
Plasma cholinesterase and other liver function tests in hepatic amebiasis.
Liver Cirrhosis
A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid.
Liver Cirrhosis
A variant serum cholinesterase and a confirmed point mutation at Gly-365 to Arg found in a patient with liver cirrhosis.
Liver Cirrhosis
Abnormalities of serum cholinesterase isozyme in liver cirrhosis and hepatoma (Part II).
Liver Cirrhosis
Alteration of serum cholinesterase isozyme in patients with liver cirrhosis.
Liver Cirrhosis
Changes of plasma cholinesterase activity during orthotopic liver transplantation in man.
Liver Cirrhosis
Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy.
Liver Cirrhosis
Clinical significance of fasting serum bile acid in the long-term observation of chronic liver disease.
Liver Cirrhosis
Clinical significance of serum hyaluronan in patients with chronic viral liver disease.
Liver Cirrhosis
Comparison of the indices of the bromsulphalein test, the serum cholinesterase and the galactose test by hepatic cirrhosis.
Liver Cirrhosis
Correlation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis.
Liver Cirrhosis
Discrimination of liver cirrhosis from chronic hepatitis by analysis of serum cholinesterase isozymes using affinity electrophoresis with concanavalin A or wheat germ agglutinin.
Liver Cirrhosis
Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein.
Liver Cirrhosis
Enzyme-linked immunosorbent assay (ELISA) for Aleuria aurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronic hepatitis.
Liver Cirrhosis
Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis B.
Liver Cirrhosis
Hypercholinesterasemia in patients with hepatocellular carcinoma: a new paraneoplastic syndrome.
Liver Cirrhosis
Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases.
Liver Cirrhosis
Mechanism of feminization in male patients with non-alcoholic liver cirrhosis: role of sex hormone-binding globulin.
Liver Cirrhosis
Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Liver Cirrhosis
Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.
Liver Cirrhosis
Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection.
Liver Cirrhosis
Serum vitamin D? does not correlate with liver fibrosis in chronic hepatitis C.
Liver Cirrhosis
[Clinical evaluation of the measurement of hepatosplenic volume ratio by computed tomography]
Liver Cirrhosis
[Clinical value of measuring the activity of serum cholinesterase and its isoenzyme in chronic hepatitis and liver cirrhosis]
Liver Cirrhosis
[Correlation between small intestine phosphatase and serum pseudocholinesterase in liver cirrhosis]
Liver Cirrhosis
[Decrease in plasmatic cholinesterase activity in severe bacterial infections: comparison with the decrease observed in severe liver cirrhosis]
Liver Cirrhosis
[Mathematical models using conventional laboratory indicators to predict hepatic fibrosis progressing in chronic hepatitis B]
Liver Cirrhosis
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
Liver Cirrhosis
[The cause of serum cholinesterase activity decrease in hepatitis and liver cirrhosis.]
Liver Cirrhosis, Alcoholic
Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis.
Liver Cirrhosis, Alcoholic
[Serum levels of pseudocholinesterase in alcoholic cirrhosis patients. Correlation with the extent of anatomo-functional damage. Unfavorable prognostic index]
Liver Diseases
A patient with Churg-Strauss syndrome who underwent endoscopic sinus surgery under general anesthesia -A case report-.
Liver Diseases
Acetylcholinesterase (AChE) inhibition aggravates fasting-induced triglyceride accumulation in the mouse liver.
Liver Diseases
Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease.
Liver Diseases
Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients.
Liver Diseases
Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review.
Liver Diseases
Changes in liver and plasma acetylcholinesterase in rats with cirrhosis induced by bile duct ligation.
Liver Diseases
Changes of plasma cholinesterase activity during orthotopic liver transplantation in man.
Liver Diseases
Circulating intercellular adhesion molecule 1 predicts non-specific elevation of alpha 1-fetoprotein.
Liver Diseases
Clinical and analytical considerations in the utilization of cholinesterase measurements.
Liver Diseases
Clinical application of the measurement of serum asialoglycoproteins to estimate residual liver function in patients with chronic liver diseases with or without hepatocellular carcinoma.
Liver Diseases
Colchicine reduces procollagen III and increases pseudocholinesterase in chronic liver disease.
Liver Diseases
Determination of genetic variants of serum cholinesterase in healthy adults and patients with liver diseases.
Liver Diseases
Development and application of serum cholinesterase activity measurement using benzoylthiocholine iodide.
Liver Diseases
Discrimination of liver cirrhosis from chronic hepatitis by analysis of serum cholinesterase isozymes using affinity electrophoresis with concanavalin A or wheat germ agglutinin.
Liver Diseases
Horseshoe kidney and membranous glomerulonephritis with cold activation of complement.
Liver Diseases
Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients.
Liver Diseases
Intra-individual variation of analytes in serum from patients with chronic liver diseases.
Liver Diseases
Low Serum Levels of Zonulin in Patients with HCV-Infected Chronic Liver Diseases.
Liver Diseases
Novel predictors for liver transplantation or death in drug-induced acute liver failure.
Liver Diseases
Nucleos(t)ide analogs improve long-term prognosis in patients with chronic hepatitis B-associated liver failure.
Liver Diseases
Plasma cholinesterase activity in liver disease: its value as a diagnostic test of liver function compared with flocculation tests and plasma protein determinations.
Liver Diseases
PLASMA ESTERASE ACTIVITY IN PATIENTS WITH LIVER DISEASE AND THE NEPHROTIC SYNDROME.
Liver Diseases
Predictive value of preoperative serum cholinesterase concentration in patients with liver dysfunction undergoing cardiac surgery.
Liver Diseases
Preoperative assessment of congestive liver dysfunction using technetium-99 m galactosyl human serum albumin liver scintigraphy in patients with severe valvular heart disease.
Liver Diseases
Prolonged apnoea after suxamethonium: an analysis of the first 225 cases reported to the Danish Cholinesterase Research Unit.
Liver Diseases
Pseudocholinesterase in gestational diabetes: positive correlation with LDL and negative correlation with triglyceride.
Liver Diseases
Relationship between urinary fractional excretion of sodium and life prognosis in liver cirrhosis patients.
Liver Diseases
S protein/vitronectin in chronic liver diseases: correlations with serum cholinesterase, coagulation factor X and complement component C3.
Liver Diseases
Separation of serum cholinesterase isozymes by an improved polyacrylamide gel electrophoresis and its application for the study of liver diseases (Part I).
Liver Diseases
Serum butyrylcholinesterase/HDL-cholesterol ratio and atherogenic index of plasma in patients with fatty liver disease.
Liver Diseases
Serum cholinesterase activity helps to distinguish between liver disease and non-liver disease aberration in liver function tests.
Liver Diseases
Serum cholinesterase activity in the diagnosis of nonalcoholic fatty liver disease in type 2 diabetic patients.
Liver Diseases
Serum cholinesterase activity in the normal individual and in people with liver disease.
Liver Diseases
Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D.
Liver Diseases
Serum thymosin beta4 levels in patients with hepatitis B virus-related liver failure.
Liver Diseases
Similar behaviour of lecithin:cholesterol acyltransferase and pseudocholinesterase in liver disease and hyperlipoproteinemia.
Liver Diseases
Studies on cholinesterase. IV. On the relationship between cholinesterase of basal ganglia and liver diseases.
Liver Diseases
Supplementation of antioxidants prevents oxidative stress during a deep saturation dive.
Liver Diseases
Suxamethonium apnoea associated with pregnancy and liver dysfunction in a treated cretin.
Liver Diseases
Theophylline pharmacokinetics and liver function indexes in chronic liver disease.
Liver Diseases
Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.
Liver Diseases
[Activity of serum cholinesterase in certain liver diseases, particularly in virus hepatitis]
Liver Diseases
[Blood cholinesterase and hepatic function: a comparison with BSP and galactose elimination as well as serum albumin concentration]
Liver Diseases
[Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases]
Liver Diseases
[Cholinesterase in suprahepatic, arterial and peripheral vein blood in liver disease.]
Liver Diseases
[Cholinesterase inhibition in liver diseases by additional loading with BC 51 (ubretid).]
Liver Diseases
[Cholinesterase, iron & transaminase in blood serum: comparative study in acute hepatitis, chronic liver diseases & extrahepatic obstructive jaundice.]
Liver Diseases
[Clinical experience with a new method for the determination of monoglyceride lipase (author's transl)]
Liver Diseases
[Comparative laparoscopic, bioptic and clinical enzymological studies in liver cirrhosis and other chronic liver diseases]
Liver Diseases
[Course of activity of serum cholinesterase in various liver diseases especially in infectious hepatitis of adults]
Liver Diseases
[Determination of serum cholinesterase activity and its significance in liver diseases]
Liver Diseases
[Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement.]
Liver Diseases
[Diagnostic and prognostic significance of cholinesterase (CHE) in chronic liver diseases]
Liver Diseases
[Differences in serum cholinesterase and serum glutamic oxalacetic transaminase activity in liver diseases.]
Liver Diseases
[Disc electrophoresis in the differential diagnosis of liver diseases. A study of lactate dehydrogenase- and cholinesterase isoenzymes together with the protein pattern in the serum revealed with disc electrophoresis]
Liver Diseases
[Effect of dibutyryl cyclic AMP in the treatment of hepatocellular carcinoma--intraarterial infusion therapy combined with anticancer agent for hepatocellular carcinoma with portal vein thrombosis]
Liver Diseases
[Evaluation of screening methods for cholinesterase variants from daily laboratory data]
Liver Diseases
[On the effect of a blood extract on the respiration of human liver sections and the activity of serum cholinesterase in liver diseases.]
Liver Diseases
[Plasma cholinesterase (CHE, pseudocholinesterase), its importance in liver diseases and prolonged succinyldicholine-induced apnea]
Liver Diseases
[Prognostic significance of activity of serum cholinesterase, catalase and ceruloplasmin in liver disease]
Liver Diseases
[Prognostic significance of determination of coagulation factors V and IX and serum cholinesterase in liver diseases]
Liver Diseases
[Prognostic value of serum cholinesterase activity in liver disease (author's transl)]
Liver Diseases
[Pseudocholinesterase in patients with and without liver diseases (author's transl)]
Liver Diseases
[Recovery from pancytopenia and liver dysfunction after administration of thiamazole for hyperthyroidism]
Liver Diseases
[Serum cholinesterase activity (CHE) in different classes of chronic liver diseases (author's transl)]
Liver Diseases
[Serum cholinesterase isozymes in liver diseases, with evaluation of slab gel electrophoresis in the analysis of isozymes]
Liver Diseases
[Serum cholinesterase synthesis in children with liver diseases with special reference to acute icteric and anicteric hepatitis]
Liver Diseases
[Significance of pseudocholinesterase (acylcholinacylhydrolase 3.1.1.8.) in the diagnosis of liver diseases]
Liver Diseases
[Takato-Ara, Ucko, Hanger, and Mac Lagan tests and serum cholinesterase in liver diseases; serial tests and prognostic value.]
Liver Diseases
[Testing of the activity of serum cholinesterase in patients with liver disease with the aid of the cholinesterase test-paper "Acholest"]
Liver Diseases
[Usefulness of serum pseudocholinesterase isoenzymes in acute and chronic liver diseases and neoplasms (experimental and clinical study)]
Liver Diseases, Alcoholic
Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
Liver Diseases, Alcoholic
Relationship between content of hepatic glutathione S-transferases and the kinetics of indocyanine green elimination in various liver diseases.
Liver Diseases, Alcoholic
[Proceedings: Relationship of serum cholinesterase level in chronic alcoholic liver disease and appearance of delirium tremens: therapeutic effect of oximes]
Liver Failure
Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV.
Liver Failure
Treatment of hepatocellular carcinoma and the exacerbation of liver function.
Liver Failure
[Usefulness of cholinesterase determination in ascitic fluid in the differential diagnosis of ascites]
Liver Failure, Acute
Antithrombin III is associated with acute liver failure in patients with end-stage heart failure undergoing mechanical circulatory support.
Liver Failure, Acute
Pharmacologic cholinesterase inhibition improves survival in acetaminophen-induced acute liver failure in the mouse.
Liver Failure, Acute
Proceedings: Serum pseudocholinesterase concentrations in fulminant hepatic failure.
Liver Neoplasms
Probing simple structural modification of ?-mangostin on its cholinesterase inhibition and cytotoxicity.
Liver Neoplasms
[Liver and serum cholinesterase activity in primary and metastatic cancer of the liver]
Lordosis
Cholinergic regulation of female sexual behavior in rats demonstrated by manipulation of endogenous acetylcholine.
Lung Diseases
Prognostic nomogram for the severity of acute organophosphate insecticide self-poisoning: a retrospective observational cohort study.
Lung Diseases
[Serum cholinesterase. Its significance in pulmonary diseases and bronchology]
Lung Diseases
[State of the autonomic nervous system and cholinesterase activity in blood in chronic non-specific lung diseases]
Lung Diseases, Obstructive
Ipratropium in patients with COPD receiving cholinesterase inhibitors.
Lung Injury
Butyrylcholinesterase in Guinea Pig Lung Lavage: A Novel Biomarker to Assess Lung Injury Following Inhalation Exposure to Nerve Agent VX.
Lung Injury
Pulmonary toxicity of the insecticide fenitrothion in the rat following a single field exposure.
Lung Neoplasms
A new test for the presumptive diagnosis of neoplastic disease. Further investigations of cholinesterase in plasma, whole blood and blood cells on cancer of the lung, extrapulmonary tumors and tuberculosis.
Lung Neoplasms
Cholinesterase activity of human lung tumours varies according to their histological classification.
Lung Neoplasms
Ectoenzymes and cholinesterase activity and biomarkers of oxidative stress in patients with lung cancer.
Lung Neoplasms
Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma.
Lung Neoplasms
[The diagnostic value of serum cholinesterase activity determination in stomach and lung cancer]
Lung Neoplasms
[The effect of anesthesia and surgical trauma on the activity of pseudocholinesterase in the blood of patients with suppurative processes in the lung, cancer of the stomach and esophagus]
Lupus Erythematosus, Systemic
Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
Lymphatic Metastasis
Risk factors for nonalcoholic fatty liver disease after gastrectomy for gastric cancer.
Lymphatic Metastasis
Tissue concentration of platelet-derived endothelial cell growth factor in colorectal cancer.
Lymphopenia
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2?years of age - a multicenter retrospective study.
Malabsorption Syndromes
Elevated levels of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with malabsorption syndrome.
Malaria, Cerebral
Acetylcholinesterase activities in cerebrospinal fluid of patients with Plasmodium falciparum cerebral malaria.
Malnutrition
Are single measurements of pseudocholinesterase and albumin markers for inflammatory activity or nutritional status in Crohn's disease?
Malnutrition
Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.
Malnutrition
Histochemical and biochemical studies of butyrylcholinesterase activity in adult and developing cerebellum. Effects of abnormal thyroid state and undernutrition.
Malnutrition
Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.
Malnutrition
Low serum cholinesterase predicts complication risk after orthopedic surgery in elderly patients: an observational pilot study.
Malnutrition
Malnutrition and Laboratory Markers in Geriatric Patients. A Comparison of Neurologic-psychiatric, Internal and Trauma Surgical Diseases.
Malnutrition
Malnutrition in African adults. I. Serum proteins, cholinesterase, and protein-bound lipid.
Malnutrition
Nutritional effects on heart acetylcholinesterase and butyrocholinesterase activity.
Malnutrition
Plasma cholinesterase: double-edged parameter in the diagnosis of acute organophosphorus poisoning.
Malnutrition
Postnatal malnutrition and regional cholinesterase activities in brain of pigs.
Malnutrition
Prognostic significance of serum cholinesterase in patients with acute decompensated heart failure: a prospective comparative study with other nutritional indices.
Malnutrition
Serum cholinesterase and histopathology of the liver in severe protein calorie malnutrition.
Malnutrition
The effects of nutrition on plasma cholinesterase activity and cocaine toxicity in mice.
Malnutrition
The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.
Malnutrition
[Limits and relevance of the laboratory diagnosis of malnutrition in the elderly]
Malnutrition
[Progress in management of severe tuberculosis or tuberculosis with severe complication].
Malnutrition
[The evaluation of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) level in peripheral blood of patients with chronic lower respiratory tract infection]
Mania
A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania.
Mania
Donepezil-associated manic episode with psychotic features: a case report and review of the literature.
Mania
Effect of Rivastigmine (Acetyl Cholinesterase Inhibitor) versus Placebo on Manic Episodes in Patients with Bipolar Disorders: Results from a Double Blind, Randomized, Placebo-Controlled Clinical Trial.
Mania
Mania after administration of cholinesterase inhibitors in patients with dementia and comorbid bipolar disorder: two case reports.
Melanoma
Induction of cellular contractions in the human melanoma cell line SK-mel 28 after muscarinic cholinergic stimulation.
Melanoma
Lycodine type alkaloids from Lycopodiastrum casuarinoides with cytotoxic and cholinesterase inhibitory activities.
Melanoma
[Pseudocholinesterase in patients with and without liver diseases (author's transl)]
Memory Disorders
A long-acting cholinesterase inhibitor reverses spatial memory deficits in mice.
Memory Disorders
Ameliorative effect of tacrine on spatial memory deficit in chronic two-vessel occluded rats is reversible and mediated by muscarinic M1 receptor stimulation.
Memory Disorders
Aralia cordata protects against amyloid beta protein (25-35)-induced neurotoxicity in cultured neurons and has antidementia activities in mice.
Memory Disorders
Bergenia ciliata ameliorates streptozotocin-induced spatial memory deficits through dual cholinesterase inhibition and attenuation of oxidative stress in rats.
Memory Disorders
Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats.
Memory Disorders
Catalpol ameliorates beta amyloid-induced degeneration of cholinergic neurons by elevating brain-derived neurotrophic factors.
Memory Disorders
Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
Memory Disorders
Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease.
Memory Disorders
Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil.
Memory Disorders
Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.
Memory Disorders
Cognitive Facilitation and Antioxidant Effects of an Essential Oil Mix on Scopolamine-Induced Amnesia in Rats: Molecular Modeling of In Vitro and In Vivo Approaches.
Memory Disorders
Comparative effects of the alpha7 nicotinic partial agonist, S 24795, and the cholinesterase inhibitor, donepezil, against aging-related deficits in declarative and working memory in mice.
Memory Disorders
Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey.
Memory Disorders
Development of an interactive tailored information application to improve patient medication adherence.
Memory Disorders
Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation.
Memory Disorders
Effect of diet supplemented with P. ostreatus and L. subnudus on memory index and key enzymes linked with Alzheimer's disease in streptozotocin-induced diabetes rats.
Memory Disorders
Effects of isovanihuperzine A on cholinesterase and scopolamine-induced memory impairment.
Memory Disorders
Effects of the cholinesterase inhibitors donepezil and metrifonate on scopolamine-induced impairments in the spatial cone field orientation task in rats.
Memory Disorders
Identification of new chromenone derivatives as cholinesterase inhibitors and molecular docking studies.
Memory Disorders
Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats.
Memory Disorders
Medial septum tau accumulation induces spatial memory deficit via disrupting medial septum-hippocampus cholinergic pathway.
Memory Disorders
Pelargonidin improves memory deficit in amyloid ?25-35 rat model of Alzheimer's disease by inhibition of glial activation, cholinesterase, and oxidative stress.
Memory Disorders
Reduced expression of the vesicular acetylcholine transporter causes learning deficits in mice.
Memory Disorders
Scopolamine-induced deficits in social memory in mice: reversal by donepezil.
Memory Disorders
Scutellarin protects against A?-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesterase.
Memory Disorders
The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits.
Memory Disorders
Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?
Meningioma
Characterization of activities and forms of cholinesterases in human primary brain tumors.
Meningioma
Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma.
Meningioma
Monomers and dimers of acetylcholinesterase in human meningioma are anchored to the membrane by glycosylphosphatidylinositol.
Meningism
[Cholinesterase in plasma and cerebrospinal fluid in patients with viral meningitis]
Meningitis
Ricinus communis agglutinin I reacting and non-reacting butyrylcholinesterase in human cerebrospinal fluid.
Meningitis, Bacterial
Cholinesterase modulations in patients with acute bacterial meningitis.
Meningitis, Bacterial
CSF acetyl and butyryl cholinesterase activities in children with bacterial meningitis.
Meningitis, Viral
[Cholinesterase in plasma and cerebrospinal fluid in patients with viral meningitis]
Meningococcal Infections
[Catecholamine excretion and cholinesterase activity in meningococcal infection in children]
Metabolic Syndrome
Butyrylcholinesterase activity and metabolic syndrome in obese patients.
Metabolic Syndrome
Butyrylcholinesterase and ?-Glutamyltransferase Activities and Oxidative Stress Markers Are Altered in Metabolic Syndrome, But Are Not Affected by Body Mass Index.
Metabolic Syndrome
Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome.
Metabolic Syndrome
Butyrylcholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity.
Metabolic Syndrome
Changes in Cholinesterase Activity in Blood of Adolescent with Metabolic Syndrome after Supplementation with Extract from Aronia melanocarpa.
Metabolic Syndrome
Functional Analysis and Molecular Docking studies of Medicinal Compounds for AChE and BChE in Alzheimer's Disease and Type 2 Diabetes Mellitus.
Metabolic Syndrome
Nicotinamide reduces inflammation and oxidative stress via the cholinergic system in fructose-induced metabolic syndrome in rats.
Metabolic Syndrome
Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction.
Metabolic Syndrome
Plasma proteomics reveals markers of metabolic stress in HIV infected children with severe acute malnutrition.
Metabolic Syndrome
Relationship between butyrylcholinesterase activity and lipid parameters in workers occupationally exposed to pesticides.
Metabolic Syndrome
Relationship Between Paraoxonase-1 and Butyrylcholinesterase Activities and Nutritional Status in Mexican Children.
Metabolic Syndrome
Relationship between serum butyrylcholinesterase and the metabolic syndrome.
Metabolic Syndrome
Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach.
Metabolic Syndrome
Serum gamma-glutamyltransferase and/or serum cholinesterase as markers of the metabolic syndrome.
Metabolic Syndrome
Weakened cholinergic blockade of inflammation associates with diabetes-related depression.
Metabolic Syndrome
[Mortality rates in patients with Alzheimer's disease treated with atypical neuroleptic drugs]
Methemoglobinemia
Propanil-chloracne and methomyl toxicity in workers of a pesticide manufacturing plant.
Miosis
Biological monitoring of metabolites of sarin and its by-products in human urine samples.
Miosis
Cholinergic Crisis Owing to Distigmine Bromide Complicated by Hyperosmolar Hyperglycemic State.
Miosis
Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats.
Miosis
Elevated frequency of sister chromatid exchanges in lymphocytes of victims of the Tokyo sarin disaster and in experiments exposing lymphocytes to by-products of sarin synthesis.
Miosis
Evaluation of miosis, behavior and cholinesterase inhibition from low-level, whole-body vapor exposure to soman in African green monkeys (Chlorocebus sabeus)*
Miosis
Fresh frozen plasma as a successful antidotal supplement in acute organophosphate poisoning.
Miosis
Opposite changes in blood pressure and pulse rate in two patients with distigmine and rivastigmine intoxication.
Miosis
Suspected chlorpyrifos toxicosis in a llama, and plasma pseudocholinesterase activity in llamas given chlorpyrifos.
Miosis
The possible role of intravenous lipid emulsion in the treatment of chemical warfare agent poisoning.
Miosis
[Acute respiratory failure associated with cholinergic crisis: report of five cases and review of the literature].
Miosis
[Effect of ethyl-p-nitrophenyl phenylphosphonothiate (EPN) on tryptophan pyrrolase activity in relation to miosis and change in serum cholinesterase activities]
Miosis
[Othe suitability of paraoxon miosis of the human eye for testing of cholinesterase reactivators]
Mouth Diseases
Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.
Movement Disorders
A Case Report on Dyskinesia Following Rivastigmine Patch 13.3 mg/24 hours for Alzheimer's Disease: Perspective in the Movement Disorders Spectrum Following Use of Cholinesterase Inhibitors.
Movement Disorders
Metabolic treatment of syndrome linked with Parkinson's disease and hypothalamus pituitary gonadal hormones by turmeric curcumin in Bisphenol-A induced neuro-testicular dysfunction of wistar rat.
Movement Disorders
Unexpected extrapyramidal symptoms and pulmonary aspergillosis in exertional heatstroke with fulminant liver failure: a case report.
Mucopolysaccharidosis III
A patient with Sanfilippo syndrome and pseudocholinesterase deficiency, further complicated by post-tonsillectomy haemorrhage.
Multiple Sclerosis
Alterations in the cholinesterase and adenosine deaminase activities and inflammation biomarker levels in patients with multiple sclerosis.
Multiple Sclerosis
Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.
Multiple Sclerosis
Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.
Multiple Sclerosis
Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.
Multiple Sclerosis
Improvement of motor function in multiple sclerosis by use of protopam chloride.
Multiple Sclerosis
[CHOLINESTERASE ACTIVITY OF THE CEREBROSPINAL FLUID OF MULTIPLE SCLEROSIS PATIENTS.]
Multiple Sclerosis
[Histochemical demonstration of glial enzyme activity. II. Reagent and neoplastic glia]
Multiple Sclerosis
[On the determination of the cholinesterase content of human sera by means of indicator paper (Archolest). II. Enzyme content in multiple sclerosis and other neurologic diseases]
Muscle Cramp
Hazards associated with aerial spraying of organophosphate insecticides in Israel.
Muscle Cramp
Treatment of Myasthenia Gravis With High-Dose Cholinesterase Inhibitors and Calcineurin Inhibitors Caused Spontaneous Muscle Cramps in Patients.
Muscle Hypotonia
The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa.
Muscle Spasticity
Congenital megacolon; a comparison of the spastic and hypertrophied segments with respect to Cholinesterase activities and sensitivities to Acetylcholine, DFP and the barium ion.
Muscle Weakness
Congenital myasthenia associated with facial malformations in Iraqi and Iranian Jews. A new genetic syndrome.
Muscle Weakness
Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis.
Muscle Weakness
Environmental Toxicology and Health Effects Associated with Methyl Parathion Exposure - A Scientific Review.
Muscle Weakness
Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by Muscle Specific Kinase autoantibody.
Muscle Weakness
[Legionella pneumonia caused by aspiration of hot spring water after sarin exposure]
Muscular Atrophy
Acetylcholinesterase inhibitor responsive myasthenia in a Filipino male with X-linked recessive spinal and bulbar muscular atrophy.
Muscular Atrophy, Spinal
Acetylcholinesterase and ATPases in motor neuron degenerative diseases.
Muscular Diseases
A light and electron microscopic histochemical study on the mechanism of DFP-induced acute and subacute myopathy.
Muscular Diseases
Endplates after esterase inactivation in vivo: correlation between esterase concentration, functional response and fine structure.
Muscular Diseases
[Nosographic approach of heriditary myopathies. Attempt at classification and diagnosis by means of erythrocyte cholinesterase and serum pseudocholinesterase analysis]
Muscular Dystrophies
Cholinesterase activity and inherited muscular dystrophy of the cicken.
Muscular Dystrophies
Molecular forms of acetylcholinesterase and pseudocholinesterase in chicken skeletal muscles: their distribution and change with muscular dystrophy.
Muscular Dystrophies
Muscular dystrophy alters the processing of light acetylcholinesterase but not butyrylcholinesterase forms in liver of Lama2(dy) mice.
Muscular Dystrophies
Muscular dystrophy with laminin deficiency decreases acetylcholinesterase activity in thymus of dystrophic Lama2dy mice.
Muscular Dystrophies
Muscular dystrophy with laminin deficiency decreases the content of butyrylcholinesterase tetramers in sciatic nerves of Lama2dy mice.
Muscular Dystrophies
[Cholinesterase activity and dibucaine number in progressive muscular dystrophy]
Muscular Dystrophies
[Nosographic approach of heriditary myopathies. Attempt at classification and diagnosis by means of erythrocyte cholinesterase and serum pseudocholinesterase analysis]
Myalgia
Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis.
Myalgia
Suxamethonium-induced jaw stiffness and myalgia associated with atypical cholinesterase: case report.
Myasthenia Gravis
Acute and repeated restraint stress have little effect on pyridostigmine toxicity or brain regional cholinesterase inhibition in rats.
Myasthenia Gravis
Acute effects of oral pyridostigmine bromide on conditioned operant performance in rats.
Myasthenia Gravis
Autoimmune Channelopathies: Well-Established and Emerging Immunotherapy-Responsive Diseases of the Peripheral and Central Nervous Systems.
Myasthenia Gravis
Cholinesterase based amperometric biosensors for assay of anticholinergic compounds.
Myasthenia Gravis
Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
Myasthenia Gravis
Effects of Distigmine on Electrical Field Stimulation-Induced Contraction of Mouse Urinary Bladder Smooth Muscles.
Myasthenia Gravis
Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Myasthenia Gravis
Experience in the treatment of myasthenia gravis with double filtration plasmapheresis.
Myasthenia Gravis
Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis.
Myasthenia Gravis
IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies.
Myasthenia Gravis
Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine.
Myasthenia Gravis
MuSK Myasthenia Gravis Presenting with Bilateral Vocal Cord Abduction Paresis: A Case Report and Literature Review.
Myasthenia Gravis
Myasthenia gravis: prognostic significance of clinical data in the prediction of post-thymectomy respiratory crises.
Myasthenia Gravis
New Insights into the Exploitation of Vitis vinifera L. cv. Aglianico Leaf Extracts for Nutraceutical Purposes.
Myasthenia Gravis
Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action.
Myasthenia Gravis
Potentiation of pyridostigmine bromide toxicity in mice by selected adrenergic agents and caffeine.
Myasthenia Gravis
Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
Myasthenia Gravis
Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
Myasthenia Gravis
Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors-implications for early Myasthenia gravis treatment.
Myasthenia Gravis
Prolonged postoperative apnea complicating gynecologic surgery; atypical cholinesterase and myasthenia gravis.
Myasthenia Gravis
Pseudo-internuclear ophthalmoplegia as a sign of overlapping myasthenia gravis in a patient with 'intractable' hypothyroidism.
Myasthenia Gravis
Reactive oxygen species mediate pyridostigmine-induced neuronal apoptosis: involvement of muscarinic and NMDA receptors.
Myasthenia Gravis
Slow-binding inhibition of acetylcholinesterase by a 6-methyluracil alkyl-ammonium derivative: mechanism and advantages for myasthenia gravis treatment.
Myasthenia Gravis
Sustainable Effects of Distigmine Bromide on Urinary Bladder Contractile Function.
Myasthenia Gravis
The effect of muscular exercise on the serum cholinesterase level in normal adults and in patients with myasthenia gravis.
Myasthenia Gravis
Treatment of Myasthenia Gravis With High-Dose Cholinesterase Inhibitors and Calcineurin Inhibitors Caused Spontaneous Muscle Cramps in Patients.
Myasthenia Gravis
Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis.
Myasthenia Gravis
Ultrastructural effects of pyridostigmine on neuromuscular junctions in rat diaphragm.
Myasthenia Gravis
[DUODENAL ULCER AND PROTRACTED CHOLINESTERASE INHIBITION. OBSERVATION OF 2 PATIENTS WITH MYASTHENIA GRAVIS.]
Myasthenia Gravis
[Effect of polymethylene-bis-(N-methyl-carbamic acid-m-trimethylammonium-phenol) BC 40, BC 47, BC 48 on cholinesterase activity and muscle activity in myasthenia gravis pseudoparalytica.]
Myasthenia Gravis
[Mechanism of the Long-lasting Potentiating Effect of Distigmine on Urinary Bladder Motility].
Myasthenia Gravis
[Myasthenia gravis and LE nephritis: problems of treatment with cholinesterase inhibitors during long-term dialysis (author's transl)]
Myasthenia Gravis
[THE BEHAVIOR OF SERUM CHOLINESTERASE IN THE COURSE OF PSEUDOPARALYTIC MYASTHENIA GRAVIS. A CONTRIBUTION TO THE DISTINCTION OF VARIOUS FORMS OF THE MYASTHENIC SYNDROME.]
Myasthenia Gravis
[Therapy of myasthenia gravis with cholinesterase inhibitors--principles and pharmacologic monitoring]
Myasthenic Syndromes, Congenital
Identification of previously unreported mutations in CHRNA1, CHRNE and RAPSN genes in three unrelated Italian patients with congenital myasthenic syndromes.
Myelodysplastic Syndromes
Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Myelodysplastic Syndromes
GM-CSF-mediated impairment of liver to synthesize albumin, cholinesterase, and cholesterol.
Myocardial Infarction
Amyloid-? peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients.
Myocardial Infarction
Amyloid-beta Peptides in Plasma and Cognitive Decline After 1 Year Follow-Up in Alzheimer's Disease Patients.
Myocardial Infarction
National Veterans Health Administration hospitalizations for syncope compared to acute myocardial infarction, fracture, or pneumonia in community-dwelling elders: outpatient medication and comorbidity profiles.
Myocardial Infarction
Role of plasma pseudocholinesterase activity in the diagnosis of acute myocardial infarction with special reference to cardiac arrhythmias.
Myocardial Infarction
Some observations on the cholinesterase activity of plasma in myocardial infarction.
Myocardial Infarction
The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease.
Myocardial Infarction
[Change in blood cholinesterase activity in patients with myocardial infarct]
Myocardial Infarction
[Cholinesterase activity of the heart in experimental myocardial infarct]
Myocardial Infarction
[Cholinesterase activity of the human heart in hypertrophy and myocardial infarct]
Myocardial Infarction
[Cholinesterase and monoaminoxidase activity of the ischemic and non-ischemic portions of the heart in the acute phase of myocardial infarction]
Myocardial Infarction
[Clinical course of early myocardial infarction and changes in the cholinesterase activity in the serum]
Myocardial Infarction
[Enzyme diagnosis of liver dysfunction in acute myocardial infarct and its complications]
Myocardial Ischemia
Vagal modulation of high mobility group box-1 protein mediates electroacupuncture-induced cardioprotection in ischemia-reperfusion injury.
Myocardial Ischemia
[Cholinesterase activity of blood monocytes in healthy subjects and ischemic heart disease patients]
Myocardial Ischemia
[Diagnostic coefficients of ischemic heart disease in diabetes mellitus]
Myocarditis
[On the problem of the effect of strophanthin K on the activity of cardiac cholinesterase in experimental myocarditis.]
Myxedema
Serum electrophoretic lipoprotein factors and pseudocholinesterase activity in thyroid disease.
Narcolepsy
Potentiation of a functional autoantibody in narcolepsy by a cholinesterase inhibitor.
Necrobiotic Disorders
[Clinico-morphologic and histochemical changes in the neuromuscular apparatus in acute carbophos poisoning]
Neoplasm Metastasis
Breast cancer metastasis alters acetylcholinesterase activity and the composition of enzyme forms in axillary lymph nodes.
Neoplasm Metastasis
Cholinesterase activities and biochemical determinations in patients with prostate cancer: influence of Gleason score, treatment and bone metastasis.
Neoplasm Metastasis
Prognostic Significance of Hematopoietic-cell Serglycin for the Survival of Hepatocellular Carcinoma: A Single-center Retrospective Study.
Neoplasm Metastasis
Prognostic significance of host- and tumor-related factors in patients with gastric cancer.
Neoplasm Metastasis
Risk factors for nonalcoholic fatty liver disease after gastrectomy for gastric cancer.
Neoplasm Metastasis
Tissue concentration of platelet-derived endothelial cell growth factor in colorectal cancer.
Neoplasm Metastasis
Value of gamma-glutamyltransferase in the diagnosis of liver metastases.
Neoplasms
"Nutritional" markers as prognostic indicators of postoperative sepsis in cancer patients.
Neoplasms
A new test for the presumptive diagnosis of neoplastic disease. Further investigations of cholinesterase in plasma, whole blood and blood cells on cancer of the lung, extrapulmonary tumors and tuberculosis.
Neoplasms
Acetylcholinesterase and butyrylcholinesterase activities in human thyroid cancer cells.
Neoplasms
Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas.
Neoplasms
Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors.
Neoplasms
Amplification and deletion of the ACHE and BCHE cholinesterase genes in sporadic breast cancer.
Neoplasms
Amplification of butyrylcholinesterase and acetylcholinesterase genes in normal and tumor tissues: putative relationship to organophosphorous poisoning.
Neoplasms
Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer.
Neoplasms
Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.
Neoplasms
BACTERIOSTATIC CHEMOTHERAPEUTIC AND MALIGNANT TUMOR GROWTH; CHANGE OF SERUM CHOLINESTERASE ACTIVITY UNDER PROLONGED ADMINISTRATION OF BACTERIOSTATIC CHEMOTHERAPEUTIC.
Neoplasms
Bee venom attenuates neurodegeneration and motor impairment and modulates the response to L-dopa or rasagiline in a mice model of Parkinson's disease.
Neoplasms
Biological Evaluation of Azomethine-dihydroquinazolinone Conjugates as Cancer and Cholinesterase Inhibitors.
Neoplasms
Butyrylcholinesterase: An economical marker of disease activity in oral squamous cell carcinoma before and after therapy.
Neoplasms
Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation.
Neoplasms
Cell origin of human adenovirus type 12-induced subcutaneous tumor in Syrian hamsters.
Neoplasms
Cerebrospinal fluid cholinergic biomarkers are associated with postoperative delirium in elderly patients undergoing Total hip/knee replacement: a prospective cohort study.
Neoplasms
Characterization of activities and forms of cholinesterases in human primary brain tumors.
Neoplasms
Cholinesterase activity and acetylcholinesterase glycosylation are altered in human breast cancer.
Neoplasms
Cholinesterase activity and enzyme components in healthy and cancerous human colorectal sections.
Neoplasms
Cholinesterase activity of human lung tumours varies according to their histological classification.
Neoplasms
Cholinesterase response in the rhabdomyosarcoma tumor and small intestine of the BALB/c mice and the radioprotective actions of exogenous ATP after lethal dose of neutron radiation.
Neoplasms
Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats.
Neoplasms
Clinical and analytical considerations in the utilization of cholinesterase measurements.
Neoplasms
Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV.
Neoplasms
Colorimetric method for measuring pseudocholinesterase, acetylcholinesterase and whole blood cholinesterase. Its use in the presumptive diagnosis of cancer.
Neoplasms
Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
Neoplasms
Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue.
Neoplasms
Comprehensive profiling of phytochemical compounds, antioxidant activities, anti-HepG2 cell proliferation, and cholinesterase inhibitory potential of Elaeagnus mollis leaf extracts.
Neoplasms
Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Neoplasms
Diagnostic and prognostic significance of serum cholinesterase and lactate dehydrogenase in breast cancer.
Neoplasms
Diagnostic significance of serum cholinesterase and lactate dehydrogenase in skin malignancy.
Neoplasms
Does Alzheimer's disease protect against cancers? A nationwide population-based study.
Neoplasms
Effect of cholinesterase inhibitor galanthamine on circulating tumor necrosis factor alpha in rats with lipopolysaccharide-induced peritonitis.
Neoplasms
Effect of Ginger and Turmeric Rhizomes on Inflammatory Cytokines Levels and Enzyme Activities of Cholinergic and Purinergic Systems in Hypertensive Rats.
Neoplasms
Ellagic acid and rosmarinic acid attenuate doxorubicin-induced testicular injury in rats.
Neoplasms
Enzyme histochemistry of ovarina lipoid cell hyperplasia in a masculinized patient.
Neoplasms
Estimation of serum cholinesterase & lactate dehydrogenase levels for diagnosis & prognosis in lymphoreticular malignancy.
Neoplasms
Experience from a real-life cohort: outcome of patients with hepatocellular carcinoma following transarterial chemoembolization.
Neoplasms
Exploring cancer development in adulthood: cholinesterase depression and genotoxic effect from chronic exposure to organophosphate pesticides among rural farm children.
Neoplasms
Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma.
Neoplasms
Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors.
Neoplasms
Expression of cholinesterases in human kidney and its variation in renal cell carcinoma types.
Neoplasms
Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma.
Neoplasms
Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
Neoplasms
HER-2 amplification but not butyrylcholinesterase multability reflects aggressiveness of European-originated ovarian tumors.
Neoplasms
Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma.
Neoplasms
Immunological characterization of partially purified cholinesterase from ascitic fluid of Ehrlich tumor.
Neoplasms
INFLUENCE OF TUMOR ON ACTIVITIES OF CATALASE AND CHOLINESTERASE OF THE LIVER OF HOST ANIMAL.
Neoplasms
Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease.
Neoplasms
Long-term prognostic factors of patients with hepatocellular carcinoma who survive over 10 years after hepatectomy.
Neoplasms
Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion.
Neoplasms
Lycodine type alkaloids from Lycopodiastrum casuarinoides with cytotoxic and cholinesterase inhibitory activities.
Neoplasms
Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection.
Neoplasms
Molecular mechanism of inflammatory response in mouse liver caused by exposure to CeCl(3).
Neoplasms
Multifarious Functions of Butyrylcholinesterase in Neuroblastoma: Impact of BCHE Deletion on the Neuroblastoma Growth In Vitro and In Vivo.
Neoplasms
Muscarinic cholinergic signaling and overactive bladder-like symptoms associated with invasive bladder cancer.
Neoplasms
Nicotinamide reduces inflammation and oxidative stress via the cholinergic system in fructose-induced metabolic syndrome in rats.
Neoplasms
Paraoxonase-1 activity is related to Trichinella spiralis-induced hepatitis in rats.
Neoplasms
Pharmacologic cholinesterase inhibition improves survival in experimental sepsis.
Neoplasms
Plasma cholinesterase activity in patients with uterine cervical cancer during radiotherapy.
Neoplasms
Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy.
Neoplasms
Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients.
Neoplasms
Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma.
Neoplasms
Prognostic and diagnostic value of serum pseudocholinesterase, serum aspartate transaminase, and serum alinine transaminase in malignancies treated by radiotherapy.
Neoplasms
Prognostic index for survival in patients after treatment for primary hepatocellular carcinoma.
Neoplasms
Prognostic significance of bioelectrical impedance phase angle in advanced cancer: preliminary observations.
Neoplasms
Prognostic significance of host- and tumor-related factors in patients with gastric cancer.
Neoplasms
Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma.
Neoplasms
Prophylactic effects of ellagic acid and rosmarinic acid on doxorubicin-induced neurotoxicity in rats.
Neoplasms
Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.
Neoplasms
Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation.
Neoplasms
Risk factors and cancer recurrence associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non-small cell lung cancer.
Neoplasms
Risk factors for early death due to recurrence after resection of large hepatocellular carcinomas.
Neoplasms
Risk factors for nonalcoholic fatty liver disease after gastrectomy for gastric cancer.
Neoplasms
Serum cholesterol levels in patients with cancer. Relationship with nutritional status.
Neoplasms
Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.
Neoplasms
Serum enzyme activity in bone tumors and osteomyelitis (LDH, GOT, GPT, CPK, CHE, ALP, AP, PP, ALD).
Neoplasms
Serum pseudocholinesterase activity & protein bound fucose level in oral malignancy.
Neoplasms
Solid-phase synthesis and biological evaluation of a parallel library of 2,3-dihydro-1,5-benzothiazepines.
Neoplasms
Studies of cholinesterase activity. VI. The depression of serum cholinesterase activity by a locally implanted human tumor in the guinea pig.
Neoplasms
STUDIES OF CHOLINESTERASE ACTIVITY. VII. KINETIC CONSTANTS OF SERUM CHOLINESTERASE IN NORMAL POPULATIONS AND THOSE WITH NEOPLASMS.
Neoplasms
Synthesis and Initial Characterization of a Selective, Pseudo-irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer.
Neoplasms
Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
Neoplasms
The Cholinergic System and Inflammation: Common Pathways in Delirium Pathophysiology.
Neoplasms
The expression of cholinesterases in human renal tumours varies according to their histological types.
Neoplasms
The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.
Neoplasms
Tissue concentration of platelet-derived endothelial cell growth factor in colorectal cancer.
Neoplasms
[Behavior of cholinesterase in relation to anesthesia in patients with tumors during various stages of growth]
Neoplasms
[Behavior of cholinesterase in the blood of patients affected by malignant neoplasms of the oropharynx]
Neoplasms
[Behavior of the cholinesterase activity of the blood in patients with malignant neoplasms.]
Neoplasms
[Changes in the activity of serum lactate dehydrogenase and serum cholinesterase in surgical treatment of cancer of the colon]
Neoplasms
[Cholinesterase activity of the blood and tissue in cases of cervical erosions and cancer]
Neoplasms
[Determination of the level of cholinesterase activity in the jugular and carotid blood and in the general venous circulation in patients with cerebral neoplasms.]
Neoplasms
[Diagnostic value of biochemical tumor markers in serum of patients with cancer of the ovary]
Neoplasms
[Enzymes of benign and malignant tumors of the liver; cholinesterase and tributyrinase.]
Neoplasms
[Histochemical demonstration of glial enzyme activity. II. Reagent and neoplastic glia]
Neoplasms
[Impact of Chai Qin Cheng Qi decoction on cholinergic anti-inflammatory pathway in rats with severe acute pancreatitis]
Neoplasms
[In connection with the paradoxical activity of adrenalin in cancer patients and its effect on the action of cholinesterase.]
Neoplasms
[Liver and serum cholinesterase activity in primary and metastatic cancer of the liver]
Neoplasms
[Mineral metabolism and tumor growth. II. Potassium content of the tumor, acetylcholine, cholinesterase and lymphocytes in the blood.]
Neoplasms
[On variations of the muscle-relaxant effects of d-tubocurarine in patients with neoplasms. II. Behavior of the plasma cholinesterase and electrolyte activity.]
Neoplasms
[Possibilities and limitations of control of the course of tumor treatment by serum cholinesterase determination]
Neoplasms
[Prostaglandin E(2) and omeprazole in treating poisoning related acute mucosal lesion]
Neoplasms
[Reduced nutritional status of the surgical tumor patient--a risk factor for postoperative complications?]
Neoplasms
[Relation between cholinesterase activity and incorporation of amino acids into proteins. II. Incorporation of C14-labeled glycine into homogenized tissue of tumor homo- and heterografts under the influence of acetylphosphate.]
Neoplasms
[State of the liver after radiotherapy of cancer of the stomach and larynx with metronidazole radiosensitization]
Neoplasms
[Studies of the activity of ceruloplasmin, SGOT, SGPT and cholinesterase in various neoplasm types]
Neoplasms
[STUDIES ON SIGNIFICANCE OF THE FALL OF THE BLOOD CHOLINESTERASE LEVEL IN CASE OF MALIGNANT TUMOR. EXPERIMENTAL AND CLINICAL RESEARCH.]
Neoplasms
[Usefulness of serum pseudocholinesterase isoenzymes in acute and chronic liver diseases and neoplasms (experimental and clinical study)]
Neoplasms, Neuroepithelial
Activation of acetyl- and butyrylcholinesterase by enzymatic removal of sialic acid from intact neuroblastoma and astroblastoma cells in culture.
Neoplastic Processes
[Serum cholinesterase activity in the differential diagnosis of neoplastic processes]
Nephritis
[Myasthenia gravis and LE nephritis: problems of treatment with cholinesterase inhibitors during long-term dialysis (author's transl)]
Nephrosis
Serum cholinesterase activity and protein-bound iodine fluctuations during therapy of a case of nephrosis.
Nephrotic Syndrome
Activity of serum enzymes in puromycin aminonucleoside-induced nephrotic syndrome.
Nephrotic Syndrome
Hereditary serum cholinesterase deficiency associated with severe lipid deposition in the kidney.
Nephrotic Syndrome
PLASMA ESTERASE ACTIVITY IN PATIENTS WITH LIVER DISEASE AND THE NEPHROTIC SYNDROME.
Nephrotic Syndrome
Relationship between serum cholinesterase and low density lipoproteins in children with nephrotic syndrome.
Nephrotic Syndrome
[DETERMINATION OF THE ENZYMATIC ACTIVITY IN CHILDHOOD. V. SERUM CHOLINESTERASE IN NEPHROTIC SYNDROME.]
Nervous System Diseases
A therapeutic approach to cerebrovascular diseases based on indole substituted hydrazides and hydrazines able to interact with human vascular adhesion protein-1, monoamine oxidases (A and B), AChE and BuChE.
Nervous System Diseases
Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
Nervous System Diseases
Anti-inflammatory and acetylcholinesterase activity of extract, fractions and five compounds isolated from the leaves and twigs of Artemisia annua growing in Cameroon.
Nervous System Diseases
Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide 25-35 and Cholinesterase Inhibitory Property of Its Bioactive Compounds.
Nervous System Diseases
Anticholinesterase and antioxidant potentials of Nonea micrantha Bioss. & Reut along with GC-MS analysis.
Nervous System Diseases
Cholinesterase inhibitors from Sargassum and Gracilaria gracilis: seaweeds inhabiting South Indian coastal areas (Hare Island, Gulf of Mannar).
Nervous System Diseases
Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti- Alzheimer's study.
Nervous System Diseases
Computational and Kinetic Studies of Acetylcholine Esterase Inhibition by Phenserine.
Nervous System Diseases
CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients.
Nervous System Diseases
Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
Nervous System Diseases
Exploring the role of BCHE in the onset of Diabetes, Obesity and Neurological Disorders.
Nervous System Diseases
Inhibition of enzymes associated with metabolic and neurological disorder by dried pomegranate sheets as a function of pomegranate cultivar and fruit puree.
Nervous System Diseases
Potential association of reduced cholinesterase activity with Trypanosoma evansi pathogenesis in buffaloes.
Nervous System Neoplasms
Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors.
Neural Tube Defects
A prospective study of amniotic fluid cholinesterases: comparison of quantitative and qualitative methods for the detection of open neural tube defects.
Neural Tube Defects
Acetylcholinesterase and butyrylcholinesterase measurement in the pre-natal detection of neural tube defects and other fetal malformations.
Neural Tube Defects
Amniotic fluid cholinesterase measurement as a rapid method for the exclusion of fetal neural tube defects.
Neural Tube Defects
Amniotic fluid cholinesterase of valproate-induced exencephaly in the mouse: an animal model for prenatal diagnosis of neural tube defects.
Neural Tube Defects
Cholinesterase evaluation in the prenatal diagnosis of open neural tube defects.
Neural Tube Defects
Cholinesterases exhibiting aryl acylamidase activity in human amniotic fluid.
Neural Tube Defects
Comparison of the modified gel disc electrophoresis of amniotic fluid cholinesterase with other methods in the prenatal diagnosis of neural tube defects.
Neural Tube Defects
Determination of amniotic fluid acetylcholinesterase activity in the antenatal diagnosis of foetal malformations: the first ten years.
Neural Tube Defects
Diagnosis of neural tube defects by estimation of amniotic fluid acetylcholinesterase.
Neural Tube Defects
Gel electrophoresis of maternal and fetal serum cholinesterases from normal pregnancies and of those affected by neural tube defects.
Neural Tube Defects
Prenatal diagnosis of neural tube defects. V. The value of amniotic fluid cholinesterase studies.
Neural Tube Defects
[Determination of alpha-fetoprotein, cholinesterase and alpha 2-macroglobulin in the amniotic fluid in the diagnosis of neural tube defects]
Neural Tube Defects
[Determination of the acetylcholinesterase activities of the amniotic fluid on a centrifugal analyzer]
Neural Tube Defects
[Prenatal diagnosis of abnormalities of the neuroectodermal tube. Limitations of the assay of amniotic alpha fetoprotein and acetylcholinesterase and value of the qualitative study of cholinesterases. Apropos of 6 cases of anencephaly]
Neural Tube Defects
[Prenatal diagnosis of neural tube defects. Value of electrophoresis of cholinesterases]
Neuralgia
Low dose of donepezil improves gabapentin analgesia in the rat spared nerve injury model of neuropathic pain: single and multiple dosing studies.
Neuralgia
Oral donepezil reduces hypersensitivity after nerve injury by a spinal muscarinic receptor mechanism.
Neuralgia
Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations.
Neuralgia
Relief of hypersensitivity after nerve injury from systemic donepezil involves spinal cholinergic and ?-aminobutyric acid mechanisms.
Neuralgia
The antiallodynic effects of intrathecal cholinesterase inhibitors in a rat model of neuropathic pain.
Neurilemmoma
Characterization of molecular forms of acetyl- and butyrylcholinesterase in human acoustic neurinomas.
Neurilemmoma
Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma.
Neuritis
Cholinesterase activities in the autonomic nervous system of rabbits with experimental allergic neuritis: a biochemical study.
Neuritis
Cholinesterase activities in the somatic nervous system of rabbits with experimental allergic neuritis.
Neuritis, Autoimmune, Experimental
Cholinesterase activities in the autonomic nervous system of rabbits with experimental allergic neuritis: a biochemical study.
Neuritis, Autoimmune, Experimental
Cholinesterase activities in the somatic nervous system of rabbits with experimental allergic neuritis.
Neurobehavioral Manifestations
A population-based study of dosing and persistence with anti-dementia medications.
Neurobehavioral Manifestations
A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia.
Neurobehavioral Manifestations
Acetylcholinesterase and butyrylcholinesterase inhibition by nectriapyrone and tryptophol isolated from endophytic fungus Phomopsis sp.
Neurobehavioral Manifestations
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
Neurobehavioral Manifestations
Behavioral symptomatology and psychopharmacology of Lewy body dementia.
Neurobehavioral Manifestations
Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.
Neurobehavioral Manifestations
Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Neurobehavioral Manifestations
Dementia with cerebrovascular disease: the benefits of early treatment.
Neurobehavioral Manifestations
Double-blind placebo-controlled study of velnacrine in Alzheimer's disease.
Neurobehavioral Manifestations
Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.
Neurobehavioral Manifestations
Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people.
Neurobehavioral Manifestations
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurobehavioral Manifestations
Present and prospective clinical therapeutic regimens for Alzheimer's disease.
Neurobehavioral Manifestations
The cholinergic hypothesis of Alzheimer's disease: a review of progress.
Neurobehavioral Manifestations
Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group.
Neurobehavioral Manifestations
[Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
Neurobehavioral Manifestations
[Treatment for non-cognitive symptoms in Alzheimer's disease]
Neuroblastoma
Activation of acetyl- and butyrylcholinesterase by enzymatic removal of sialic acid from intact neuroblastoma and astroblastoma cells in culture.
Neuroblastoma
Cholinesterases in neural development: new findings and toxicologic implications.
Neuroblastoma
Cholinesterases modulate cell adhesion in human neuroblastoma cells in vitro.
Neuroblastoma
Design, Synthesis, and Evaluation of Donepezil-Like Compounds as AChE and BACE-1 Inhibitors.
Neuroblastoma
Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template.
Neuroblastoma
Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells.
Neuroblastoma
Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors.
Neuroblastoma
Modulation of the number of muscarinic receptors in mouse neuroblastoma cells by soman.
Neuroblastoma
Morphine tolerance in a human neuroblastoma line: changes in choline acetylase and cholinesterase activities.
Neuroblastoma
Multifarious Functions of Butyrylcholinesterase in Neuroblastoma: Impact of BCHE Deletion on the Neuroblastoma Growth In Vitro and In Vivo.
Neuroblastoma
Probing simple structural modification of ?-mangostin on its cholinesterase inhibition and cytotoxicity.
Neuroblastoma
Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo.
Neuroblastoma
Tacrine interacts with different sites on nicotinic receptor subtypes in SH-SY5Y neuroblastoma and M10 cells.
Neuroblastoma
[Rapid simultaneous isolation of microsomes and plasma membranes from neuroblastoma C 1300 N 18 cells]
Neurodegenerative Diseases
5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds.
Neurodegenerative Diseases
A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety.
Neurodegenerative Diseases
Abietane-type diterpenoids from the roots of Caryopteris mongolica and their cholinesterase inhibitory activities.
Neurodegenerative Diseases
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.
Neurodegenerative Diseases
Advances in the pharmacological management of Parkinson disease.
Neurodegenerative Diseases
Alkaloids pharmacological activities - Prospects for the development of phytopharmaceuticals for neurodegenerative diseases.
Neurodegenerative Diseases
Aminobenzimidazoles and Structural Isomers as Templates for Dual-Acting Butyrylcholinesterase Inhibitors and hCB2 R Ligands To Combat Neurodegenerative Disorders.
Neurodegenerative Diseases
Amyloid, Cholinesterase, Melatonin, and Metals and Their Roles in Aging and Neurodegenerative Diseases.
Neurodegenerative Diseases
Anticeramide antibody and butyrylcholinesterase in peripheral neuropathies.
Neurodegenerative Diseases
Anticholinergic and antioxidant activities of usnic acid-an activity-structure insight.
Neurodegenerative Diseases
Antioxidant activity and acetylcholinesterase inhibition of grape skin anthocyanin (GSA).
Neurodegenerative Diseases
Benzobicyclo[3.2.1]octene Derivatives as a New Class of Cholinesterase Inhibitors.
Neurodegenerative Diseases
Biochemical Profiling and Elucidation of Biological Activities of Beta vulgaris L. Leaves and Roots Extracts.
Neurodegenerative Diseases
Biological evaluation of synthetic ?,?-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-? aggregation.
Neurodegenerative Diseases
Biphenylalkoxyamine Derivatives-Histamine H3 Receptor Ligands with Butyrylcholinesterase Inhibitory Activity.
Neurodegenerative Diseases
Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease.
Neurodegenerative Diseases
Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool.
Neurodegenerative Diseases
Cholinesterase and Tyrosinase Inhibitory Potential and Antioxidant Capacity of Lysimachia verticillaris L. and Isolation of the Major Compounds.
Neurodegenerative Diseases
Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds.
Neurodegenerative Diseases
Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold.
Neurodegenerative Diseases
Design, synthesis and cholinesterase inhibitory properties of new oxazole benzylamine derivatives.
Neurodegenerative Diseases
Development of an Efficient Protocol for Cimifugin Isolation from Peucedanum schottii and Evaluation of Enzyme Inhibitory Activity.
Neurodegenerative Diseases
Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.
Neurodegenerative Diseases
Dual monoamine oxidase and cholinesterase Inhibitors with different heterocyclic scaffolds.
Neurodegenerative Diseases
Effect of viologen-phosphorus dendrimers on acetylcholinesterase and butyrylcholinesterase activities.
Neurodegenerative Diseases
Effects of Resveratrol and other Polyphenols on the most common Brain Age-Related Diseases.
Neurodegenerative Diseases
Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE epsilon4, and hyperhomocysteinemia in neurodegenerative dementias.
Neurodegenerative Diseases
Fluorescent Determination of Butyrylcholinesterase Activity and Its Application in Biological Imaging and Pesticide Residue Detection.
Neurodegenerative Diseases
Honey as the Potential Natural Source of Cholinesterase Inhibitors in Alzheimer's Disease.
Neurodegenerative Diseases
Immobilization of transgenic plant cells towards bioprinting for production of a recombinant biodefense agent.
Neurodegenerative Diseases
In vitro anticholinesterase, antimonoamine oxidase and antioxidant properties of alkaloid extracts from kola nuts (Cola acuminata and Cola nitida).
Neurodegenerative Diseases
Increased cholinergic activity under conditions of low estrogen leads to adverse cardiac remodeling.
Neurodegenerative Diseases
Indole Alkaloids And Semisynthetic Indole Derivatives As Multifunctional Scaffolds Aiming The Inhibition Of Enzymes Related To Neurodegenerative Diseases - A Focus On Psychotria L. Genus.
Neurodegenerative Diseases
Indole alkaloids of Psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors.
Neurodegenerative Diseases
Inhibitory potential of the leaves and berries of Myrtus communis L. (myrtle) against enzymes linked to neurodegenerative diseases and their antioxidant actions.
Neurodegenerative Diseases
Local salt substitutes "Obu-otoyo" activate acetylcholinesterase and butyrylcholinesterase and induce lipid peroxidation in rat brain.
Neurodegenerative Diseases
Melatonin as a structural template in the development of novel drugs for neurodegenerative disorders.
Neurodegenerative Diseases
Molecular dynamics and regulation of butyrylcholinesterase cholinergic activity by RNA binding proteins.
Neurodegenerative Diseases
Multifunctional Mercapto-tacrine Derivatives for Treatment of Age-related Neurodegenerative Diseases.
Neurodegenerative Diseases
Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3 R Antagonism for Neurodegenerative Diseases.
Neurodegenerative Diseases
Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update.
Neurodegenerative Diseases
New indane derivatives containing 2-hydrazinothiazole as potential acetylcholinesterase and monoamine oxidase-B inhibitors.
Neurodegenerative Diseases
New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.
Neurodegenerative Diseases
Phytochemical profile of a blend of black chokeberry and lemon juice with cholinesterase inhibitory effect and antioxidant potential
Neurodegenerative Diseases
Phytochemical profile of a blend of black chokeberry and lemon juice with cholinesterase inhibitory effect and antioxidant potential.
Neurodegenerative Diseases
Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activation.
Neurodegenerative Diseases
RP-UHPLC-MS Chemical Profiling, Biological and In Silico Docking Studies to Unravel the Therapeutic Potential of Heliotropium crispum Desf. as a Novel Source of Neuroprotective Bioactive Compounds.
Neurodegenerative Diseases
Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum.
Neurodegenerative Diseases
Shared Molecular Signatures Across Neurodegenerative Diseases and Herpes Virus Infections Highlights Potential Mechanisms for Maladaptive Innate Immune Responses.
Neurodegenerative Diseases
Synthesis and Initial Characterization of a Selective, Pseudo-irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer.
Neurodegenerative Diseases
Synthesis, biological evaluation and molecular modeling of substituted 2-aminobenzimidazoles as novel inhibitors of acetylcholinesterase and butyrylcholinesterase.
Neurodegenerative Diseases
The cholinergic deficiency syndrome and its therapeutic implications.
Neurodegenerative Diseases
The use of chemometrics to study multifunctional indole alkaloids from Psychotria nemorosa (Palicourea comb. nov.). Part II: Indication of peaks related to the inhibition of butyrylcholinesterase and monoamine oxidase-A.
Neurodegenerative Diseases
Treatment of Apathy in Huntington's Disease and Other Movement Disorders.
Neurodegenerative Diseases
Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage.
Neurodegenerative Diseases
UHPLC-ESI-ORBITRAP-MS analysis of the native Mapuche medicinal plant palo negro (Leptocarpha rivularis DC. - Asteraceae) and evaluation of its antioxidant and cholinesterase inhibitory properties.
Neurodermatitis
[Blood levels of acetylcholine and serum cholinesterase activity in children with neurodermatitis constitutionalis with and without bronchial asthma]
Neuroectodermal Tumors, Primitive
[Cholinesterase activity in transplantable tissue cultures]
Neuroendocrine Tumors
Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients.
Neuroinflammatory Diseases
Alendronate reduces the cognitive and neurological disturbances induced by combined doses of d-galactose and aluminum chloride in mice.
Neuroinflammatory Diseases
Effect of anti-dementia drugs on LPS induced neuroinflammation in mice.
Neuroinflammatory Diseases
Evaluating the Memory Enhancing Effects of Angelica gigas in Mouse Models of Mild Cognitive Impairments.
Neuroinflammatory Diseases
Rhizoma Coptidis for Alzheimer's Disease and Vascular Dementia: A Literature Review.
Neuroinflammatory Diseases
The modulatory role of prime identified compounds in Geophila repens in mitigating scopolamine-induced neurotoxicity in experimental rats of Alzheimer's disease via attenuation of cholinesterase, ?-secretase, MAPt levels and inhibition of oxidative stress imparts inflammation.
Neuroleptic Malignant Syndrome
Anticholinergic toxicity masquerading as neuroleptic malignant syndrome: a case report and review.
Neuroleptic Malignant Syndrome
Effect of Delirium on Physical Function in Noncardiac Thoracic Surgery Patients.
Neurologic Manifestations
Activity of Paraoxonase/Arylesterase and Butyrylcholinesterase in Peripheral Blood of Gulf War Era Veterans With Neurologic Symptom Complexes or Post-Traumatic Stress Disorder.
Neurologic Manifestations
Activity of Paraoxonase/Arylesterase and Butyrylcholinesterase in Peripheral Blood of Gulf War Era Veterans With Neurologic Symptom Complexes or Post-Traumatic Stress Disorder: Erratum.
Neurologic Manifestations
Muscarinic receptor-mediated pyridostigmine-induced neuronal apoptosis.
Neurologic Manifestations
Neurotoxicity resulting from coexposure to pyridostigmine bromide, deet, and permethrin: implications of Gulf War chemical exposures.
Neuroma, Acoustic
Characterization of molecular forms of acetyl- and butyrylcholinesterase in human acoustic neurinomas.
Neuromuscular Diseases
Acetylcholinesterase and ATPases in motor neuron degenerative diseases.
Neuromuscular Diseases
Cumulative reduction in serum cholinesterase following repeated therapeutic plasma exchange.
Neuromuscular Diseases
Deep neuromuscular blockade and surgical conditions during laparoscopic ventral hernia repair: A randomised, blinded study.
Neutropenia
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2?years of age - a multicenter retrospective study.
Nevus
Clinical factors that affect blood gases in non-smoking women with chronic liver disease.
Nevus
[Studies on classification of nevus pigmentosus and cholinesterase activity of nevus cell]
Non-alcoholic Fatty Liver Disease
Risk factors for nonalcoholic fatty liver disease after gastrectomy for gastric cancer.
Non-alcoholic Fatty Liver Disease
Serum cholinesterase activity in the diagnosis of nonalcoholic fatty liver disease in type 2 diabetic patients.
Non-alcoholic Fatty Liver Disease
Serum cytokeratin 18 M30 antigen level and its correlation with nutritional parameters in middle-aged Japanese males with nonalcoholic fatty liver disease (NAFLD).
Nutrition Disorders
[Serum cholinesterase in childhood. II. Serum cholinesterase activity and serum protein level in acute dyspepsia and chronic nutrition disorders]
Obesity
A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety.
Obesity
Acetylcholinesterase and butyrylcholinesterase activities in obese Beagle dogs before and after weight loss.
Obesity
Butyrylcholinesterase and obesity in individuals with the CHE2 C5+ and CHE2 C5- phenotypes.
Obesity
Butyrylcholinesterase Deficiency Promotes Adipose Tissue Growth and Hepatic Lipid Accumulation in Male Mice on High-Fat Diet.
Obesity
Butyrylcholinesterase gene transfer in obese mice prevents postdieting body weight rebound by suppressing ghrelin signaling.
Obesity
Effect of BCHE single nucleotide polymorphisms on lipid metabolism markers in women.
Obesity
Effect of pomegranate extracts on brain antioxidant markers and cholinesterase activity in high fat-high fructose diet induced obesity in rat model.
Obesity
Effects of energetic restriction diet on butyrylcholinesterase in obese women from southern Brazil - A longitudinal study.
Obesity
Exploring the role of BCHE in the onset of Diabetes, Obesity and Neurological Disorders.
Obesity
Functional Analysis and Molecular Docking studies of Medicinal Compounds for AChE and BChE in Alzheimer's Disease and Type 2 Diabetes Mellitus.
Obesity
Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids.
Obesity
GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE, and secondary associations with metabolic risk factors.
Obesity
Liver Enzymes Correlate With Metabolic Syndrome, Inflammation, and Endothelial Dysfunction in Prepubertal Children With Obesity.
Obesity
Liver fat content measured by magnetic resonance spectroscopy at 3.0 tesla independently correlates with plasminogen activator inhibitor-1 and body mass index in type 2 diabetic subjects.
Obesity
Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction.
Obesity
Production of butyrylcholinesterase by Caco-2 cells: lack of relationship with triglyceride production.
Obesity
Pseudocholinesterase in obesity: hypercaloric diet induced changes in experimental obese mice.
Obesity
Relationship between butyrylcholinesterase activity and lipid parameters in workers occupationally exposed to pesticides.
Obesity
Relationship between serum butyrylcholinesterase and obesity in dogs: A preliminary report.
Obesity
Serum butyrylcholinesterase and the risk of future type 2 diabetes: The Kansai Healthcare Study.
Obesity
Serum Cholinesterase Is Inversely Associated with Body Weight Change in Men Undergoing Routine Health Screening.
Obesity
The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.
Obesity
Treating Cocaine Addiction, Obesity, and Emotional Disorders by Viral Gene Transfer of Butyrylcholinesterase.
Obesity
[Serum cholinesterase activity in non-alcoholic fatty liver. Effect of obesity on the activity and role of its measurement in the differential diagnosis in chronic hepatitis]
Obesity, Abdominal
Abdominal Obesity Associated with Elevated Serum Butyrylcholinesterase Activity, Insulin Resistance and Reduced High Density Lipoprotein-Cholesterol Levels.
Obesity, Abdominal
Relationship between serum butyrylcholinesterase and the metabolic syndrome.
Obesity, Abdominal
Thrombotic tendency in diabetes mellitus. Revisiting and revising a study initiated 30 years ago.
Obstetric Labor, Premature
Imbalances emerge in cardiac autonomic cell signaling after neonatal exposure to terbutaline or chlorpyrifos, alone or in combination.
Occupational Diseases
Acute, severe cholinesterase inhibitors poisonings in the material of occupational diseases and toxicology ward in PoznaÅ.
Oligodendroglioma
Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors.
Oligodendroglioma
Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma.
Onchocerciasis
[Drop in blood cholinesterase in the course of treatment of onchocerciasis by an organophosphorus compound (Metrifonate)]
Opisthorchiasis
[Biochemical characteristics of hepatic functions in different clinical forms of chronic opisthorchiasis]
Opisthorchiasis
[Changes in the activity of gamma-glutamyltransferase and cholinesterase in the blood of patients with opisthorchiasis at different phases of the disease]
Osteomyelitis
Serum enzyme activity in bone tumors and osteomyelitis (LDH, GOT, GPT, CPK, CHE, ALP, AP, PP, ALD).
Osteoporosis
Drug use differs by care level. A cross-sectional comparison between older people living at home or in a nursing home in Oslo, Norway.
Osteoporosis
Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis.
Otitis
Correlation between peri-operative complication in middle ear cholesteatoma surgery using STAMCO, ChOLE, and SAMEO-ATO classifications.
Otosclerosis
[Study of the activity of true and false blood cholinesterase with the aim of finding directed therapy of vestibular disorders due to operation on the stapes for otosclerosis]
Ovarian Hyperstimulation Syndrome
Pseudocholinesterase deficiency: a dangerous, unrecognized complication of the ovarian hyperstimulation syndrome.
Overweight
Butyrylcholinesterase activity in young men and women: Association with cardiovascular risk factors.
Overweight
Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction.
Overweight
Plasma fibronectin in overweight men and women: correlation with serum triglyceride levels and serum cholinesterase activity.
Overweight
Relationship Between Paraoxonase-1 and Butyrylcholinesterase Activities and Nutritional Status in Mexican Children.
Overweight
Serum cholinesterase activity correlates with serum insulin, C-peptide and free fatty acids levels in patients with type 2 diabetes.
Pancreatic Neoplasms
Characterization of low active ghrelin ratio in patients with advanced pancreatic cancer.
Pancreatic Neoplasms
Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Pancreatic Neoplasms
Hepatic changes and serum ferritin in pancreatic cancer and other gastrointestinal diseases: the role of cholestasis.
Pancreatic Neoplasms
Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion.
Pancreatitis
Baseline Serum Cystatin C Is a Potential Predictor for Acute Kidney Injury in Patients with Acute Pancreatitis.
Pancreatitis
Total cholesterol level for assessing pancreatic insufficiency due to chronic pancreatitis.
Pancreatitis
[Impact of Chai Qin Cheng Qi decoction on cholinergic anti-inflammatory pathway in rats with severe acute pancreatitis]
Pancreatitis
[The serum enzymogram for the evaluation of the effectiveness of hemosorption in patients with acute destructive pancreatitis]
Pancreatitis, Chronic
Hepatic changes and serum ferritin in pancreatic cancer and other gastrointestinal diseases: the role of cholestasis.
Pancreatitis, Chronic
THE CONCENTRATION OF ACETYLCHOLINE AND THE LEVEL CHOLINESTERASE ACTIVITY IN THE SERUM OF PATIENTS WITH GASTRIC ULCER, DUODENAL ULCER AND ALCOHOLIC CHRONIC PANCREATITIS.
Paralysis
An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans.
Paralysis
Antagonism of succinylcholine paralysis in a patient with atypical pseudocholinesterase.
Paralysis
Awareness during emergence from anaesthesia: significance of neuromuscular monitoring in patients with butyrylcholinesterase deficiency.
Paralysis
Biochemical and clinical profile after organophosphorus poisoning--a placebo-controlled trial using pralidoxime.
Paralysis
Correlation of plasma cholinesterase activity and duration of action of succinylcholine during pregnancy.
Paralysis
Correlative electrophysiological and anatomical studies concerning the site of origin of escape rhythm during complete atrioventricular block in the dog.
Paralysis
Customized anesthetic preservation of ictal threshold in electroconvulsive therapy: role of adjunctive remifentanil with etomidate.
Paralysis
Delayed recovery from paralysis associated with plasma cholinesterase deficiency.
Paralysis
Delayed recovery from paralysis by succinylcholine in patient with preoperatively unrecognized and inherited pseudocholinesterase deficiency.
Paralysis
Differential cholinesterase inhibition and muscarinic receptor changes in CD-1 mice made tolerant to malathion.
Paralysis
Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis.
Paralysis
Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine.
Paralysis
Hereditary pseudocholinesterase deficiency discovery after electroconvulsive therapy.
Paralysis
Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing.
Paralysis
New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter.
Paralysis
Premature awakening and underuse of neuromuscular monitoring in a registry of patients with butyrylcholinesterase deficiency.
Paralysis
Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors.
Paralysis
Prolonged apnea following succinylcholine administration in undiagnosed acute organophosphate poisoning.
Paralysis
Prolonged Neuromuscular Paralysis Following Rapid-Sequence Intubation with Succinylcholine (April).
Paralysis
Prolonged paralysis after a test dose of mivacurium in a patient with atypical serum cholinesterase.
Paralysis
Prolonged Paralysis After Electroconvulsive Therapy Due to Butyrylcholinesterase Gene Mutation.
Paralysis
Prolonged Paralysis Following Emergent Cesarean Section with Succinylcholine Despite Normal Dibucaine Number.
Paralysis
Prolonged succinylcholine-induced apnea caused by atypical cholinesterase: report of case.
Paralysis
Pseudocholinesterase activity of human whole blood, bank blood, and blood protein solutions.
Paralysis
Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
Paralysis
RELATIONSHIP BETWEEN DEPRESSION OF BRAIN OR PLASMA CHOLINESTERASE AND PARALYSIS IN CHICKENS CAUSED BY CERTAIN ORGANIC PHOSPHORUS COMPOUNDS.
Paralysis
Reversal of succinylcholine induced apnea with an organophosphate scavenging recombinant butyrylcholinesterase.
Paralysis
Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.
Paralysis
The antagonism of muscle relaxants by ambenonium and methoxyambenonium in the cat.
Paralysis
Train-of-four nerve stimulation in the management of prolonged neuromuscular blockade following succinylcholine.
Paralysis
[Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium.]
Paralysis
[Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Paralysis
[Electromyographic investigation on the indication and therapy of poliomyelitic paralysis with cholinesterase inhibitors.]
Paralysis
[Electrophysiological aspects of intermediate syndrome in organophosphate poisonings]
Paralysis
[Localization of cholinesterase in the transverse striated muscles of dogs with experimental lead-induced paralysis]
Paraneoplastic Syndromes
Hypercholinesterasemia in patients with hepatocellular carcinoma: a new paraneoplastic syndrome.
Parasitemia
Status of oxidative stress, trace elements, sialic acid and cholinesterase activity in cattle naturally infected with Babesia bigemina.
Parasitic Diseases
Cholinesterase activity after treatment with mebendazole, thiabendazole and metronidazole in patients with various parasitic diseases.
Parasitic Diseases
Effects of agricultural pond eutrophication on survival and health status of Scinax nasicus tadpoles.
Paresis
Cholinesterase levels in blood plasma and erythrocytes from calves, normal delivering cows and cows suffering from parturient paresis.
Paresis
[Action of cholinesterase & electrophoretic blood protein fractions in epilepsy & paresis.]
Paresis
[Cholinesterase, iron and serum protein electrophoretic patterns in serum of patients with hemiparesis of cerebrovascular origin treated at Ladek-Spa]
Parkinson Disease
A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease.
Parkinson Disease
A Randomized Trial of Oral and Transdermal Rivastigmine for Postural Instability in Parkinson Disease Dementia.
Parkinson Disease
Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease.
Parkinson Disease
Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease.
Parkinson Disease
Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice.
Parkinson Disease
An association between organophosphate pesticides exposure and Parkinsonism amongst people in an agricultural area in Ubon Ratchathani Province, Thailand.
Parkinson Disease
An examination of three prescribing cascades in a cohort of older adults with dementia.
Parkinson Disease
Assessing cognitive change in Parkinson's disease: development of practice effect-corrected reliable change indices.
Parkinson Disease
Assessment of cholinesterase and tyrosinase inhibitory and antioxidant effects of Hypericum perforatum L. (St. John's wort)
Parkinson Disease
Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia.
Parkinson Disease
Changes in cerebral glucose metabolism in patients with Parkinson disease with dementia after cholinesterase inhibitor therapy.
Parkinson Disease
Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis.
Parkinson Disease
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Parkinson Disease
Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis.
Parkinson Disease
Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
Parkinson Disease
Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease.
Parkinson Disease
Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Parkinson Disease
Cholinesterase-inhibitor therapy for dementia: novel clinical substrates and mechanisms for treatment response.
Parkinson Disease
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
Parkinson Disease
Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.
Parkinson Disease
Comparison of recovery profiles in patients with Parkinson's disease for 2 types of neuromuscular blockade reversal agent following deep brain stimulator implantation.
Parkinson Disease
CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients.
Parkinson Disease
Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
Parkinson Disease
Donepezil as add-on treatment of psychotic symptoms in patients with dementia of the Alzheimer's type.
Parkinson Disease
Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study.
Parkinson Disease
Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.
Parkinson Disease
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease.
Parkinson Disease
Dual monoamine oxidase and cholinesterase Inhibitors with different heterocyclic scaffolds.
Parkinson Disease
Effect of Delirium on Physical Function in Noncardiac Thoracic Surgery Patients.
Parkinson Disease
Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease.
Parkinson Disease
Effects of augmenting cholinergic neurotransmission on balance in Parkinson's disease.
Parkinson Disease
Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical Data.
Parkinson Disease
Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data.
Parkinson Disease
Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies.
Parkinson Disease
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
Parkinson Disease
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
Parkinson Disease
Evaluation of the neuroprotective and antidiabetic potential of phenol-rich extracts from virgin olive oils by in vitro assays.
Parkinson Disease
Feeling the need ... the need for speed (of processing training) in Parkinson disease.
Parkinson Disease
Impact of Rivastigmine on Cognitive Dysfunction and Falling in Parkinson's Disease Patients.
Parkinson Disease
Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study.
Parkinson Disease
Metabolic treatment of syndrome linked with Parkinson's disease and hypothalamus pituitary gonadal hormones by turmeric curcumin in Bisphenol-A induced neuro-testicular dysfunction of wistar rat.
Parkinson Disease
Metabolite Profiling by Hyphenated Liquid Chromatographic Mass Spectrometric Technique (HPLC-DAD-ESI-Q-TOF-MS/MS) and Neurobiological Potential of Haplophyllum sahinii and H. vulcanicum Extracts.
Parkinson Disease
Neuroprotective Effects and Mechanisms of Action of Multifunctional Agents Targeting Free Radicals, Monoamine Oxidase B and Cholinesterase in Parkinson's Disease Model.
Parkinson Disease
Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review.
Parkinson Disease
Nutraceutical Potential of Phenolics from 'Brava' and 'Mansa' Extra-Virgin Olive Oils on the Inhibition of Enzymes Associated to Neurodegenerative Disorders in Comparison with Those of 'Picual' and 'Cornicabra'.
Parkinson Disease
Parkinson's disease dementia: clinical correlates of brain spect perfusion and treatment.
Parkinson Disease
Parkinson's disease-related visual hallucinations unresponsive to atypical antipsychotics treated with cholinesterase inhibitors: a case series.
Parkinson Disease
Phytochemical profile of a blend of black chokeberry and lemon juice with cholinesterase inhibitory effect and antioxidant potential.
Parkinson Disease
Pisa syndrome in a patient with pathologically confirmed Parkinson's disease.
Parkinson Disease
Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
Parkinson Disease
Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia.
Parkinson Disease
Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand.
Parkinson Disease
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.
Parkinson Disease
Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies.
Parkinson Disease
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
Parkinson Disease
Serum Butyrylcholinesterase Activity: A Biomarker for Parkinson's Disease and Related Dementia.
Parkinson Disease
The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia.
Parkinson Disease
The effect of donepezil on increased regional cerebral blood flow in the posterior cingulate cortex of a patient with Parkinson's disease dementia.
Parkinson Disease
The interplay of cholinergic function, attention, and falls in Parkinson's disease.
Parkinson Disease
The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30.
Parkinson Disease
The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.
Parkinson Disease
The Use of Transdermal Therapeutic Systems in Psychiatric Care: A Primer on Patches.
Parkinson Disease
Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.
Parkinson Disease
Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage.
Parkinson Disease
[Cholinesterase content of the brain in cerebral tumors and paralysis agitans.]
Parkinson Disease
[Cholinesterase inhibitors for the treatment of dementia in Parkinson's disease.]
Parkinson Disease
[Psychological and cognitive problems in Parkinson disease--therapeutic possibilities]
Parkinson Disease
[Severe bradycardia in general anaesthesia in a patient treated with cholinesterase inhibitors for dementia.]
Parkinsonian Disorders
An association between organophosphate pesticides exposure and Parkinsonism amongst people in an agricultural area in Ubon Ratchathani Province, Thailand.
Parkinsonian Disorders
Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Parkinsonian Disorders
Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.
Parkinsonian Disorders
Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage.
Parkinsonian Disorders
[Diagnosis and treatment of Parkinson's syndrome. What is important for the general practitioner?]
Parkinsonian Disorders
[Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient]
Parkinsonian Disorders
[Treatment for dementia in parkinsonian syndromes. Efficacy of cholinesterase inhibitors]
Parvoviridae Infections
Changes in choline and cholinesterase in saliva of dogs with parvovirus infection.
Parvoviridae Infections
Parvovirus b19 infection after plasma exchange for myasthenia gravis.
Pediatric Obesity
Cholinesterase and paraoxonase (PON1) enzyme activities in Mexican-American mothers and children from an agricultural community.
Pediatric Obesity
Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction.
Pelvic Inflammatory Disease
Evaluation of pelvic inflammatory disease potential in cholinesterase inhibitor pesticide-exposed females.
Peptic Ulcer
Serum cholinesterase activity in children with gastroduodenitis or peptic ulcer disease.
Peptic Ulcer
[Association of mutant alleles of serum cholinesterase with various multi-factorial and infectious diseases]
Peptic Ulcer
[Changes in blood ceruloplasmin, catalase and pseudocholinesterase activity in patients with peptic ulcers of the stomach and duodenum depending on the type of anesthesia and preoperative care]
Peptic Ulcer
[Changes of the aluminum and silicon contents and cholinergic activity of the blood depending on the course of the gastroduodenal ulcer]
Peptic Ulcer
[Clinical significance of the determination of whole blood cholinesterase activity in patients with peptic ulcer]
Peptic Ulcer
[Content of catecholamines and acetylcholine and the cholinesterase activity in the stomach tissues in certain complications of peptic ulcer]
Peptic Ulcer
[Modifications of blood cholinesterase activity in peptic ulcer and gastric cancer.]
Peptic Ulcer
[Trial treatment of gastroduodenal ulcers with pyridine-2-aldoxime methyl methanesulfonate (RP 7676), a cholinesterase reactivator.]
Periapical Periodontitis
[Cholinesterase in periodontal membrane suffering from so-called pyorrhea and apical periodontitis]
Pericarditis
LEFT-SIDED AMOEBIC LIVER ABSCESS WITH PULMONARY INVOLVEMENT, PERICARDITIS, AND PSEUDOCHOLINESTERASE DEFICIENCY.
Periodontal Diseases
Clinical associations between acetylcholine levels and cholinesterase activity in saliva and gingival crevicular fluid and periodontal diseases.
Periodontitis
Determination of pseudocholinesterase activity in the gingival crevicular fluid, saliva, and serum from patients with juvenile periodontitis and rapidly progressive periodontitis.
Peripheral Arterial Disease
Serum Cholinesterase Levels Are Associated With 2-Year Ischemic Outcomes After Angioplasty and Stenting for Peripheral Artery Disease.
Peripheral Nervous System Diseases
Anticeramide antibody and butyrylcholinesterase in peripheral neuropathies.
Peripheral Nervous System Diseases
Muscular dystrophy with laminin deficiency decreases the content of butyrylcholinesterase tetramers in sciatic nerves of Lama2dy mice.
Peripheral Nervous System Diseases
The effects of occupational exposure to chlorpyrifos on the peripheral nervous system: a prospective cohort study.
Peritonitis
Effect of cholinesterase inhibitor galanthamine on circulating tumor necrosis factor alpha in rats with lipopolysaccharide-induced peritonitis.
Peritonitis
[Changes in the cholinesterase activity and the acetylcholine and catecholamine contents in the intestinal tissues of rats with experimental peritonitis]
Peritonitis
[Effect of transfusion of UV-irradiated blood on the changes in serum cholinesterase activity in patients with peritonitis]
Persian Gulf Syndrome
Cholinesterase inhibitors and stress: effects on brain muscarinic receptor density in mice.
Persian Gulf Syndrome
Peripheral cholinergic function in humans with chronic fatigue syndrome, Gulf War syndrome and with illness following organophosphate exposure.
Pheochromocytoma
Quantification of acetylcholine in cell culture systems by semi-micro high-performance liquid chromatography and electrospray ionization mass spectrometry.
Pheochromocytoma
Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells.
Pigmentation Disorders
Sulphonamides incorporating 1,3,5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile.
Pigmentation Disorders
Synthesis of calix[4]azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action.
Plague
Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits.
Pleural Effusion
Light's criteria revisited: consistency and comparison with new proposed alternative criteria for separating pleural transudates from exudates.
Pleural Effusion
Pleural fluid to serum cholinesterase ratio for the separation of transudates and exudates.
Pleural Effusion
Pleural to serum cholinesterase ratio in separation of transudative and exudative pleural effusions.
Pleural Effusion
[Diagnostic efficiency of pseudocholinesterase level in discrimination of transudates-exudates]
Pleural Effusion
[Distinguishing pleural transudates and exudates through the quantification of biochemical parameters]
Pleural Effusion
[Pleural fluid to serum cholinesterase ratio to discriminate between transudates and exudates: reevaluation in 177 patients]
Pneumonia
Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.
Pneumonia
Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Pneumonia
Identification of missense mutation (G365R) of the butyrylcholinesterase (BCHE) gene in a Japanese patient with familial cholinesterasemia.
Pneumonia
Microfabricated potentiometric sensor for personalized methacholine challenge tests during the COVID-19 pandemic.
Pneumonia
Risk Prediction of Postoperative Pneumonia After Subtotal Esophagectomy Based on Preoperative Serum Cholinesterase Concentrations.
Pneumonia
[The value of determination of serum cholinesterase levels in judgment of severity and prognosis in patients with severe pneumonia].
Poliomyelitis
[CHOLINESTERASE ACTIVITY IN THE TISSUES OF WHITE MICE WITH EXPERIMENTAL POLIOMYELITIS.]
Poliomyelitis
[Cholinesterase activity of different tissues of white mice in experimental poliomyelitis.]
Poliomyelitis
[Studies on changes in cholinesterase activities in blood under acupuncture treatment of sequelae of poliomyelitis]
Polycystic Kidney, Autosomal Dominant
[A family of adult polycystic kidney disease associated with pseudocholinesterase deficiency]
Polyendocrinopathies, Autoimmune
Genetic screening in the Persian Jewish community: A pilot study.
Polyneuropathies
Histochemically demonstrable non-specific cholinesterase as an indicator of peripheral nerve lesion in carbon disulphide-induced polyneuropathy.
Polyuria
Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3.
Pre-Eclampsia
Butyrylcholinesterase (BChE) activity is associated with the risk of preeclampsia: influence on lipid and lipoprotein metabolism and oxidative stress.
Pre-Eclampsia
Evaluation of the Relationship between Adenosine Deaminase, Myeloperoxidase, Cholinesterase, Preeclampsia Severity and Neonatal Outcomes.
Pre-Eclampsia
Suxamethonium apnoea associated with pregnancy and liver dysfunction in a treated cretin.
Pre-Eclampsia
[Activity of blood cholinesterase in normal pregnancy and in pregnancy toxemias]
Pre-Eclampsia
[Behavior of the cholinesterase activity in the blood and cerebrospinal fluid of women in late pregnancy toxemias]
Pre-Eclampsia
[Urinary excretion of adrenaline and noradrenaline, acetylcholine and cholinesterase content of the blood in women with late pregnancy toxemia]
Pressure Ulcer
Predicting the outcome of long-term care by clinical and functional indices: the role of nutritional status.
Primary Dysautonomias
Pilot study of pyridostigmine in constipated patients with autonomic neuropathy.
Prostatic Neoplasms
Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development.
Prostatic Neoplasms
Cholinesterase activities and biochemical determinations in patients with prostate cancer: influence of Gleason score, treatment and bone metastasis.
Prostatic Neoplasms
Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy.
Prostatic Neoplasms
Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.
Prostatic Neoplasms
[Liver disorder owing to estrogen therapy in prostatic cancer. The correlation between serum level of cholinesterase and dose of diethylstilbestrol diphosphate]
Protein-Energy Malnutrition
Butyrylcholinesterase as a prognostic marker: a review of the literature.
Protein-Energy Malnutrition
Dual significance of hepatic cholinesterase as an index of liver involvement and state of protein-calorie malnutrition.
Protein-Energy Malnutrition
Effect of vitamin A on cholinesterase activity in normal children and in children with protein-calorie malnutrition.
Protein-Energy Malnutrition
Serum cholinesterase and histopathology of the liver in severe protein calorie malnutrition.
Proteinuria
Biological indices predictive of survival in 519 Italian terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care.
Proteinuria
[Cholinesterase, arylesterase and proteinuria. A clinical trial in glomerular and tubular proteinuria (author's transl)]
Pruritus
Hematological biomarkers in farm workers exposed to organophosphorus pesticides in the Gaza Strip.
Pruritus
Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients.
Pruritus
[Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement.]
Psoriasis
A study of fructose-1,6-diphosphatealdolase, lactatedechydrogenase, leucineaminopeptidase, aspartate- and alanine-transaminase, alkaline phosphatase and cholinesterase in the blood serum of patients with psoriasis.
Psoriasis
[Investigation on activity of serum cholinesterase and on therapeutic effect of intravenous novocain in psoriasis.]
Psoriasis
[Studies on serum cholinesterase and the effect of intravenous novocain in psoriasis.]
Psychomotor Agitation
Preliminary evidence that rivastigmine-induced inhibition of serum butyrylcholinesterase activity improves behavioral symptoms in Japanese patients with Alzheimer's disease.
Pulmonary Disease, Chronic Obstructive
Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.
Pulmonary Disease, Chronic Obstructive
Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study.
Pulmonary Disease, Chronic Obstructive
COPD Exacerbation and Cholinesterase Therapy in Dementia Patients.
Pulmonary Disease, Chronic Obstructive
Decreased activity of butyrylcholinesterase in blood plasma of patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Epidemiology of Dementia in Elderly Chronic Obstructive Pulmonary Disease Patients Living in China's Northwestern High-Elevation Area.
Pulmonary Disease, Chronic Obstructive
Ipratropium in patients with COPD receiving cholinesterase inhibitors.
Pulmonary Edema
2-pyridine aldoxime methiodide in the treatment of post-operative acute pulmonary edema: possible role of cholinesterase.
Pulmonary Heart Disease
Serum cholinesterase and euglobulin lysis time in chronic cor pulmonale.
Pyelonephritis
[Enzymological evaluation of the hepatotoxicity of ampicillin and its therapeutic form, roscillin, in the treatment of pyelonephritis in pregnancy]
Pyloric Stenosis
Determination of cholinesterase and acetylcholinesterase in amniotic fluid. Uses in prenatal diagnosis and quality control.
Rabies
[Inhibition of cholinesterase activity in the brain of rats by phosphoorganic inhibitors with different degrees of hydrophobia]
Red-Cell Aplasia, Pure
Parvovirus b19 infection after plasma exchange for myasthenia gravis.
Renal Insufficiency
Pseudocholinesterase in gestational diabetes: positive correlation with LDL and negative correlation with triglyceride.
Renal Insufficiency, Chronic
[Levels of plasma pseudocholinesterase in chronic renal insufficiency patients and hemodialysis]
Reperfusion Injury
Vagal modulation of high mobility group box-1 protein mediates electroacupuncture-induced cardioprotection in ischemia-reperfusion injury.
Respiratory Insufficiency
Allergic reaction to suxamethonium during emergency caesarean section and pseudocholinesterase deficiency in the same patient.
Respiratory Insufficiency
Effects of cholinesterase inhibitors and serotonin-1A receptor agonists on morphine-induced ventilatory depression and antinociception in rats.
Respiratory Insufficiency
Fresh frozen plasma as a successful antidotal supplement in acute organophosphate poisoning.
Respiratory Insufficiency
Respiratory failure triggered by cholinesterase inhibitors may involve activation of a reflex sensory pathway by acetylcholine spillover.
Respiratory Insufficiency
The possible role of intravenous lipid emulsion in the treatment of chemical warfare agent poisoning.
Respiratory Insufficiency
[Acute respiratory failure associated with cholinergic crisis: report of five cases and review of the literature].
Respiratory Insufficiency
[Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment].
Respiratory Insufficiency
[Respiratory depression in the newborn due to a congenital anomaly in plasma cholinesterase]
Respiratory Insufficiency
[Therapeutic effects of benthiactzine against respiratory failure induced by cholinesterase inhibitor in rats]
Respiratory Paralysis
Management of acute childhood poisonings caused by selected insecticides and herbicides.
Respiratory Paralysis
Mechanism of the clonidine-induced protection against acetylcholinesterase inhibitor toxicity.
Respiratory Paralysis
Poisoning from oral ingestion of carbofuran (Furadan 4F), a cholinesterase-inhibiting carbamate insecticide, and its effects on cholinesterase activity in various biological fluids.
Restless Legs Syndrome
The Use of Transdermal Therapeutic Systems in Psychiatric Care: A Primer on Patches.
Retinal Detachment
Prognosis of primary rhegmatogenous retinal detachments. 1. Associations between clinical detachment characteristics, subretinal fluid butyrylcholinesterase and visual outcome following scleral buckling procedures.
Retinal Detachment
Subretinal fluid butyrylcholinesterase. 1. Source of the enzyme and factors affecting its concentration in subretinal fluid from primary rhegmatogenous retinal detachments.
Retinal Detachment
[Activity of alkaline phosphatase, cholinesterase and aspartic aminopherase in subretinal fluid in retinal detachment]
Retinal Detachment
[Butyrylcholinesterase activity in the subretinal fluid in retinal detachment]
Rhabdomyolysis
Postsynaptic neuromuscular dysfunction in organophosphate induced intermediate syndrome.
Rhabdomyolysis
Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study.
Rhabdomyosarcoma
Cholinesterase response in the rhabdomyosarcoma tumor and small intestine of the BALB/c mice and the radioprotective actions of exogenous ATP after lethal dose of neutron radiation.
Rheumatic Diseases
Studies on the cholinesterase activity of red cell, plasma and synovial fluid with special reference to rheumatic diseases.
Rheumatic Diseases
[Activity of cholinesterase in the blood serum in rheumatism in children.]
Rheumatic Diseases
[Association of mutant alleles of serum cholinesterase with various multi-factorial and infectious diseases]
Rheumatic Diseases
[Behavior of several enzymes (oxalacetic and pyruvic transaminases, lacticodehydrogenase and cholinesterase in serum) in rheumatic disease.]
Rheumatic Diseases
[Change in cholinesterase activity in children with rheumatism in relation to various factors]
Rheumatic Diseases
[Correlation between the content of acetylcholine 2nd cholinesterase in the blood and state of the autonomic nervous system in children with rheumatism]
Rheumatic Diseases
[Diphenylamine and pseudocholinesterase tests in the evaluation of dynamics of inflammatory forms of rheumatic diseases]
Rheumatic Diseases
[Fluctuations in blood acetylcholine and cholinesterase levels in children with rheumatism]
Rheumatic Diseases
[Protein fractions and cholinesterase in the blood serum as an indication of the activity of rheumatism in children.]
Rhinitis, Allergic, Seasonal
[Study of serum cholinesterase in patients with pollinosis in relation to specific desensitizing treatment.]
Salmonella Infections
Pathological physiology of salmonellosis. II. Plasma cholinesterase in infections due to Enterobacteriaceae.
Salmonella Infections
[Physiopathology of Salmonella infections. IV. Regeneration of blood cholinesterase in children during active typhoid fever and during convalescence.]
Sarcoma, Experimental
[Muscle and tumor tissue cholinesterase activity during Jensen sarcoma growth]
Sarcopenia
Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia.
Sarcopenia
Low serum cholinesterase predicts complication risk after orthopedic surgery in elderly patients: an observational pilot study.
Sarcopenia
Urinary titin N-terminal fragment concentration is an indicator of preoperative sarcopenia and nutritional status in patients with gastrointestinal tract and hepatobiliary pancreatic malignancies.
Schistosomiasis
Effect of hycanthone and niridazole on cholinesterase levels in experimental schistosomiasis.
Schistosomiasis haematobia
Schistosoma haematobium in Ajara community of Badagry. Metrifonate trials in the treatment of the disease.
Scoliosis
Corrected scoliosis, cholinesterase deficiency, and cesarean section: a case report.
Scoliosis
[Decreased cholinesterase activity in the serum of juveniles with idiopathic scoliosis]
Seizures
Acute administration of diazepam or midazolam minimally alters long-term neuropathological effects in the rat brain following acute intoxication with diisopropylfluorophosphate.
Seizures
Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice.
Seizures
Anatomical localization and time course of Fos expression following soman-induced seizures.
Seizures
Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning.
Seizures
Blockade of hippocampal long-term potentiation following soman pretreatment in the rat.
Seizures
Capacities of metabotropic glutamate modulators in counteracting soman-induced seizures in rats.
Seizures
Comparative seizure inducing properties of various cholinesterase inhibitors: antagonism by diazepam and midazolam.
Seizures
Distortion product otoacoustic emissions as non-invasive biomarkers and predictors of soman-induced central neurotoxicity: a preliminary study.
Seizures
Effects of anticholinergic-antiparkinsonian drugs on striatal neurotransmitter levels of rats intoxicated with soman.
Seizures
Effects of antidepressants on longevity and dementia onset among adults with Down syndrome: a retrospective study.
Seizures
Effects of antimuscarinic antiparkinsonian drugs on brightness discrimination performance in rats.
Seizures
Effects of single exposure to chlorphenvinphos, an organophosphate insecticide, on electrical activity (EEG) of the rat brain.
Seizures
Effects of soman poisoning on mitochondrial respiratory enzyme activity in the mouse hippocampus and cerebral cortex.
Seizures
Efficacy of antidotal treatment against sarin poisoning: the superiority of benactyzine and caramiphen.
Seizures
Grand mal seizures after 2-chloroprocaine epidural anesthesia in a patient with plasma cholinesterase deficiency.
Seizures
Ketamine combinations for the field treatment of soman-induced self-sustaining status epilepticus. Review of current data and perspectives.
Seizures
Magnesium sulfate treatment against sarin poisoning: dissociation between overt convulsions and recorded cortical seizure activity.
Seizures
Mapping of cerebral metabolic activation in three models of cholinergic convulsions.
Seizures
Modeling and simulation of organophosphate-induced neurotoxicity: Prediction and validation by experimental studies.
Seizures
Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced seizure activity in the guinea pig.
Seizures
Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment.
Seizures
Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication.
Seizures
Pharmacokinetic studies of intramuscular midazolam in guinea pigs challenged with soman.
Seizures
Pharmacokinetics of Three Oximes in a Guinea Pig Model and Efficacy of Combined Oxime Therapy.
Seizures
Potential of memantine, D-tubocurarine, and atropine in preventing acute toxic myopathy induced by organophosphate nerve agents: soman, sarin, tabun and VX.
Seizures
Prediction of soman-induced cerebral damage by distortion product otoacoustic emissions.
Seizures
Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Göttingen minipigs exposed to sarin vapor.
Seizures
Regulatory effects of acutely repeated nicotine treatment towards central muscarinic receptors.
Seizures
Root extract of Anacyclus pyrethrum ameliorates seizures, seizure-induced oxidative stress and cognitive impairment in experimental animals.
Seizures
SCH 23390 affords protection against soman-evoked seizures in the freely moving guinea-pig: a concomitant neurochemical, electrophysiological and behavioural study.
Seizures
Scopolamine-induced convulsions in food given fasted mice: effects of physostigmine and MK-801.
Seizures
Seizures in an Alzheimer's disease patient as a complication of colonoscopy premedication with meperidine.
Seizures
Strain differences in seizure responses and brain cholinesterase activity in rats.
Seizures
The involvement of the central cholinergic and endorphinergic systems in the nitrous oxide withdrawal syndrome in mice.
Seizures
The possible role of intravenous lipid emulsion in the treatment of chemical warfare agent poisoning.
Seizures
The role of genetic background in susceptibility to chemical warfare nerve agents across rodent and non-human primate models.
Seizures
Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutamatergic properties.
Seizures
Variation in the expression of c-fos after intoxication by soman. Comparative study using in situ hybridization and immunohistochemistry.
Seizures
[Experimental studies on the influence of some anticonvulsive drugs and of metrazol convulsions on the activity of cerebral cholinesterase]
Seizures
[MODIFIED CHOLINESTERASE ACTIVITY OF THE BRAIN IN CONVULSIONS FOLLOWING ANTICONVULSANT THERAPY.]
Sepsis
"Nutritional" markers as prognostic indicators of postoperative sepsis in cancer patients.
Sepsis
A Sustained Reduction in Serum Cholinesterase Enzyme Activity Predicts Patient Outcome following Sepsis.
Sepsis
Association between early serum cholinesterase activity and 30-day mortality in sepsis-3 patients: A retrospective cohort study.
Sepsis
Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway.
Sepsis
Effect of physostigmine on recovery from septic shock following intra-abdominal infection - Results from a randomized, double-blind, placebo-controlled, monocentric pilot trial (Anticholium® per Se).
Sepsis
Effects of a peripheral cholinesterase inhibitor on cytokine production and autonomic nervous activity in a rat model of sepsis.
Sepsis
Effects of reversible inhibition of cholinesterase and nicotine on mouse mortality and blood levels of proinflammatory cytokines during the early phase of sepsis.
Sepsis
Immune and nutritional effects of early enteral nutrition after major abdominal operations.
Sepsis
In Vivo Effects of Neostigmine and Physostigmine on Neutrophil Functions and Evaluation of Acetylcholinesterase and Butyrylcholinesterase as Inflammatory Markers during Experimental Sepsis in Rats.
Sepsis
Modulation of immune functions in polymorphonuclear neutrophils induced by physostigmine, but not neostigmine, independent of cholinergic neurons.
Sepsis
Profile of serum cholinesterase in systemic sepsis syndrome (septic shock) in intensive care unit patients.
Sepsis
Species- and concentration-dependent differences of Acetyl- and Butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Sepsis
The effect of plasmapheresis on plasma cholinesterase levels in a patient with organophosphate poisoning.
Sepsis
[Clinical analysis of patients with community-acquired pneumonia requiring hospitalization classified by age group]
Sepsis
[Decrease in plasmatic cholinesterase activity in severe bacterial infections: comparison with the decrease observed in severe liver cirrhosis]
Shock, Septic
Value of Serum Cholinesterase Activity in the Diagnosis of Septic Shock Due to Bacterial Infections.
Shock, Septic
[Prolonged apnea after suxamethonium administration during staphylococcal toxic shock]
Sick Sinus Syndrome
Sick Sinus Syndrome Observed in a Patient with Cholinesterase Deficiency.
Sjogren's Syndrome
Hydroxychloroquine therapy in patients with primary Sjögren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase.
Skin Abnormalities
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Skin Diseases
[Cholinesterase activity: histaminolytic capacity and the determination of histamine in the skin of healthy subjects and patients with various allergic dermatoses. Relation of histamine to mastocytes.]
Skin Diseases
[Differences in blood cholinesterase activity as a possible differential diagnostic criterion of eczema, atopic dermatosis and allergic eczema-like dermatitis]
Sleep Apnea, Obstructive
Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels.
Sleep Deprivation
Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation.
Sleep Initiation and Maintenance Disorders
Environmental Toxicology and Health Effects Associated with Methyl Parathion Exposure - A Scientific Review.
Sleep Initiation and Maintenance Disorders
Treatment of visual hallucinations with ramelteon in two patients with dementia Lewy bodies.
Sleep Initiation and Maintenance Disorders
[Primary care general internal medicine: relevant information in 2005]
Sleep Wake Disorders
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
Sleep Wake Disorders
New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins.
Sleep Wake Disorders
New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.
Spasm
Break the Spasm with Succinylcholine, but Risk Intraoperative Awareness with Undiagnosed Pseudocholinesterase Deficiency.
Spina Bifida Cystica
Ratio of amniotic fluid acetylcholinesterase to pseudocholinesterase as an antenatal diagnostic test for exomphalos and gastroschisis.
Spina Bifida Cystica
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
Spina Bifida Cystica
Scanning gel densitometry of amniotic fluid acetylcholinesterase and butyrylcholinesterase: quantification of 'faint-positive' bands in fetal malformations.
Spinal Cord Injuries
Effect of distigmine combined with propiverine on bladder activity in rats with spinal cord injury.
Spinal Muscular Atrophies of Childhood
Serum cholinesterase activity in infantile and juvenile spinal muscular atrophy.
Splenic Infarction
Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.
Spondylitis, Ankylosing
Proceedings: Frequency of the atypical gene E1-a of serum cholinesterase among patients with ankylosing spondylitis.
Squamous Cell Carcinoma of Head and Neck
Butyrylcholinesterase: An economical marker of disease activity in oral squamous cell carcinoma before and after therapy.
Squamous Cell Carcinoma of Head and Neck
Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study.
Starvation
Effect of starvation and refeeding on the circadian rhythms of hematological and clinico-biochemical values, and water intake of rats.
Starvation
The effect of starvation on the cholinesterase activity of the liver and serum of young male rats.
Status Epilepticus
Acute administration of diazepam or midazolam minimally alters long-term neuropathological effects in the rat brain following acute intoxication with diisopropylfluorophosphate.
Status Epilepticus
Changes in mouse brain metabolism following a convulsive dose of soman: a proton HRMAS NMR study.
Status Epilepticus
Characterization of status epilepticus induced by two organophosphates in rats.
Status Epilepticus
Ketamine combinations for the field treatment of soman-induced self-sustaining status epilepticus. Review of current data and perspectives.
Status Epilepticus
Modeling and simulation of organophosphate-induced neurotoxicity: Prediction and validation by experimental studies.
Status Epilepticus
Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced seizure activity in the guinea pig.
Status Epilepticus
Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication.
Status Epilepticus
Pharmacological dissociation of the motor and electrical aspects of convulsive status epilepticus induced by the cholinesterase inhibitor soman.
Status Epilepticus
Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats.
Steatorrhea
Secondary impairment of pancreatic function as a cause of severe malabsorption in intestinal giardiasis: a case report.
Stomach Diseases
The Role of Cholinesterase in Differential Diagnosis between Gastric Cancer and Benign Gastric Diseases.
Stomach Diseases
[The behavior of liver cholinesterase in liver, gallbladder and stomach diseases]
Stomach Neoplasms
Cholinesterase is Associated With Prognosis and Response to Chemotherapy in Advanced Gastric Cancer.
Stomach Neoplasms
Goodyschle A, a new butenolide with significant BchE inhibitory activity from Goodyera schlechtendaliana.
Stomach Neoplasms
Prognostic significance of host- and tumor-related factors in patients with gastric cancer.
Stomach Neoplasms
Risk factors for nonalcoholic fatty liver disease after gastrectomy for gastric cancer.
Stomach Neoplasms
The Role of Cholinesterase in Differential Diagnosis between Gastric Cancer and Benign Gastric Diseases.
Stomach Neoplasms
[Modifications of blood cholinesterase activity in peptic ulcer and gastric cancer.]
Stomach Neoplasms
[The effect of anesthesia and surgical trauma on the activity of pseudocholinesterase in the blood of patients with suppurative processes in the lung, cancer of the stomach and esophagus]
Stomach Ulcer
THE CONCENTRATION OF ACETYLCHOLINE AND THE LEVEL CHOLINESTERASE ACTIVITY IN THE SERUM OF PATIENTS WITH GASTRIC ULCER, DUODENAL ULCER AND ALCOHOLIC CHRONIC PANCREATITIS.
Stomach Ulcer
[Changes in acetylcholine concentration and cholinesterase activity in gastric tissues following reproduction of "steroid" stomach ulcers in animals]
Stomach Ulcer
[Prostaglandin E(2) and omeprazole in treating poisoning related acute mucosal lesion]
Stomatitis
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2?years of age - a multicenter retrospective study.
Stomatitis, Aphthous
[Relapsing Aphthous ulcer treated with traditional Chinese medicine and Western medicine therapy and the determination of urinary 17-ketosteroid and serum cholinesterase]
Strabismus
Prolonged apnea caused by inherited cholinesterase deficiency after strabismus surgery.
Strabismus
Sugammadex affects emergence agitation in children undergoing strabismus surgery.
Stroke
Admission serum cholinesterase concentration for prediction of in-hospital mortality in very elderly patients with acute ischemic stroke: a retrospective study.
Stroke
Amyloid-? peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients.
Stroke
Amyloid-beta Peptides in Plasma and Cognitive Decline After 1 Year Follow-Up in Alzheimer's Disease Patients.
Stroke
Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities.
Stroke
Education plays a greater role than age in cognitive test performance among participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Stroke
Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats.
Stroke
Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
Stroke
Increased monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of patients with acute stroke.
Stroke
Pre-Stroke Cholinesterase Inhibitor Treatment Is Beneficially Associated with Functional Outcome in Patients with Acute Ischemic Stroke and Pre-Stroke Dementia: The Fukuoka Stroke Registry.
Stroke
Quantum dot labeling of butyrylcholinesterase maintains substrate and inhibitor interactions and cell adherence features.
Stroke
Serum butyrylcholinesterase activity and phenotype associations with lipid profile in stroke patients.
Stroke
Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality.
Stupor
[Potentiation of the barbital narcosis in mice using cholinmimetic and cholinesterase blockers]
Stupor
[The effect of streptomycin on neuromuscular conductivity in cats treated with several phosphoorganic cholinesterase inhibitors]
Supranuclear Palsy, Progressive
Cholinergic approaches to the treatment of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Donepezil in the treatment of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors.
Supranuclear Palsy, Progressive
Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.
Syncope
ACP Journal Club. Review: cholinesterase inhibitors but not memantine increase syncope in older adults with mild cognitive impairment or dementia.
Syncope
Anticholinesterase-induced symptoms improved by pacemaker implantation in patients with Alzheimer's disease: analysis of 6 cases.
Syncope
Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease.
Syncope
Cholinesterase inhibitors were associated with increased risk for syncope and its consequences in older persons with dementia.
Syncope
Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.
Syncope
National Veterans Health Administration hospitalizations for syncope compared to acute myocardial infarction, fracture, or pneumonia in community-dwelling elders: outpatient medication and comorbidity profiles.
Syncope
Prevalence of positive carotid sinus massage and related risk of syncope in patients with Alzheimer's disease.
Syncope
Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures.
Syncope
Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.
Syncope
Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.
Syringomyelia
[Changes in the blood acetylcholine and cholinesterase indices of syringomyelia patients]
Tachycardia
Clinical signs and biochemical changes in calves caused by injection of ivermectin.
Tachycardia
Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats.
Tachycardia
Neonatal cholinesterase inhibitor poisoning: materno-fetal exchange of pesticide.
Tachycardia
Pyridostigmine enhances atrial tachyarrhythmias in aging spontaneously hypertensive rats.
Tachycardia
The role of enhanced vagal activity on ischemic ventricular tachycardia: pharmacologic basis of inefficiency.
Tachycardia
[Autonomic status and neurohumoral regulation in patients with refractory tachyarrhythmia]
Tardive Dyskinesia
Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
Temporomandibular Joint Disorders
Light therapy modulates serotonin levels and blood flow in women with headache. A preliminary study.
Teratoma
Scanning gel densitometry of amniotic fluid acetylcholinesterase and butyrylcholinesterase: quantification of 'faint-positive' bands in fetal malformations.
Tetanus
The action of tetanus toxin on the acetylcholine and cholinesterase contents of the rabbit's iris.
Tetanus
The effect of tetanus toxin on the choline esterase activity of the muscles of rats.
Tetanus
[Activity and localization of cholinesterase in the spinal cord of rabbits in experimental tetanus]
Tetanus
[Behavior of serum and erythrocyte cholinesterase in experimental tetanus in rabbits]
Tetanus
[Cholinesterase activity of the central nervous system and of muscles in a dynamic study of experimental tetanus poisoning]
Tetanus
[Cholinesterase inhibition in nerve tissue of animals intoxicated with tetanus toxin.]
Tetanus
[Comparison of serum cholinesterase during an industrial organo-phosphorated intoxication and in the course of tetanus (author's transl)]
Tetanus
[Compensatory effect developed by oximes in comparison with cholinesterase inhibited in vitro by tetanus toxin]
Tetanus
[Histochemical study of cholinesterase distribution in the spinal cord and spinal ganglia of rabbits in experimental tetanus intoxication]
Tetanus
[Possible interference between tetanus toxin and organo-phosphorus esters in blocking of cholinesterase]
Tetanus
[Research on a causal therapy of tetanus: combination of antitoxin with cholinesterase restoration in the treatment of clinical tetanus in man]
Tetanus
[Risks in the diagnosis and treatment of tetanus in the exercise of medical practice]
Tetanus
[The cholinesterase activity of motor plates in experimental tetanus toxin-induced tetanus.]
Thrombocytopenia
Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Thrombocytopenia
Do patients with liver cirrhosis undergoing cardiac surgery have acceptable outcomes?
Thrombocytopenia
In vivo gene amplification in non-cancerous cells: cholinesterase genes and oncogenes amplify in thrombocytopenia associated with lupus erythematosus.
Thrombocytopenia
Methicillin-resistant Staphylococcus aureus: colonization and development of infection in patients with haematological disorders.
Thrombocytopenia
Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.
Thrombosis
Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
Thrombosis
Dilute blood clot lysis time and electrophoretic lipoprotein fractions in a population sample of healthy Romanians.
Thrombosis
Prognostic index for survival in patients after treatment for primary hepatocellular carcinoma.
Thymoma
Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis.
Thyroid Diseases
Serum electrophoretic lipoprotein factors and pseudocholinesterase activity in thyroid disease.
Thyroid Neoplasms
Acetylcholinesterase and butyrylcholinesterase activities in human thyroid cancer cells.
Thyroiditis
Definition, at the molecular level, of a thyroglobulin-acetylcholinesterase shared epitope: study of its pathophysiological significance in patients with Graves' ophthalmopathy.
Thyrotoxicosis
[Blood cholinesterase in rats with experimental thyrotoxicosis and hypothyroidism]
Thyrotoxicosis
[Cholinesterase of the heart of rats with experimental thyrotoxicosis and hypothyroidism]
Torsades de Pointes
Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Torsades de Pointes
Electrocardiogram Changes of Donepezil Administration in Elderly Patients with Ischemic Heart Disease.
Toxic Optic Neuropathy
Ocular effects of organophosphates: a historical perspective of Saku disease.
Toxic Optic Neuropathy
Repeated spike exposure to the insecticide chlorpyrifos interferes with the recovery of visual sensitivity in rats.
Toxic Optic Neuropathy
The effects of physostigmine on the electroretinogram in the beagle dog.
Tremor
Comparisons of the acute effects of cholinesterase inhibitors using a neurobehavioral screening battery in rats.
Tremor
Effects of sarin on temperature and activity of rats as a model for gulf war syndrome neuroregulatory functions.
Tremor
Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.
Tremor
Impact of organophosphate exposure on farmers' health in Kulon Progo, Yogyakarta: Perspectives of physical, emotional and social health.
Tremor
Mechanism of the clonidine-induced protection against acetylcholinesterase inhibitor toxicity.
Tremor
Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses.
Tremor
Vitamin K3 (menadione) redox cycling inhibits cytochrome P450-mediated metabolism and inhibits parathion intoxication.
Tremor
[Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease.]
Trichinellosis
Studies on tissue cholinesterase in experimental trichinosis in albino rat. 1. Effect of T. spiralis infection.
Trichinellosis
Studies on tissue cholinesterase in experimental trichinosis in albino rat. 2 effects of treatment with Mintezol and 5-fluorouracil-Endoxan.
Trichinellosis
[Cholinesterase activity amd the mast cell number in rats with experimental trichinosis]
Tricuspid Valve Insufficiency
Prognostic Value of Prothrombin Time International Normalized Ratio in Acute Decompensated Heart Failure?- A Combined Marker of Hepatic Insufficiency and Hemostatic Abnormality.
Trismus
[Risks in the diagnosis and treatment of tetanus in the exercise of medical practice]
Trisomy 18 Syndrome
Determination of cholinesterase and acetylcholinesterase in amniotic fluid. Uses in prenatal diagnosis and quality control.
Tuberculosis
A new test for the presumptive diagnosis of neoplastic disease. Further investigations of cholinesterase in plasma, whole blood and blood cells on cancer of the lung, extrapulmonary tumors and tuberculosis.
Tuberculosis
Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa.
Tuberculosis
Synthesis of readily available fluorophenylalanine derivatives and investigation of their biological activity.
Tuberculosis
[Activity and genetic heterogeneity of the serum cholinesterase of tuberculosis patients]
Tuberculosis
[Activity of cholinesterase and phenyloxidase in blood in experimental tuberculosis of guinea pigs]
Tuberculosis
[Association of mutant alleles of serum cholinesterase with various multi-factorial and infectious diseases]
Tuberculosis
[Autoantibodies, acetylcholine, cholinesterase and fibrinolytic properties of blood in experimental tuberculosis]
Tuberculosis
[Progress in management of severe tuberculosis or tuberculosis with severe complication].
Tuberculosis
[STUDIES ON BLOOD ENZYMES IN TUBERCULOSIS. II. ACTIVITY OF PSEUDOCHOLINESTERASE IN PATIENTS WITH VARIOUS FORMS OF TUBERCULOSIS AND TRANSMINASE (GOT) ACTIVITY IN THE PROTEIN FRACTIONS OF THE BLOOD SERUM.]
Tuberculosis
[STUDIES ON BLOOD ENZYMES IN TUBERCULOSIS. III. PROGNOSTIC VALUE OF THE DETERMINATION OF PSEUDOCHOLINESTERASE ACTIVITY IN TUBERCULOSIS.]
Tuberculosis
[STUDIES ON BLOOD ENZYMES IN TUBERCULOSIS. IV. EFFECT OF TUBERCULIN ON THE ACTIVITY OF PSEUDOCHOLINESTERASE.]
Tuberculosis, Pulmonary
[Hourly variations of blood cholinesterase in pulmonary tuberculosis patients.]
Tuberculosis, Pulmonary
[Research on cholinesterase activity and its significance in pulmonary tuberculosis.]
Tuberculosis, Pulmonary
[Studies on cholinesterase (CEA) activity and its significance in pulmonary tuberculosis; study methods and results.]
Tuberculosis, Pulmonary
[Study of cholinesterase activity in pulmonary tuberculosis and its significance; review of literature.]
Tuberculosis, Pulmonary
[The clinical importance of serum cholinesterase activity in the course of pulmonary tuberculosis.]
Tuberculosis, Renal
[Activity of copper oxidase (ceruloplasmin), cholinesterase and 1-phosphomonoesterase of blood serum in renal tuberculosis]
Typhoid Fever
[Activity of serum cholinesterase and catalase in patients with typhoid and dysentery]
Typhoid Fever
[Physiopathology of Salmonella infections. IV. Regeneration of blood cholinesterase in children during active typhoid fever and during convalescence.]
Typhoid Fever
[The activity of serum cholinesterase and catalase as an index of the course of abdominal typhus]
Unconsciousness
Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.
Unconsciousness
Effect of physostigmine on the loss of consciousness induced by midazolam, etomidate and althesin.
Unconsciousness
Microinjection of propofol into the perifornical area induces sedation with decreasing cortical acetylcholine release in rats.
Urinary Bladder Neck Obstruction
Underactive bladder: A review of the current treatment concepts.
Urinary Bladder Neoplasms
Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer.
Urinary Bladder Neoplasms
Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
Urinary Bladder, Neurogenic
Relationship between serum cholinesterase level and urinary bladder activity in patients with or without overactive bladder and/or neurogenic bladder.
Urinary Bladder, Neurogenic
[Acute respiratory failure associated with cholinergic crisis: report of five cases and review of the literature].
Urinary Bladder, Overactive
Relationship between serum cholinesterase level and urinary bladder activity in patients with or without overactive bladder and/or neurogenic bladder.
Urinary Bladder, Underactive
Distigmine Bromide Produces Sustained Potentiation of Guinea-Pig Urinary Bladder Motility by Inhibiting Cholinesterase Activity.
Urinary Bladder, Underactive
Effects of ?1 antagonist and cholinesterase inhibitor on cystometric parameters in lumbar canal stenosis rats with underactive bladder.
Urinary Bladder, Underactive
Effects of Distigmine on Electrical Field Stimulation-Induced Contraction of Mouse Urinary Bladder Smooth Muscles.
Urinary Bladder, Underactive
The Long-Lasting Enhancing Effect of Distigmine on Acetylcholine-Induced Contraction of Guinea Pig Detrusor Smooth Muscle Correlates with Its Anticholinesterase Activity.
Urinary Incontinence
A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.
Urinary Incontinence
Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.
Urinary Incontinence
Etiology and predictors of urinary incontinence and its effect on quality of life.
Urinary Incontinence
Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia.
Urinary Incontinence
Treatment with rivastigmine or galantamine and risk of urinary incontinence: results from a Dutch database study.
Urinary Incontinence, Urge
Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia.
Urinary Incontinence, Urge
Urinary dysfunction and autonomic control in amyloid neuropathy.
Uterine Cervical Neoplasms
Muscarinic cholinergic signaling in cervical cancer cells affects cell motility via ERK1/2 signaling.
Uterine Cervical Neoplasms
Plasma cholinesterase activity in patients with uterine cervical cancer during radiotherapy.
Uterine Cervical Neoplasms
Prognostic and diagnostic value of serum pseudocholinesterase, serum aspartate transaminase, and serum alinine transaminase in malignancies treated by radiotherapy.
Uterine Cervical Neoplasms
Significance of serum butyrylcholinesterase levels in oral cancer.
Uterine Cervical Neoplasms
The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.
Uterine Inertia
[Iron, copper and cholinesterase in blood of women during labor in uterine inertia]
Uterine Neoplasms
Significance of serum tumor markers in patients with carcinoma of the ovary.
Uterine Neoplasms
[Uterine cancer and enzymatic activity of the blood. II. Specific and aspecific cholinesterase.]
Varicose Veins
A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease.
Vascular Diseases
A versatile equation to describe reversible enzyme inhibition and activation kinetics: modeling beta-galactosidase and butyrylcholinesterase.
Vascular Diseases
Cholinesterase activity in serum during general anesthesia in patients with or without vascular disease.
Vascular Diseases
Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease.
Vascular Diseases
[Blood cholinesterase activity and the content of free catecholamines in the urine in obliterating vascular diseases]
Vasculitis
A patient with Churg-Strauss syndrome who underwent endoscopic sinus surgery under general anesthesia -A case report-.
Virus Diseases
Japanese Encephalitis Virus Infection Results in Transient Dysfunction of Memory Learning and Cholinesterase Inhibition.
Virus Diseases
[Cholinesterase activity in the blood and liver of mice with mouse hepatitis virus infection]
Vitiligo
Butyrylcholinesterase is present in the human epidermis and is regulated by H(2)O(2): More evidence for oxidative stress in vitiligo.
Vitiligo
Genetic and biochemical evidence implicates the butyrylcholinesterase gene BCHE in vitiligo pathogenesis.
html completed